<SEC-DOCUMENT>0001104659-23-067945.txt : 20230605
<SEC-HEADER>0001104659-23-067945.hdr.sgml : 20230605
<ACCEPTANCE-DATETIME>20230605121912
ACCESSION NUMBER:		0001104659-23-067945
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		19
CONFORMED PERIOD OF REPORT:	20230601
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Unregistered Sales of Equity Securities
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20230605
DATE AS OF CHANGE:		20230605

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			T Stamp Inc
		CENTRAL INDEX KEY:			0001718939
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-PREPACKAGED SOFTWARE [7372]
		IRS NUMBER:				813777260
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-41252
		FILM NUMBER:		23991690

	BUSINESS ADDRESS:	
		STREET 1:		3423 PIEDMONT ROAD
		CITY:			ATLANTA
		STATE:			GA
		ZIP:			30305
		BUSINESS PHONE:		678-325-7835

	MAIL ADDRESS:	
		STREET 1:		3017 BOLLING WAY NE, FLOORS 1 AND 2
		CITY:			ATLANTA
		STATE:			GA
		ZIP:			30305
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>tm2317786d1_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:us-roles="http://fasb.org/us-roles/2021-01-31" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:IDAI="http://truststamp.ai/20230601">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02A_US%2DGAAP%2D2021 -->
<!-- Field: Set; Name: xdx; ID: xdx_035_IDAI_truststamp.ai_20230601 -->
<!-- Field: Set; Name: xdx; ID: xdx_04F_20230601_20230601 -->
<!-- Field: Set; Name: xdx; ID: xdx_056_edei%2D%2DEntityCentralIndexKey_0001718939 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2023-06-01to2023-06-01" name="dei:EntityCentralIndexKey">0001718939</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2023-06-01to2023-06-01" name="dei:AmendmentFlag">false</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="idai-20230601.xsd" xlink:type="simple" />
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2023-06-01to2023-06-01">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001718939</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-06-01</xbrli:startDate>
        <xbrli:endDate>2023-06-01</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 18pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>

<!-- Field: Rule-Page --><div style="text-align: center; margin-top: 12pt; margin-bottom: 3pt; width: 100%"><div style="border-top: Black 2pt solid; border-bottom: Black 1pt solid; text-align: center; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 18pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>UNITED STATES</b></p>

<p style="font: 18pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>SECURITIES AND EXCHANGE COMMISSION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Washington, D.C. 20549</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 18pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>FORM&#160;<span id="xdx_901_edei--DocumentType_c20230601__20230601_z1mmoTWXYqZ1"><ix:nonNumeric contextRef="From2023-06-01to2023-06-01" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>CURRENT REPORT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>PURSUANT TO SECTION&#160;13 OR 15(d)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>OF THE SECURITIES EXCHANGE ACT OF 1934</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">Date of report (Date of earliest event reported):<b> <span id="xdx_903_edei--DocumentPeriodEndDate_c20230601__20230601_zDC5G5xv0hDl"><ix:nonNumeric contextRef="From2023-06-01to2023-06-01" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate">June 1, 2023</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 24pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><span id="xdx_907_edei--EntityRegistrantName_c20230601__20230601_zElmA44yiCs2"><ix:nonNumeric contextRef="From2023-06-01to2023-06-01" name="dei:EntityRegistrantName">T STAMP INC.</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(Exact name of registrant
as specified in its charter)</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="vertical-align: top; font-size: 10pt; text-align: center; width: 32%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_900_edei--EntityIncorporationStateCountryCode_c20230601__20230601_zGqVzJHbzrA8"><ix:nonNumeric contextRef="From2023-06-01to2023-06-01" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></b></span></td>
    <td style="text-align: center; vertical-align: bottom; font-size: 10pt; width: 2%">&#160;</td>
    <td style="vertical-align: top; font-size: 10pt; text-align: center; width: 32%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90F_edei--EntityFileNumber_c20230601__20230601_zw7hSGy3B2b1"><ix:nonNumeric contextRef="From2023-06-01to2023-06-01" name="dei:EntityFileNumber">001-41252</ix:nonNumeric></span></b></span></td>
    <td style="text-align: center; vertical-align: bottom; font-size: 10pt; width: 2%">&#160;</td>
    <td style="vertical-align: top; font-size: 10pt; text-align: center; width: 32%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_909_edei--EntityTaxIdentificationNumber_c20230601__20230601_zimAhQP3mOL4"><ix:nonNumeric contextRef="From2023-06-01to2023-06-01" name="dei:EntityTaxIdentificationNumber">81-3777260</ix:nonNumeric></span></b></span></td></tr>
  <tr>
    <td style="text-align: center; vertical-align: top">(State or other jurisdiction<br />
    of incorporation)</td>
    <td style="text-align: center; vertical-align: bottom; font-size: 10pt"><b>&#160;</b></td>
    <td style="text-align: center; vertical-align: top">(Commission<br />
    File Number)</td>
    <td style="text-align: center; vertical-align: bottom; font-size: 10pt"><b>&#160;</b></td>
    <td style="text-align: center; vertical-align: top">(I.R.S. Employer<br />
    Identification Number)</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><span id="xdx_906_edei--EntityAddressAddressLine1_c20230601__20230601_zg2WXa53tjd6"><ix:nonNumeric contextRef="From2023-06-01to2023-06-01" name="dei:EntityAddressAddressLine1">3017 Bolling Way NE</ix:nonNumeric></span>, <span id="xdx_907_edei--EntityAddressAddressLine2_c20230601__20230601_ze0KoNcRVTle"><ix:nonNumeric contextRef="From2023-06-01to2023-06-01" name="dei:EntityAddressAddressLine2">Floors 1 and 2</ix:nonNumeric></span>, <span id="xdx_904_edei--EntityAddressCityOrTown_c20230601__20230601_zDYCDmL89o9h"><ix:nonNumeric contextRef="From2023-06-01to2023-06-01" name="dei:EntityAddressCityOrTown">Atlanta</ix:nonNumeric></span>, <span id="xdx_90B_edei--EntityAddressStateOrProvince_c20230601__20230601_zhHtKvSLLc82"><ix:nonNumeric contextRef="From2023-06-01to2023-06-01" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince">Georgia</ix:nonNumeric></span> <span id="xdx_905_edei--EntityAddressPostalZipCode_c20230601__20230601_zntiSL8AL8Je"><ix:nonNumeric contextRef="From2023-06-01to2023-06-01" name="dei:EntityAddressPostalZipCode">30305</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(Address of principal
executive offices, including zip code)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">Registrant&#8217;s telephone number, including area code: <b>(<span id="xdx_90E_edei--CityAreaCode_c20230601__20230601_zHNSdW9Zll1h"><ix:nonNumeric contextRef="From2023-06-01to2023-06-01" name="dei:CityAreaCode">404</ix:nonNumeric></span>) <span id="xdx_907_edei--LocalPhoneNumber_c20230601__20230601_ze2vGMG6dmCg"><ix:nonNumeric contextRef="From2023-06-01to2023-06-01" name="dei:LocalPhoneNumber">806-9906</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Not Applicable</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(Former name or former
address, if changed since last report)</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Check the appropriate box below if the Form&#160;8-K&#160;filing is
intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 33px; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Wingdings"><span id="xdx_900_edei--WrittenCommunications_c20230601__20230601_zTDjj1Jf9Hfd"><ix:nonNumeric contextRef="From2023-06-01to2023-06-01" format="ixt:booleanfalse" name="dei:WrittenCommunications">&#168;</ix:nonNumeric></span></span></span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 33px; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Wingdings"><span id="xdx_90D_edei--SolicitingMaterial_c20230601__20230601_zvH4HV6I3hb7"><ix:nonNumeric contextRef="From2023-06-01to2023-06-01" format="ixt:booleanfalse" name="dei:SolicitingMaterial">&#168;</ix:nonNumeric></span></span></span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soliciting material pursuant to Rule&#160;14a-12&#160;under the Exchange Act (17 CFR&#160;240.14a-12)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 33px; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Wingdings"><span id="xdx_90A_edei--PreCommencementTenderOffer_c20230601__20230601_zDoaJ31iF0e8"><ix:nonNumeric contextRef="From2023-06-01to2023-06-01" format="ixt:booleanfalse" name="dei:PreCommencementTenderOffer">&#168;</ix:nonNumeric></span></span></span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement&#160;communications pursuant to Rule&#160;14d-2(b)&#160;under the Exchange Act (17 CFR&#160;240.14d-2(b))</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 33px; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Wingdings"><span id="xdx_904_edei--PreCommencementIssuerTenderOffer_c20230601__20230601_zuc4vg0rQMQ7"><ix:nonNumeric contextRef="From2023-06-01to2023-06-01" format="ixt:booleanfalse" name="dei:PreCommencementIssuerTenderOffer">&#168;</ix:nonNumeric></span></span></span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement&#160;communications pursuant to Rule&#160;13e-4(c)&#160;under the Exchange Act (17 CFR&#160;240.13e-4(c))</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Securities registered pursuant to Section&#160;12(b) of the Act:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; white-space: nowrap; padding-bottom: 1pt; font-size: 10pt; text-align: center; width: 38%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Title of each class</b></span></td>
    <td style="text-align: center; font-size: 10pt; width: 2%">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: center; width: 20%"><b>Trading<br />
Symbol(s)</b></td>
    <td style="text-align: center; font-size: 10pt; width: 2%">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: center; width: 38%"><b>Name of each exchange<br />
on
which&#160;registered</b></td></tr>
  <tr>
    <td style="vertical-align: top; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_901_edei--Security12bTitle_c20230601__20230601_zy2QXPYxwCQ9"><ix:nonNumeric contextRef="From2023-06-01to2023-06-01" name="dei:Security12bTitle">Class&#160;A Common Stock, par value $0.01 per share</ix:nonNumeric></span></b></span></td>
    <td style="text-align: center; vertical-align: bottom; font-size: 10pt">&#160;</td>
    <td style="vertical-align: top; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_905_edei--TradingSymbol_c20230601__20230601_zPT2nzg0h96j"><ix:nonNumeric contextRef="From2023-06-01to2023-06-01" name="dei:TradingSymbol">IDAI</ix:nonNumeric></span></b></span></td>
    <td style="text-align: center; vertical-align: bottom; font-size: 10pt">&#160;</td>
    <td style="vertical-align: top; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90C_edei--SecurityExchangeName_c20230601__20230601_zwv8UF9Rxk86"><ix:nonNumeric contextRef="From2023-06-01to2023-06-01" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">The Nasdaq Stock Market</ix:nonNumeric></span></b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule&#160;12b-2&#160;of the Securities
Exchange Act of 1934&#160;(&#167;240.12b-2&#160;of this chapter).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Emerging growth company&#160;<span style="font-family: Wingdings"><span id="xdx_903_edei--EntityEmergingGrowthCompany_c20230601__20230601_z5WPMZJiDhdi"><ix:nonNumeric contextRef="From2023-06-01to2023-06-01" format="ixt:booleantrue" name="dei:EntityEmergingGrowthCompany">&#120;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If an emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant
to Section&#160;13(a) of the Exchange Act.&#160;<span style="font-family: Wingdings"><span id="xdx_902_edei--EntityExTransitionPeriod_c20230601__20230601_z305BDNcVnR4"><ix:nonNumeric contextRef="From2023-06-01to2023-06-01" format="ixt:booleanfalse" name="dei:EntityExTransitionPeriod">&#168;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<!-- Field: Rule-Page --><div style="margin-top: 3pt; margin-bottom: 12pt; width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 2pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>



<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.75in"><b>Item 1.01</b></td>
    <td style="text-align: justify"><b>Entry into a Material Definitive Agreement.</b></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.75in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i>Securities
Purchase Agreement</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">On June&#160;1, 2023,
T Stamp Inc., a Delaware corporation (the &#8220;<b><i>Company</i></b>&#8221;), entered into a securities purchase agreement (the &#8220;<b><i>SPA</i></b>&#8221;)
with a certain institutional investor, pursuant to which the Company agreed to issue and sell to the investor (i)&#160;in a registered
direct offering, 736,400 shares (the &#8220;<b><i>Shares</i></b>&#8221;) of Class&#160;A Common Stock, par value $0.01 per share of the
Company (the &#8220;<b><i>Class&#160;A Common Stock</i></b>&#8221;) at a price of $2.30 per share, and pre-funded warrants (the &#8220;<b><i>Pre-Funded
Warrants</i></b>&#8221;) to purchase up to 543,300 shares of Class&#160;A Common Stock at $2.299 per share, at an exercise price
of $0.001 per share of Class&#160;A Common Stock, and (ii)&#160;in a concurrent private placement, common stock purchase warrants (the
 &#8220;<b><i>Private Placement Warrants</i></b>&#8221;), exercisable for an aggregate of up to 1,279,700 shares of Class&#160;A Common
Stock, at an exercise price of $2.30 per share of Class&#160;A Common Stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The securities to be
issued in the registered direct offering were offered pursuant to the Company&#8217;s shelf registration statement on Form&#160;S-3 (File
333-271091) (the &#8220;<b><i>Shelf Registration Statement</i></b>&#8221;), initially filed by the Company with the Securities and Exchange
Commission (the &#8220;<b><i>SEC</i></b>&#8221;) under the Securities Act of 1933, as amended (the &#8220;<b><i>Securities Act</i></b>&#8221;),
on April&#160;3, 2023 and declared effective on April&#160;12, 2023. The Pre-Funded Warrants are exercisable upon issuance and will remain
exercisable until all of the Pre-Funded Warrants are exercised in full.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The Private Placement
Warrants (and the shares of Class&#160;A Common Stock issuable upon the exercise of the Private Placement Warrants) were not registered
under the Securities Act, and were offered pursuant to an exemption from the registration requirements of the Securities Act provided
u<span style="background-color: white">nder Section&#160;4(a)(2)&#160;of the Securities Act and/or Rule&#160;506 of Regulation D promulgated
under the Securities Act</span>. The Private Placement Warrants are immediately exercisable upon issuance, will expire five years from
the date of issuance, and in certain circumstances may be exercised on a cashless basis. I<span style="background-color: white">f we fail
for any reason to deliver shares of Class&#160;A Common Stock upon the valid exercise of the Pre-Funded Warrants or Private Placement
Warrants, subject to our receipt of a valid exercise notice and the aggregate exercise price, by the time period set forth in the Pre-Funded
Warrants or Private Placement Warrants, we are required to pay the applicable holder, in cash, as liquidated damages as set forth in the
Pre-Funded Warrants and Private Placement Warrants. The Pre-Funded Warrants and Private Placement Warrants also include customary buy-in
rights in the event we fail to deliver shares of common stock upon exercise thereof within the time periods set forth in the Pre-Funded
Warrants and Private Placement Warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="background-color: white">Under
the terms of the Pre-Funded Warrants and Private Placement Warrants, a holder will not be entitled to exercise any portion of any such
warrant, if, upon giving effect to such exercise, the aggregate number of shares of common stock beneficially owned by the holder (together
with its affiliates, any other persons acting as a group together with the holder or any of the holder&#8217;s affiliates, and any other
persons whose beneficial ownership of common stock would or could be aggregated with the holder&#8217;s for purposes of Section&#160;13(d)&#160;or
Section&#160;16 of the Securities Exchange Act of 1934, as amended) would exceed, for the Pre-Funded Warrants, 9.99%; and, for the Private
Placement Warrants, 4.99% of the number of shares of common stock outstanding immediately after giving effect to the exercise, as such
percentage ownership is determined in accordance with the terms of such warrant, which percentage may be increased at the holder&#8217;s
election upon 61 days&#8217; notice to the Company subject to the terms of such warrants, provided that such percentage may in no event
exceed 9.99%.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">On June&#160;5, 2023,
the Company closed the registered direct offering and the private placement offering (collectively, the &#8220;<b><i>Offering&#8221;</i></b><i>)</i>,
raising gross proceeds of $2,942,766.70 before deducting placement agent fees and other offering expenses payable by the Company. In the
event that all Private Placement Warrants are exercised for cash, the Company will receive additional gross proceeds of approximately
$2,942,766.70. The Company may use the net proceeds from the Offering for working capital, capital expenditures, and other general corporate
purposes.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Pursuant to the terms
of the SPA, the Company is required within 45 days of June&#160;1, 2023 to file a registration statement on Form&#160;S-1 or other appropriate
form if the Company is not then S-1 eligible registering the resale of the shares of Class&#160;A Common Stock issued and issuable upon
the exercise of the Private Placement Warrants. The Company is required to use commercially reasonable efforts to cause such registration
to become effective within 181 days of the closing date of the Offering, and to keep the registration statement effective at all times
until no investor owns any Private Placement Warrants or shares issuable upon exercise thereof.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Pursuant
to the terms of the SPA, from June&#160;5, 2023 until 75 days thereafter, subject to certain exceptions, we may not issue, enter into
any agreement to issue or announce the issuance or proposed issuance of any shares of common stock or common stock equivalents, or file
any registration statement or any amendment or supplement thereto, other than a prospectus supplement for the Shelf Registration Statement.
In addition, until December&#160;5, 2023, we are prohibited from effecting or entering into an agreement to effect any issuance of common
stock or common stock equivalents involving a variable rate transaction (as defined in the SPA).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0; background-color: white"><i>Placement
Agency Agreement</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify">Also in connection with the Offering, on June&#160;1,
2023, the Company entered into a placement agency agreement (the &#8220;<b><i>Placement Agency Agreement</i></b>&#8221;) with Maxim Group
LLC (the &#8220;<b><i>Placement Agent</i></b>&#8221;). Pursuant to the terms of the Placement Agency Agreement, the Placement Agent agreed
to use its reasonable best efforts to arrange for the sale of the Shares, Pre-Funded Warrants, and Private Placement Warrants. The Company
will pay the Placement Agent a cash fee equal to 7.0% of the gross proceeds generated from such sales and will reimburse the Placement
Agent for certain of its expenses in an aggregate amount up to $50,000.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The Placement Agency
Agreement contains customary representations, warranties and agreements by the Company, customary conditions to closing, indemnification
obligations of the Company and the Placement Agent, including for liabilities under the Securities Act, other obligations of the parties,
and termination provisions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">In addition, pursuant
to certain &#8220;lock-up&#8221; agreements (each, a &#8220;<b><i>Lock-Up Agreement</i></b>&#8221;) that were required to be entered into
as a condition to the closing of the SPA, our officers and directors have agreed, for a period of 60 days from June&#160;1, 2023, not
to engage in any of the following, whether directly or indirectly, without the consent of the purchaser under the SPA: offer to sell,
sell, contract to sell pledge, grant, lend, or otherwise transfer or dispose of our common stock or any securities convertible into or
exercisable or exchangeable for Class&#160;A Common Stock (the &#8220;<b><i>Lock-Up Securities</i></b>&#8221;); enter into any swap or
other arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership of the Lock-Up Securities;
make any demand for or exercise any right or cause to be filed a registration statement, including any amendments thereto, with respect
to the registration of any Lock-Up Securities; enter into any transaction, swap, hedge, or other arrangement relating to any Lock-Up Securities
subject to customary exceptions; or publicly disclose the intention to do any of the foregoing.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The foregoing does not
purport to be a complete description of each of the Placement Agency Agreement, the Pre-Funded Warrants, the Private Placement Warrants
and the SPA and is qualified in its entirety by reference to the full text of each of such document, which are filed as Exhibits 1.1,
4.1, 4.2, 4.3 and 10.1, respectively, to the Prior Report and incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">CrowdCheck Law, LLP,
securities counsel to the Company, delivered an opinion as to the validity of the Shares, Pre-Funded Warrants and shares of Class&#160;A
Common Stock issuable upon exercise of the Pre-Funded Warrants, a copy of which is filed as Exhibit&#160;5.1 to the Prior Report and is
incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i>Warrant Amendment</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In connection with the Offering, the Company also
entered into a warrant amendment agreement (the &#8220;Warrant Amendment Agreement&#8221;) with the same investor. Under the Warrant Amendment
Agreement, the Company agreed to amend its existing warrants to purchase up to an aggregate of 390,000 shares of the Company's Class&#160;A
Common Stock (collectively, the &#8220;Existing Warrants&#8221;) that were previously issued to the investor in September&#160;2022, such
that, effective upon the closing of the Offering, the amended Existing Warrants will have an exercise price of $2.30 per share and a termination
date of June&#160;5, 2028.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The foregoing summary of the Warrant Amendment is not complete, and
is qualified by reference to a copy of the Warrant Amendment filed as Exhibit&#160;10.2 to this Current Report on Form&#160;8-K.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.75in"><b>Item 3.02.</b></td>
    <td style="text-align: justify"><b>Unregistered Sale of Equity Securities.</b></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The applicable information
set forth in Item 1.01 of this Current Report on Form&#160;8-K (this &#8220;<b><i>Form&#160;8-K</i></b>&#8221;) with respect to the issuance
of Private Placement Warrants is incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i>Cautionary Statement
Regarding Forward-Looking Statements</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">This Form&#160;8-K contains
forward-looking statements within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995.
Forward-looking statements include, but are not limited to, statements that express the Company&#8217;s intentions, beliefs, expectations,
strategies, predictions or any other statements related to the Company&#8217;s future activities, or future events or conditions, which
can be identified by terminology such as &#8220;may,&#8221; &#8220;will,&#8221; &#8220;expects,&#8221; &#8220;anticipates,&#8221; &#8220;aims,&#8221;
 &#8220;potential,&#8221; &#8220;future,&#8221; &#8220;intends,&#8221; &#8220;plans,&#8221; &#8220;believes,&#8221; &#8220;estimates,&#8221;
 &#8220;continue,&#8221; &#8220;likely to&#8221; and other similar expressions intended to identify forward-looking statements, although
not all forward-looking statements contain these identifying words. These statements are not historical facts and are based on current
expectations, estimates and projections about the Company&#8217;s business based, in part, on assumptions made by its management, including,
without limitation, the intended use of proceeds upon consummation of the Offering. These statements are not guarantees of future performance
and involve risks, uncertainties and assumptions that are difficult to predict, many of which are beyond the Company&#8217;s control,
including, among other things, the Company&#8217;s ability to maintain its listing of Class&#160;A Common Stock on the Nasdaq Capital
Market, and those risks that may be included in the periodic reports and other filings that the Company files from time to time with the
SEC, which may cause the Company&#8217;s actual results, performance and achievements to differ materially from those contained in any
forward-looking statement. Any forward-looking statements speak only as of the date on which they are made, and the Company undertakes
no obligation to update any forward-looking statement to reflect events or circumstances after the date of this Form&#160;8-K, except
as required by applicable law.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 3 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white">
  <tr style="vertical-align: top">
    <td style="width: 0.75in"><b>Item 9.01.</b></td>
    <td style="text-align: justify"><b>Financial Statements and Exhibits.</b></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">(d)&#160;Exhibits</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; width: 8%"><b>Exhibit&#160;No.</b></td>
    <td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; width: 90%"><b>Description</b></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify"><a href="tm2317786d1_ex1-1.htm"><span style="font-size: 10pt">1.1</span></a></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="tm2317786d1_ex1-1.htm"><span style="font-size: 10pt">Placement Agency Agreement by and between the Company and the Placement Agent entered into on </span>June&#160;1<span style="font-size: 10pt">, 2023</span>.</a></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify"><a href="tm2317786d1_ex4-1.htm"><span style="font-size: 10pt">4.1</span></a></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="tm2317786d1_ex4-1.htm"><span style="font-size: 10pt">Form&#160;of Pre-Funded Warrant</span>.</a></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify"><a href="tm2317786d1_ex4-2.htm"><span style="font-size: 10pt">4.2</span></a></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="tm2317786d1_ex4-2.htm"><span style="font-size: 10pt">Form&#160;of Private Placement Warrant</span>.</a></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify"><a href="tm2317786d1_ex5-1.htm"><span style="font-size: 10pt">5.1</span></a></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="tm2317786d1_ex5-1.htm"><span style="font-size: 10pt">Opinion of CrowdCheck Law LLP</span>.</a></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify"><a href="tm2317786d1_ex10-1.htm"><span style="font-size: 10pt">10.1+</span></a></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="tm2317786d1_ex10-1.htm"><span style="font-size: 10pt">Form&#160;of Securities Purchase Agreement by and between the Company and a certain institutional investor dated </span>June&#160;1<span style="font-size: 10pt">, 2023</span>.</a></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify"><a href="tm2317786d1_ex10-2.htm">10.2</a></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="tm2317786d1_ex10-2.htm">Warrant Amendment by and between the Company and a certain institutional investor dated June&#160;1, 2023.</a></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify"><a href="tm2317786d1_ex5-1.htm"><span style="font-size: 10pt">23.1</span></a></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="tm2317786d1_ex5-1.htm"><span style="font-size: 10pt">Opinion of CrowdCheck Law LLP (contained in Exhibit&#160;5.1 above)</span>.</a></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">104</td>
    <td>&#160;</td>
    <td style="text-align: justify">Cover Page&#160;Interactive Data File (embedded within the Inline XBRL document).</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 4%">+</td>
    <td style="text-align: justify; width: 96%">Pursuant to Item 601(a)(5)&#160;of Regulation S-K, schedules have been omitted and will be furnished on a supplemental basis to the Securities and Exchange Commission upon request.</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SIGNATURE</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</td>
    <td colspan="2"><b>T STAMP INC.</b></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td colspan="2">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="width: 50%">&#160;</td>
    <td style="width: 5%"><i>By:</i></td>
    <td style="border-bottom: black 1pt solid; width: 45%"><i>/s/ Gareth Genner</i></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>Name: </td>
    <td>Gareth Genner</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>Title: </td>
    <td>Chief Executive Officer</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dated: June&#160;5, 2023</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 5; Options: Last -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

</body>
</html>
<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjU0KwjAQhU/QOwxZF02Dbrq0aBGrSCniNtipBNtMmcSfHslbGlvEYWAY3vveEyIWOW1MiwznVVlAhV3fao9QYoOM9oLBkW13KYRb4tU4z9r68f2BGQUGA7OcJeoShNH6MA7rFORinqi5UiBVKiUc9yL66hnZxtRovdEtaFvDkalng17zMCVU+kWWumGsOiE7QzaFZCYn+Q1KJgoO9NBP4puDoshEFI8TiZzp3n9r7s5TB+sWu9DlJvS/0QcReUk+ -->
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.1
<SEQUENCE>2
<FILENAME>tm2317786d1_ex1-1.htm
<DESCRIPTION>EXHIBIT 1.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>Exhibit 1.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PLACEMENT AGENCY AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0.5in">June&nbsp;1, 2023</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Mr.&nbsp;Gareth Genner</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Chief Executive Officer</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">T Stamp Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="background-color: white">3017 Bolling Way NE, Floors
1 and 2</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="background-color: white">Atlanta,&nbsp;GA&nbsp;30305</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Dear Mr.&nbsp;Genner:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This agreement (the &ldquo;<U>Agreement</U>&rdquo;)
constitutes the agreement between Maxim Group LLC (&ldquo;<U>Maxim</U>&rdquo; or the &ldquo;<U>Placement Agent</U>&rdquo;) and T Stamp
Inc., a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;), that Maxim shall serve as the exclusive placement agent for the Company,
on a &ldquo;commercially reasonable efforts&rdquo; basis, in connection with the proposed placement (the &ldquo;<U>Placement</U>&rdquo;)
of (i)&nbsp;registered shares (the &ldquo;<U>Shares</U>&rdquo;) of the Company&rsquo;s common stock, par value $0.01 (the &ldquo;<U>Common
Stock</U>&rdquo;), (ii)&nbsp;registered pre-funded warrants to purchase shares of Common Stock (the &ldquo;<U>Pre-Funded Warrants</U>&rdquo;)
and (iii)&nbsp;warrants to purchase shares Common Stock (the &ldquo;<U>Purchase Warrants</U>&rdquo;, collectively with the Pre-Funded
Warrants, the &ldquo;<U>Warrants</U>,&rdquo; and the shares issuable upon exercise of the Warrants, the &ldquo;<U>Warrant Shares</U>&rdquo;
and the Shares, Warrants and Warrant Shares, collectively, the &ldquo;<U>Securities</U>&rdquo;). The terms of the Placement shall be mutually
agreed upon by the Company, Maxim and the purchasers of the Securities (each, a &ldquo;<U>Purchaser</U>&rdquo; and collectively, the &ldquo;<U>Purchasers</U>&rdquo;)
and nothing herein constitutes that Maxim would have the power or authority to bind the Company or any Purchaser or an obligation for
the Company to issue any Securities or complete the Placement. This Agreement and the documents executed and delivered by the Company
and the Purchasers in connection with the Placement, including the Purchase Agreement and the Warrants (as hereinafter defined) shall
be collectively referred to herein as the &ldquo;<U>Transaction Documents</U>.&rdquo; The date of the closing of the Placement shall be
referred to herein as a &ldquo;<U>Closing Date</U>.&rdquo; The Company expressly acknowledges and agrees that Maxim&rsquo;s obligations
hereunder are on a commercially reasonable efforts basis only and that the execution of this Agreement does not constitute a legal or
binding commitment by Maxim to purchase the Securities or introduce the Company to investors and does not ensure the successful placement
of the Securities or any portion thereof or the success of Maxim with respect to securing any other financing on behalf of the Company.
The Placement Agent may retain other brokers or dealers to act as sub-agents or selected-dealers on its behalf in connection with the
Placement. The sale of the Securities to any Purchaser will be evidenced by a securities purchase agreement (the &ldquo;<U>Purchase Agreement</U>&rdquo;)
between the Company and such Purchaser in a form reasonably acceptable to the Company and Maxim. Capitalized terms that are not otherwise
defined herein have the meanings given to such terms in the Purchase Agreement. Prior to the signing of the Purchase Agreement, officers
of the Company will be available to answer inquiries from prospective Purchasers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>SECTION&nbsp;1.</U></FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>REPRESENTATIONS
AND WARRANTIES OF THE COMPANY; COVENANTS OF THE COMPANY</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Representations
of the Company</U>. Each of the representations and warranties (together with any related disclosure schedules thereto) and covenants
made by the Company to the Purchasers in the Purchase Agreement in connection with the Placement is hereby incorporated herein by reference
into this Agreement (as though fully restated herein) and is, as of the date of this Agreement and as of the Closing Date, hereby made
to, and in favor of, the Placement Agent. In addition to the foregoing, the Company represents and warrants that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Company has prepared and filed with the U.S. Securities and Exchange Commission (the &ldquo;<B>Commission</B>&rdquo;) a registration statement
on Form&nbsp;S-3 (Registration No.&nbsp;333-</FONT> 271091), and amendments thereto, and related preliminary prospectuses, for the registration
under the Securities Act of 1933, as amended (the &ldquo;<B>Securities Act</B>&rdquo;), of the Securities (other than the Purchase Warrants
which shall be issued in accordance with an exemption from the registration requirements of the Securities Act), which registration statement,
as so amended (including post-effective amendments, if any) became effective on April&nbsp;12, 2023. At the time of such filing, the Company
met the requirements of Form&nbsp;S-3 under the Securities Act. Such registration statement meets the requirements set forth in Rule&nbsp;415(a)(1)(x)&nbsp;under
the Securities Act and complies with said Rule. The Company will file with the Commission pursuant to Rule&nbsp;424(b)&nbsp;under the
Securities Act, and the rules&nbsp;and regulations (the &ldquo;<B>Rules&nbsp;and Regulations</B>&rdquo;) of the Commission promulgated
thereunder, a supplement to the form of prospectus included in such registration statement relating to the placement of the Securities
and the plan of distribution thereof and has advised the Placement Agent of all further information (financial and other) with respect
to the Company required to be set forth therein. Such registration statement, including the exhibits thereto, as amended at the date of
this Agreement, is hereinafter called the &ldquo;<B>Registration Statement</B>&rdquo;; such prospectus in the form in which it appears
in the Registration Statement is hereinafter called the &ldquo;<B>Base Prospectus</B>&rdquo;; and the supplemented form of prospectus,
in the form in which it will be filed with the Commission pursuant to Rule&nbsp;424(b)&nbsp;(including the Base Prospectus as so supplemented)
is hereinafter called the &ldquo;<B>Prospectus Supplement</B>.&rdquo; Any reference in this Agreement to the Registration Statement, the
Base Prospectus or the Prospectus Supplement shall be deemed to refer to and include the documents incorporated by reference therein (the
 &ldquo;<B>Incorporated Documents</B>&rdquo;) pursuant to Item 12 of Form&nbsp;S-3 which were filed under the Securities Exchange Act of
1934, as amended (the &ldquo;<B>Exchange Act</B>&rdquo;), on or before the date of this Agreement, or the issue date of the Base Prospectus
or the Prospectus Supplement, as the case may be; and any reference in this Agreement to the terms &ldquo;amend,&rdquo; &ldquo;amendment&rdquo;
or &ldquo;supplement&rdquo; with respect to the Registration Statement, the Base Prospectus or the Prospectus Supplement shall be deemed
to refer to and include the filing of any document under the Exchange Act after the date of this Agreement, or the issue date of the Base
Prospectus or the Prospectus Supplement, as the case may be, deemed to be incorporated therein by reference. All references in this Agreement
to financial statements and schedules and other information which is &ldquo;contained,&rdquo; &ldquo;included,&rdquo; &ldquo;described,&rdquo;
 &ldquo;referenced,&rdquo; &ldquo;set forth&rdquo; or &ldquo;stated&rdquo; in the Registration Statement, the Base Prospectus or the Prospectus
Supplement (and all other references of like import) shall be deemed to mean and include all such financial statements and schedules and
other information which is or is deemed to be incorporated by reference in the Registration Statement, the Base Prospectus or the Prospectus
Supplement, as the case may be. No stop order suspending the effectiveness of the Registration Statement or the use of the Base Prospectus
or the Prospectus Supplement has been issued, and no proceeding for any such purpose is pending or has been initiated or, to the Company's
knowledge, is threatened by the Commission. For purposes of this Agreement, &ldquo;<B>free writing prospectus</B>&rdquo; has the meaning
set forth in Rule&nbsp;405 under the Securities Act and the &ldquo;<B>Time of Sale Prospectus</B>&rdquo; means the preliminary prospectus,
if any, together with the free writing prospectuses, if any, used in connection with the Placement, including any documents incorporated
by reference therein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">2.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Registration Statement (and any further documents to be filed with the Commission) contains all exhibits and schedules as required by
the Securities Act. Each of the Registration Statement and any post-effective amendment thereto, at the time it became effective, complied
in all material respects with the Securities Act and the Exchange Act and the applicable Rules&nbsp;and Regulations and did not and, as
amended or supplemented, if applicable, will not, contain any untrue statement of a material fact or omit to state a material fact required
to be stated therein or necessary to make the statements therein not misleading. The Base Prospectus, the Time of Sale Prospectus and
the Prospectus Supplement, each as of its respective date, comply in all material respects with the Securities Act and the Exchange Act
and the applicable Rules&nbsp;and Regulations. Each of the Base Prospectus, the Time of Sale Prospectus and the Prospectus Supplement,
as amended or supplemented, did not and will not contain as of the date thereof any untrue statement of a material fact or omit to state
a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading.
The Incorporated Documents, when they were filed with the Commission, conformed in all material respects to the requirements of the Exchange
Act and the applicable Rules&nbsp;and Regulations, and none of such documents, when they were filed with the Commission, contained any
untrue statement of a material fact or omitted to state a material fact necessary to make the statements therein (with respect to Incorporated
Documents incorporated by reference in the Base Prospectus or Prospectus Supplement), in the light of the circumstances under which they
were made not misleading; and any further documents so filed and incorporated by reference in the Base Prospectus, the Time of Sale Prospectus
or Prospectus Supplement, when such documents are filed with the Commission, will conform in all material respects to the requirements
of the Exchange Act and the applicable Rules&nbsp;and Regulations, as applicable, and will not contain any untrue statement of a material
fact or omit to state a material fact necessary to make the statements therein, in the light of the circumstances under which they were
made, not misleading. No post-effective amendment to the Registration Statement reflecting any facts or events arising after the date
thereof which represent, individually or in the aggregate, a fundamental change in the information set forth therein is required to be
filed with the Commission. There are no documents required to be filed with the Commission in connection with the transaction contemplated
hereby that (x)&nbsp;have not been filed as required pursuant to the Securities Act or (y)&nbsp;will not be filed within the requisite
time period. There are no contracts or other documents required to be described in the Base Prospectus, the Time of Sale Prospectus or
Prospectus Supplement, or to be filed as exhibits or schedules to the Registration Statement, which (x)&nbsp;have not been described or
filed as required or (y)&nbsp;will not be filed within the requisite time period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">3.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Company is eligible to use free writing prospectuses in connection with the Placement pursuant to Rules&nbsp;164 and 433 under the Securities
Act. Any free writing prospectus that the Company is required to file pursuant to Rule&nbsp;433(d)&nbsp;under the Securities Act has been,
or will be, filed with the Commission in accordance with the requirements of the Securities Act and the applicable rules&nbsp;and regulations
of the Commission thereunder. Each free writing prospectus that the Company has filed, or is required to file, pursuant to Rule&nbsp;433(d)&nbsp;under
the Securities Act or that was prepared by or behalf of or used by the Company complies or will comply in all material respects with the
requirements of the Securities Act and the applicable rules&nbsp;and regulations of the Commission thereunder. The Company will not, without
the prior consent of the Placement Agent, prepare, use or refer to, any free writing prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">4.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Assuming
the accuracy of the Purchasers&rsquo; representations and warranties set forth in the Purchase Agreement, no registration under the Securities
Act is required for the offer and sale of the Purchase Warrants or the shares issuable upon exercise of the Purchase Warrants by the Company
to the Purchasers as contemplated thereby.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>There
are no affiliations with any FINRA member firm among the Company's officers, directors or, to the knowledge of the Company, any ten percent
(10.0%) or greater stockholder of the Company, except as set forth in the Registration Statement and the other documents the Company has
filed or furnished with the Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Covenants
of the Company</U>. </FONT>The Company has delivered, or will as promptly as practicable deliver, to the Placement Agent materially complete
conformed copies of the Registration Statement and of each consent and certificate of experts, as applicable, filed as a part thereof,
and conformed copies of the Registration Statement (without exhibits), the Base Prospectus, the Time of Sale Prospectus and the Prospectus
Supplement, as amended or supplemented, in such quantities and at such places as the Placement Agent reasonably requests. Neither the
Company nor any of its directors and officers has distributed and none of them will distribute, prior to the Closing Date, any offering
material in connection with the offering and sale of the Securities pursuant to the Placement other than the Base Prospectus, the Time
of Sale Prospectus, the Prospectus Supplement, the Registration Statement, copies of the documents incorporated by reference therein and
any other materials permitted by the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>SECTION&nbsp;2</U></FONT>.
 &#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>REPRESENTATIONS OF THE PLACEMENT AGENT</U>. The Placement Agent represents and warrants that it (i)&nbsp;is
a member in good standing of FINRA, (ii)&nbsp;is registered as a broker/dealer under the Exchange Act, (iii)&nbsp;is licensed as a broker/dealer
under the laws of the states applicable to the offers and sales of the Securities by such Placement Agent, (iv)&nbsp;is and will be a
body corporate validly existing under the laws of its place of incorporation, and (v)&nbsp;has full power and authority to enter into
and perform its obligations under this Agreement. The Placement Agent will immediately notify the Company in writing of any change in
its status as such. The Placement Agent covenants that it will use its reasonable best efforts to conduct the Placement hereunder in
compliance with the provisions of this Agreement and the requirements of applicable law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>SECTION&nbsp;3</U></FONT>.
 &#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>COMPENSATION</U>. In consideration of the services to be provided for hereunder, the Company
shall pay to the Placement Agent or their respective designees their pro rata portion (based on the Securities placed) of the following
compensation with respect to the Securities which they are placing:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>A
cash fee (the &ldquo;<B>Cash Fee</B>&rdquo;) equal to an aggregate of seven percent (7.0%) of the aggregate gross proceeds raised in the
Placement. The Cash Fee shall be paid at the closing of the Placement (the &ldquo;<B>Closing</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>Subject
to compliance with FINRA Rule&nbsp;5110(f)(2)(D), the Company also agrees, in case of Closing of the Placement, to reimburse the Placement
Agent for all travel and other out-of-pocket expenses incurred, including the reasonable fees, costs and disbursements of its legal counsel,
in an amount not to exceed an aggregate of $50,000 (inclusive of any advances received by the Placement Agent from the Company). The Company
will reimburse Placement Agent directly upon the Closing of the Placement from the gross proceeds raised in the Placement. In the event
that this Agreement shall terminate prior to the consummation of the Placement, Maxim shall nevertheless still be entitled to reimbursement
for its actual expenses; provided, however, that such expenses shall not exceed $10,000, in the aggregate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">C.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Placement Agent reserves the right to reduce any item of its compensation or adjust the terms thereof as specified herein in the event
that a determination shall be made by FINRA to the effect that such Placement Agent&rsquo;s aggregate compensation is in excess of FINRA
rules&nbsp;or that the terms thereof require adjustment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>SECTION&nbsp;4</U></FONT>.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>INDEMNIFICATION</U>.
The Company agrees to the indemnification and other agreements set forth in the Indemnification Provisions (the &ldquo;<B>Indemnification</B>&rdquo;)
attached hereto as <U>Addendum A</U>, the provisions of which are incorporated herein by reference and shall survive the termination or
expiration of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>SECTION&nbsp;5</U></FONT>.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>ENGAGEMENT
TERM</U>. The Placement Agent&rsquo;s engagement hereunder shall be until the final closing date of the Placement (the period of time
during which this Agreement remains in effect is referred to herein as the &ldquo;<B>Term</B>&rdquo;). Notwithstanding anything to the
contrary contained herein, the provisions concerning confidentiality and indemnification and contribution contained herein and the Company&rsquo;s
obligations contained in the Indemnification Provisions will survive any expiration or termination of this Agreement. The Placement Agent
agrees not to use any confidential information concerning the Company provided to the Placement Agent by the Company for any purposes
other than those contemplated under this Agreement. In addition, if the Company completes any financing of equity, equity-linked, convertible
or debt or other capital raising activity with, or receives any proceeds from, any of the investors who were contacted or introduced to
the Company by the Placement Agent during the Term (the &ldquo;<B>PA Investors</B>&rdquo;) within twelve (12) months after the Closing
or termination of this Agreement (other than for &ldquo;Cause&rdquo; as defined in the Engagement Agreement), then the Company will pay
to the Placement Agent upon the closing of such financing as a financing participation right the compensation set forth in Section&nbsp;3(A)&nbsp;above
with respect to the funds received by the Company from the PA Investors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>SECTION&nbsp;6</U></FONT>.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>PLACEMENT
AGENT INFORMATION</U>. The Company agrees that any information or advice rendered by the Placement Agent in connection with this engagement
is for the confidential use of the Company only in their evaluation of the Placement and, except as otherwise required by law, the Company
will not disclose or otherwise refer to the advice or information in any manner without the Placement Agent&rsquo;s prior written consent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>SECTION&nbsp;7</U></FONT>.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>NO
FIDUCIARY RELATIONSHIP</U>. This Agreement does not create, and shall not be construed as creating rights enforceable by any person or
entity not a party hereto, except those entitled hereto by virtue of the Indemnification Provisions hereof. The Company acknowledges and
agrees that the Placement Agent is not and shall not be construed as a fiduciary of the Company and shall have no duties or liabilities
to the equity holders or the creditors of the Company or any other person by virtue of this Agreement or the retention of such Placement
Agent hereunder, all of which are hereby expressly waived.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>SECTION&nbsp;8</U></FONT>.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>CLOSING</U>.
The obligations of the Placement Agent, and the closing of the sale of the Securities hereunder are subject to the accuracy, when made
and on the Closing Date, of the representations and warranties on the part of the Company and its subsidiaries contained herein and in
the Purchase Agreement, to the accuracy of the statements of the Company and its subsidiaries made in any certificates pursuant to the
provisions hereof, to the performance by the Company and its subsidiaries of their obligations hereunder, and to each of the following
additional terms and conditions, except as otherwise disclosed to and acknowledged and waived by the Placement Agent to the Company:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">A.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;No
stop order suspending the effectiveness of the Registration Statement shall have been issued and no proceedings for that purpose shall
have been initiated or threatened by the Commission, and any request for additional information on the part of the Commission (to be included
in the Registration Statement, the Base Prospectus, the Prospectus Supplement or otherwise) shall have been complied with to the reasonable
satisfaction of the Placement Agent. Any filings required to be made by the Company in connection with the Placement shall have been timely
filed with the Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">B.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Placement Agent shall not have discovered and disclosed to the Company on or prior to the Closing Date that the Registration Statement,
the Base Prospectus, the Prospectus Supplement or any amendment or supplement thereto contains an untrue statement of a fact which, in
the reasonable opinion of counsel for the Placement Agent, is material or omits to state any fact which, in the reasonable opinion of
such counsel, is material and is required to be stated therein or is necessary to make the statements therein not misleading.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">C.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;All
corporate proceedings and other legal matters incident to the authorization, form, execution, delivery and validity of each of this Agreement,
the Securities, the Registration Statement, the Base Prospectus and the Prospectus Supplement and all other legal matters relating to
this Agreement and the transactions contemplated hereby shall be reasonably satisfactory in all material respects to counsel for the Placement
Agent, and the Company shall have furnished to such counsel all documents and information that they may reasonably request to enable them
to pass upon such matters.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">D.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Placement Agent shall have received from outside counsel to the Company such counsel&rsquo;s written opinions, addressed to the Placement
Agent and the Purchasers and dated as of the Closing Date, in form and substance reasonably satisfactory to the Placement Agent, the Purchasers,
and Placement Agent&rsquo;s legal counsel.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">E.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;On
the Closing Date, the Placement Agent shall have received a &ldquo;comfort&rdquo; letter from Cherry Bekaert, LLP and Marcum, LLP, or
such other independent registered public accounting firm of the Company as of such date, addressed to each of the Placement Agent and
in the form and substance satisfactory in all respects to the Placement Agent and Placement Agent&rsquo;s legal counsel.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;On
the Closing Date, Placement Agent shall have received a certificate of the chief executive officer of the Company, dated, as applicable,
as of the date of such Closing, to the effect that, as of the date of this Agreement and as of the applicable date, the representations
and warranties of the Company contained herein and in the Purchase Agreement were and are accurate in all material respects, except for
such changes as are contemplated by this Agreement and except as to representations and warranties that were expressly limited to a state
of facts existing at a time prior to the applicable Closing Date, and that, as of the applicable date, the obligations to be performed
by the Company hereunder on or prior thereto have been fully performed in all material respects. If necessary, on the Closing Date, the
Placement Agent shall have received a certificate of the chief financial officer of the Company, dated, as applicable, as of the date
of such Closing, providing a customary certification as to such accounting or financial matters that are included or incorporated by reference
in the Registration Statement or the Prospectus Supplement that Marcum</FONT> or Cherry Bekaert is unable to provide assurances on in
the letter contemplated by Section&nbsp;8(E)&nbsp;above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">G.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;On
the Closing Date, Placement Agent shall have received a certificate of the Secretary of the Company, dated, as applicable, as of the date
of such Closing, certifying to the organizational documents, good standing in the state of incorporation of the Company and board resolutions
relating to the Placement of the Securities from the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">H.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Neither
the Company nor any of its subsidiaries (i)&nbsp;shall have sustained since the date of the latest audited financial statements included
or incorporated by reference in the Registration Statement, the Base Prospectus and the Prospectus Supplement, any loss or interference
with its business from fire, explosion, flood, terrorist act or other calamity, whether or not covered by insurance, or from any labor
dispute or court or governmental action, order or decree, otherwise than as set forth in or contemplated by the Registration Statement,
the Base Prospectus and the Prospectus Supplement, (ii)&nbsp;since such date there shall not have been any change in the capital stock
or long-term debt of the Company or any of its subsidiaries or any change, or any development involving a prospective change, in or affecting
the business, general affairs, management, financial position, stockholders' equity, results of operations or prospects of the Company
and its subsidiaries, otherwise than as set forth in or contemplated by the Registration Statement, the Base Prospectus and the Prospectus
Supplement, and (iii)&nbsp;since such date there shall not have been any new or renewed inquiries by the Commission, FINRA or any other
regulatory body regarding the Company, the effect of which, in any such case described in clause (i), (ii)&nbsp;or (iii), is, in the judgment
of the Placement Agent, so material and adverse as to make it impracticable or inadvisable to proceed with the sale or delivery of the
Securities on the terms and in the manner contemplated by the Base Prospectus, Time of Sale Prospectus and Prospectus Supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">I.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Common Stock is registered under the Exchange Act and, as of the Closing Date, the Shares and the shares of Common Stock underlying the
Purchase Warrants and the Pre-Funded Warrants shall be listed and admitted and authorized for trading on the Trading Market or other applicable
U.S. national exchange, or an application for such listing shall have been submitted to the Trading Market, and satisfactory evidence
of such action shall have been provided to the Placement Agent. The Company shall have taken no action designed to, or likely to have
the effect of terminating the registration of the Common Stock under the Exchange Act or delisting or suspending from trading the Common
Stock from the Trading Market or other applicable U.S. national exchange, nor, except as disclosed in the Base Prospectus and Prospectus
Supplement, has the Company received any information suggesting that the Commission or the Trading Market or other U.S. applicable national
exchange is contemplating terminating such registration or listing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">J.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;No
action shall have been taken and no statute, rule, regulation or order shall have been enacted, adopted or issued by any governmental
agency or body which would, as of the Closing Date, prevent the issuance or sale of the Securities or materially and adversely affect
or potentially and adversely affect the business or operations of the Company; and no injunction, restraining order or order of any other
nature by any federal or state court of competent jurisdiction shall have been issued as of the Closing Date which would prevent the issuance
or sale of the Securities or materially and adversely affect or potentially and adversely affect the business or operations of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">K.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Company shall have prepared and filed with the Commission a Form&nbsp;8-K with respect to the Placement, including as an exhibit thereto
this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">L.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Company shall have entered into a Purchase Agreement with each of the Purchasers and such agreements shall be in full force and effect
and shall contain representations, warranties and covenants of the Company as agreed between the Company and the Purchasers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">M.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;FINRA
shall have raised no objection to the fairness and reasonableness of the terms and arrangements of this Agreement. In addition, the Company
shall, if requested by the Placement Agent, make or authorize Placement Agent&rsquo;s counsel to make on the Company&rsquo;s behalf, any
filing with the FINRA Corporate Financing Department pursuant to FINRA Rule&nbsp;5110 with respect to the Placement and pay all filing
fees required in connection therewith.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">N.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Prior
to the Closing Date, the Company shall have furnished to the Placement Agent such further information, certificates and documents as the
Placement Agent may reasonably request.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If any of the conditions specified
in this Section&nbsp;8 shall not have been fulfilled when and as required by this Agreement, or if any of the certificates, opinions,
written statements or letters furnished to the Placement Agent or to Placement Agent&rsquo;s counsel pursuant to this Section&nbsp;8 shall
not be reasonably satisfactory in form and substance to the Placement Agent and to Placement Agent&rsquo;s legal counsel, all obligations
of the Placement Agent hereunder may be cancelled by the Placement Agent at, or at any time prior to, the consummation of the Closing.
Notice of such cancellation shall be given to the Company in writing or orally. Any such oral notice shall be confirmed promptly thereafter
in writing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>SECTION&nbsp;9</U></FONT>.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="text-transform: uppercase"><U>Reserved.</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>SECTION&nbsp;10</U></FONT>.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>GOVERNING
LAW</U>. This Agreement will be governed by, and construed in accordance with, the laws of the State of New York applicable to agreements
made and to be performed entirely in such State, without regard to the conflicts of laws principles thereof. This Agreement may not be
assigned by either party without the prior written consent of the other party. This Agreement shall be binding upon and inure to the
benefit of the parties hereto, and their respective successors and permitted assigns. Any right to trial by jury with respect to any
dispute arising under this Agreement or any transaction or conduct in connection herewith is waived. Any dispute arising under this Agreement
may be brought into the courts of the State of New York or into the federal court located in New York, New York and, by execution and
delivery of this Agreement, the Company hereby accepts for itself and in respect of its property, generally and unconditionally, the
jurisdiction of aforesaid courts. Each party hereto hereby irrevocably waives personal service of process and consents to process being
served in any such suit, action or proceeding by delivering a copy thereof via overnight delivery (with evidence of delivery) to such
party at the address in effect for notices to it under this Agreement and agrees that such service shall constitute good and sufficient
service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any
manner permitted by law. The Company agrees that a final judgment in any such action, proceeding or counterclaim brought in any such
court shall be conclusive and binding upon the Company and may be enforced in any other courts to the jurisdiction of which the Company
is or may be subject, by suit upon such judgment. If either party shall commence an action or proceeding to enforce any provisions of
a Transaction Document, then the prevailing party in such action or proceeding shall be reimbursed by the other party for its attorney's
fees and other costs and expenses incurred with the investigation, preparation and prosecution of such action or proceeding. This paragraph
shall survive any termination of this Agreement, in whole or in part.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>SECTION&nbsp;11</U></FONT>.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>ENTIRE
AGREEMENT/MISC</U>. This Agreement (including the attached Indemnification Provisions) embodies the entire agreement and understanding
between the parties hereto, and supersedes all prior agreements and understandings, relating to the subject matter hereof. If any provision
of this Agreement is determined to be invalid or unenforceable in any respect, such determination will not affect such provision in any
other respect or any other provision of this Agreement, which will remain in full force and effect. This Agreement may not be amended
or otherwise modified or waived except by an instrument in writing signed by both Placement Agent and the Company. The representations,
warranties, agreements and covenants contained herein shall survive the closing of the Placement and delivery of the Securities. This
Agreement may be executed in two or more counterparts, all of which when taken together shall be considered one and the same agreement
and shall become effective when counterparts have been signed by each party and delivered to the other party, it being understood that
both parties need not sign the same counterpart. In the event that any signature is delivered by facsimile transmission or a .pdf format
file, such signature shall create a valid and binding obligation of the party executing (or on whose behalf such signature is executed)
with the same force and effect as if such facsimile or .pdf signature page&nbsp;were an original thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>SECTION&nbsp;12</U></FONT>.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>CONFIDENTIALITY</U>.
The Placement Agent (i)&nbsp;will keep the Confidential Information (as such term is defined below) confidential and will not (except
as required by applicable law or stock exchange requirement, regulation or legal process (&ldquo;<B>Legal Requirement</B>&rdquo;), without
the Company&rsquo;s prior written consent, disclose to any person any Confidential Information, and (ii)&nbsp;will not use any Confidential
Information other than in connection with the Placement. The Placement Agent further agrees, severally and not jointly, to disclose the
Confidential Information only to its Representatives (as such term is defined below) who need to know the Confidential Information for
the purpose of the Placement, and who are informed by the Placement Agent of the confidential nature of the Confidential Information.
The term &ldquo;<B>Confidential Information</B>&rdquo; shall mean, all confidential, proprietary and non-public information (whether written,
oral or electronic communications) furnished by the Company to a Placement Agent or its Representatives in connection with such Placement
Agent&rsquo;s evaluation of the Placement. The term &ldquo;<B>Confidential Information</B>&rdquo; will not, however, include information
which (i)&nbsp;is or becomes publicly available other than as a result of a disclosure by a Placement Agent or its Representatives in
violation of this Agreement, (ii)&nbsp;is or becomes available to a Placement Agent or any of its Representatives on a non-confidential
basis from a third-party, (iii)&nbsp;is known to a Placement Agent or any of its Representatives prior to disclosure by the Company or
any of its Representatives, or (iv)&nbsp;is or has been independently developed by a Placement Agent and/or the Representatives without
use of any Confidential Information furnished to it by the Company. The term &ldquo;Representatives&rdquo; shall mean the Placement Agent&rsquo;s
directors, board committees, officers, employees, financial advisors, attorneys and accountants. This provision shall be in full force
until the earlier of (a)&nbsp;the date that the Confidential Information ceases to be confidential and (b)&nbsp;two (2)&nbsp;years from
the date hereof. Notwithstanding any of the foregoing, in the event that the Placement Agent or any of their respective Representatives
are required by Legal Requirement to disclose any of the Confidential Information, such Placement Agent and their respective Representatives
will furnish only that portion of the Confidential Information which such Placement Agent or their respective Representative, as applicable,
is required to disclose by Legal Requirement as advised by counsel, and will use reasonable efforts to obtain reliable assurance that
confidential treatment will be accorded the Confidential Information so disclosed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>SECTION&nbsp;13</U></FONT>.<I>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</I><U>NOTICES</U>.
Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall be in writing and shall
be deemed given and effective on the earliest of (a)&nbsp;the date of transmission, if such notice or communication is sent to the email
address specified on the signature pages&nbsp;attached hereto prior to 6:30 p.m.&nbsp;(New York City time) on a business day, (b)&nbsp;the
next business day after the date of transmission, if such notice or communication is sent to the email address on the signature pages&nbsp;attached
hereto on a day that is not a business day or later than 6:30 p.m.&nbsp;(New York City time) on any business day, (c)&nbsp;the third
business day following the date of mailing, if sent by U.S. internationally recognized air courier service, or (d)&nbsp;upon actual receipt
by the party to whom such notice is required to be given. The address for such notices and communications shall be as set forth on the
signature pages&nbsp;hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>SECTION&nbsp;14</U></FONT>.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="text-transform: uppercase"><U>Press
Announcements</U></FONT>. The Company agrees that the Placement Agent shall, from and after any Closing, have the right to reference the
Placement and the Placement Agent&rsquo;s role in connection therewith in the Placement Agent&rsquo;s marketing materials and on its website
and to place advertisements in financial and other newspapers and journals, in each case at its own expense.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[<I>The remainder of this page&nbsp;has been intentionally
left blank.</I>]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Please confirm that the foregoing
correctly sets forth our agreement by signing and returning to Maxim the enclosed copy of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD></TD><TD COLSPAN="2" STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Very truly yours,</FONT></TD>
</TR><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 50%">&nbsp;</TD><TD STYLE="text-align: left; width: 3%">&nbsp;</TD><TD STYLE="text-align: justify; width: 47%">&nbsp;</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD>&nbsp;</TD><TD COLSPAN="2" STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>Maxim GROUP LLC</B></FONT></TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD>&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD>&nbsp;</TD><TD STYLE="text-align: left"> By:</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: justify">&nbsp; <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
Cliff Teller</I></FONT></TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD>&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name: Cliff Teller</FONT></TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD>&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:
Co-President</FONT></TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD>&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD>&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Address
for notice</U></FONT>:</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD>&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: justify">300 Park Avenue</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD>&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: justify">New York, NY 10022</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD>&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: justify">Attention: James Siegel, General Counsel</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD>&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: justify">Email:</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD>Accepted and Agreed to as of</TD><TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD>the date first written above:</TD><TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
     </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 94%; margin-left: 0.5in">
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-transform: uppercase"><FONT STYLE="font-size: 10pt">T
    STAMP Inc.</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: italic 10pt Times New Roman, Times, Serif; width: 47%"><FONT STYLE="font-size: 10pt">&nbsp; /s/ Gareth Genner</FONT></TD>
    <TD STYLE="width: 50%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Name: Gareth Genner</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Title:&#8239;&#8239;Chief Executive
    Officer &nbsp; &nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><U>Address for notice:</U></FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">T Stamp Inc.</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">3017 Bolling Way NE, Floors 1 and
    2</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Atlanta,&nbsp;GA&nbsp;30305</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Attn: Gareth Genner</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Email:</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[<I>Signature Page&nbsp;to May&nbsp;2023 Placement
Agency Agreement Between</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Maxim
Group LLC and T Stamp Inc.</I></FONT>]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ADDENDUM A</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>INDEMNIFICATION PROVISIONS</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In connection with the engagement
of Maxim Group LLC (the &ldquo;Placement Agent&rdquo;) by T Stamp Inc. (the &ldquo;Company&rdquo;) pursuant to a placement agency agreement
dated as of the date hereof, between the Company and the Placement Agent, as it may be amended from time to time in writing (the &ldquo;Agreement&rdquo;),
the Company hereby agrees as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;To
the extent permitted by law, the Company will indemnify the Placement Agent and its affiliates, directors, officers, employees and controlling
persons (within the meaning of Section&nbsp;15 of the Securities Act of 1933, as amended, or Section&nbsp;20 of the Securities Exchange
Act of 1934, as amended) against all losses, claims, damages, expenses and liabilities, as the same are incurred (including the reasonable
fees and expenses of counsel), relating to or arising out of its activities hereunder or pursuant to the Agreement, except, with regard
to the Placement Agent, to the extent that any losses, claims, damages, expenses or liabilities (or actions in respect thereof) are found
in a final judgment (not subject to appeal) by a court of law to have resulted primarily and directly from the Placement Agent&rsquo;s
willful misconduct or gross negligence in performing the services described herein, as the case may be.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Promptly
after receipt by the Placement Agent of notice of any claim or the commencement of any action or proceeding with respect to which the
Placement Agent is entitled to indemnity hereunder, the Placement Agent will notify the Company in writing of such claim or of the commencement
of such action or proceeding, and the Company will assume the defense of such action or proceeding and will employ counsel reasonably
satisfactory to the Placement Agent and will pay the fees and expenses of such counsel. Notwithstanding the preceding sentence, the Placement
Agent will be entitled to employ counsel separate from counsel for the Company and from any other party in such action if counsel for
the Placement Agent reasonably determines that it would be inappropriate under the applicable rules&nbsp;of professional responsibility
for the same counsel to represent both the Company and the Placement Agent. In such event, the reasonable fees and disbursements of no
more than one such separate counsel will be paid by the Company. The Company will have the exclusive right to settle the claim or proceeding
provided that the Company will not settle any such claim, action or proceeding without the prior written consent of the Placement Agent,
which will not be unreasonably withheld.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Company agrees to notify the Placement Agent promptly of the assertion against it or any other person of any claim or the commencement
of any action or proceeding relating to a transaction contemplated by the Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;If
for any reason the foregoing indemnity is unavailable to the Placement Agent or insufficient to hold the Placement Agent harmless, then
the Company shall contribute to the amount paid or payable by the Placement Agent, as the case may be, as a result of such losses, claims,
damages or liabilities in such proportion as is appropriate to reflect not only the relative benefits received by the Company on the one
hand, and the Placement Agent on the other, but also the relative fault of the Company on the one hand and the Placement Agent on the
other that resulted in such losses, claims, damages or liabilities, as well as any relevant equitable considerations. The amounts paid
or payable by a party in respect of losses, claims, damages and liabilities referred to above shall be deemed to include any legal or
other fees and expenses incurred in defending any litigation, proceeding or other action or claim. Notwithstanding the provisions hereof,
the Placement Agent&rsquo;s share of the liability hereunder shall not be in excess of the amount of fees actually received, or to be
received, by the Placement Agent under the Agreement (excluding any amounts received as reimbursement of expenses incurred by the Placement
Agent).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 11; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;These
Indemnification Provisions shall remain in full force and effect whether or not the transaction contemplated by the Agreement is completed
and shall survive the termination of the Agreement, and shall be in addition to any liability that the Company might otherwise have to
any indemnified party under the Agreement or otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[<I>The remainder of this page&nbsp;has been intentionally
left blank.</I>]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD></TD><TD COLSPAN="2" STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Very truly yours,</FONT></TD>
</TR><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 50%">&nbsp;</TD><TD STYLE="text-align: left; width: 3%">&nbsp;</TD><TD STYLE="text-align: justify; width: 47%">&nbsp;</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD>&nbsp;</TD><TD COLSPAN="2" STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>Maxim GROUP LLC</B></FONT></TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD>&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD>&nbsp;</TD><TD STYLE="text-align: left"> By:</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: justify">&nbsp; <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
Cliff Teller</I></FONT></TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD>&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name: Cliff Teller</FONT></TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD>&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:
Co-President</FONT></TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD>&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD>&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Address
for notice</U></FONT>:</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD>&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: justify">300 Park Avenue</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD>&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: justify">New York, NY 10022</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD>&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: justify">Attention: James Siegel, General Counsel</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD>&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: justify">Email:</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD>Accepted and Agreed to as of</TD><TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD>the date first written above:</TD><TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
     </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 94%; margin-left: 0.5in">
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-transform: uppercase"><FONT STYLE="font-size: 10pt">T
    STAMP Inc.</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: italic 10pt Times New Roman, Times, Serif; width: 47%"><FONT STYLE="font-size: 10pt">&nbsp; /s/ Gareth Genner</FONT></TD>
    <TD STYLE="width: 50%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Name: Gareth Genner</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Title:&#8239;&#8239;Chief Executive
    Officer &nbsp; &nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><U>Address for notice:</U></FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">T Stamp Inc.</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">3017 Bolling Way NE, Floors 1 and
    2</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Atlanta,&nbsp;GA&nbsp;30305</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Attn: Gareth Genner</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Email:</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[<I>Signature Page&nbsp;to Indemnification Provisions</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>Pursuant to May&nbsp;2023 Placement Agency
Agreement</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>between
Maxim Group LLC and T Stamp</I></FONT><I> <FONT STYLE="background-color: white">Inc.]</FONT></I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 13; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.1
<SEQUENCE>3
<FILENAME>tm2317786d1_ex4-1.htm
<DESCRIPTION>EXHIBIT 4.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: left; margin-top: 0; margin-bottom: 0"></P>

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Exhibit 4.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin: 0pt 0"><B>&#8239;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>PRE-FUNDED COMMON STOCK
PURCHASE WARRANT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="text-transform: uppercase"><B>T
Stamp,&#8239;Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant Shares: _______</FONT></TD>
  <TD STYLE="width: 50%">Initial Exercise Date: June&#8239;1, 2023</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">THIS COMMON STOCK PURCHASE
WARRANT (the &ldquo;<U>Warrant</U>&rdquo;) certifies that, for value received, Armistice Capital Master Fund Ltd. or its assigns (the
 &ldquo;<U>Holder</U>&rdquo;) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set
forth, at any time on or after the date hereof (the &ldquo;<U>Initial Exercise Date</U>&rdquo;) and until this Warrant is exercised in
full (the &ldquo;<U>Termination Date</U>&rdquo;) but not thereafter, to subscribe for and purchase from T STAMP,&#8239;INC., a Delaware
corporation (the &ldquo;<U>Company</U>&rdquo;), up to _______ shares (as subject to adjustment hereunder, the &ldquo;<U>Warrant Shares</U>&rdquo;)
of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined
in Section&#8239;2(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section&#8239;1</U></FONT><FONT STYLE="font-size: 10pt">.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Definitions</U>.
Capitalized terms used and not otherwise defined herein shall have the meanings set forth in that certain Securities Purchase Agreement
(the &ldquo;<U>Purchase Agreement</U>&rdquo;), dated June&#8239;1, 2023, among the Company and the purchasers signatory thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section&#8239;2</U></FONT><FONT STYLE="font-size: 10pt">.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Exercise</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Exercise
of Warrant</U>. Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time or times on
or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company of a duly executed PDF copy submitted
by e-mail (or e-mail attachment) of the Notice of Exercise in the form annexed hereto (the &ldquo;<U>Notice of Exercise</U>&rdquo;).
Within the earlier of (i)&#8239;two (2)&#8239;Trading Days and (ii)&#8239;the number of Trading Days comprising the Standard Settlement
Period (as defined in Section&#8239;2(d)(i)&#8239;herein) following the date of exercise as aforesaid, the Holder shall deliver the aggregate
Exercise Price for the shares specified in the applicable Notice of Exercise by wire transfer or cashier&rsquo;s check drawn on a United
States bank unless the cashless exercise procedure specified in Section&#8239;2(c)&#8239;below is specified in the applicable Notice
of Exercise. No ink-original Notice of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization)
of any Notice of Exercise be required. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically
surrender this Warrant to the Company until the Holder has purchased all of the Warrant Shares available hereunder and the Warrant has
been exercised in full, in which case, the Holder shall surrender this Warrant to the Company for cancellation within three (3)&#8239;Trading
Days of the date on which the final Notice of Exercise is delivered to the Company. Partial exercises of this Warrant resulting in purchases
of a portion of the total number of Warrant Shares available hereunder shall have the effect of lowering the outstanding number of Warrant
Shares purchasable hereunder in an amount equal to the applicable number of Warrant Shares purchased. The Holder and the Company shall
maintain records showing the number of Warrant Shares purchased and the date of such purchases. The Company shall deliver any objection
to any Notice of Exercise within one (1)&#8239;Business Day of receipt of such notice. <B>The Holder and any assignee, by acceptance
of this Warrant, acknowledge and agree that, by reason of the provisions of this paragraph, following the purchase of a portion of the
Warrant Shares hereunder, the number of Warrant Shares available for purchase hereunder at any given time may be less than the amount
stated on the face hereof.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Exercise
Price</U>. The aggregate exercise price of this Warrant, except for a nominal exercise price of $0.001 per Warrant Share, was pre-funded
to the Company on or prior to the Initial Exercise Date and, consequently, no additional consideration (other than the nominal exercise
price of $0.001 per Warrant Share) shall be required to be paid by the Holder to any Person to effect any exercise of this Warrant. The
Holder shall not be entitled to the return or refund of all, or any portion, of such pre-paid aggregate exercise price under any circumstance
or for any reason whatsoever, including in the event this Warrant shall not have been exercised prior to the Termination Date. The remaining
unpaid exercise price per share of Common Stock under this Warrant shall be $0.001, subject to adjustment hereunder (such remaining unpaid
exercise price, the &ldquo;<U>Exercise Price</U>&rdquo;)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Cashless
Exercise</U>. This Warrant may also be exercised, in whole or in part, at such time by means of a &ldquo;cashless exercise&rdquo; in
which the Holder shall be entitled to receive a number of Warrant Shares equal to the quotient obtained by dividing [(A-B) (X)] by (A),
where:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in; text-align: left">(A) &#8239;=</TD><TD STYLE="text-align: justify"> as applicable:
(i)&#8239;the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise if such Notice of Exercise
is (1)&#8239;both executed and delivered pursuant to Section&#8239;2(a)&#8239;hereof on a day that is not a Trading Day or (2)&#8239;both
executed and delivered pursuant to Section&#8239;2(a)&#8239;hereof on a Trading Day prior to the opening of &ldquo;regular trading hours&rdquo;
(as defined in Rule&#8239;600(b)&#8239;of Regulation NMS promulgated under the federal securities laws) on such Trading Day, (ii)&#8239;at
the option of the Holder, either (y)&#8239;the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise
or (z)&#8239;the Bid Price of the Common Stock on the principal Trading Market as reported by Bloomberg L.P. (&ldquo;<U>Bloomberg</U>&rdquo;)
as of the time of the Holder&rsquo;s execution of the applicable Notice of Exercise if such Notice of Exercise is executed during &ldquo;regular
trading hours&rdquo; on a Trading Day and is delivered within two (2)&#8239;hours thereafter (including until two (2)&#8239;hours after
the close of &ldquo;regular trading hours&rdquo; on a Trading Day) pursuant to Section&#8239;2(a)&#8239;hereof or (iii)&#8239;the VWAP
on the date of the applicable Notice of Exercise if the date of such Notice of Exercise is a Trading Day and such Notice of Exercise
is both executed and delivered pursuant to Section&#8239;2(a)&#8239;hereof after the close of &ldquo;regular trading hours&rdquo; on
such Trading Day;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in; text-align: left">(B) &#8239;=</TD><TD STYLE="text-align: justify"> the Exercise
Price of this Warrant, as adjusted hereunder; and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in; text-align: left">(X) &#8239;=</TD><TD STYLE="text-align: justify"> the number
of Warrant Shares that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant if such exercise
were by means of a cash exercise rather than a cashless exercise.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">If Warrant Shares
are issued in such a cashless exercise, the parties acknowledge and agree that in accordance with Section&#8239;3(a)(9)&#8239;of the
Securities Act, the Warrant Shares shall take on the registered characteristics of the Warrants being exercised.&#8239;&#8239;The Company
agrees not to take any position contrary to this Section&#8239;2(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Bid Price</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a)&#8239;if the Common Stock is then listed
or quoted on a Trading Market, the bid price of the Common Stock for the time in question (or the nearest preceding date) on the Trading
Market on which the Common Stock is then listed or quoted as reported by Bloomberg (based on a Trading Day from 9:30 a.m.&#8239;(New
York City time) to 4:02 p.m.&#8239;(New York City time)), (b)&#8239; if OTCQB or OTCQX is not a Trading Market, the volume weighted average
price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c)&#8239;if the Common Stock
is not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on The Pink Open Market
(or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common
Stock so reported, or (d)&#8239;in all other cases, the fair market value of a share of Common Stock as determined by an independent
appraiser selected in good faith by the Purchasers of a majority in interest of the Securities then outstanding and reasonably acceptable
to the Company, the fees and expenses of which shall be paid by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>VWAP</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a)&#8239;if the Common Stock is then listed
or quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg (based on a Trading Day from 9:30 a.m.&#8239;(New
York City time) to 4:02 p.m.&#8239;(New York City time)), (b)&#8239; if the OTCQB Venture Market (&ldquo;<U>OTCQB</U>&rdquo;) or the
OTCQX Best Market (&ldquo;<U>OTCQX</U>&rdquo;) is not a Trading Market, the volume weighted average price of the Common Stock for such
date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c)&#8239;if the Common Stock is not then listed or quoted for
trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on the Pink Open Market (&ldquo;<U>Pink Market</U>&rdquo;)
operated by the OTC Markets,&#8239;Inc. (or a similar organization or agency succeeding to its functions of reporting prices), the most
recent bid price per share of the Common Stock so reported, or (d)&#8239;in all other cases, the fair market value of a share of Common
Stock as determined by an independent appraiser selected in good faith by the Purchasers of a majority in interest of the Securities
then outstanding and reasonably acceptable to the Company, the fees and expenses of which shall be paid by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">d)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">&#8239;<U>Mechanics
of Exercise.</U></FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Delivery
of Warrant Shares Upon Exercise</U>. The Company shall cause the Warrant Shares purchased hereunder to be transmitted by the Transfer
Agent to the Holder by crediting the account of the Holder&rsquo;s or its designee&rsquo;s balance account with The Depository Trust
Company through its Deposit or Withdrawal at Custodian system (&ldquo;<U>DWAC</U>&rdquo;) if the Company is then a participant in such
system and either (A)&#8239;there is an effective registration statement permitting the issuance of the Warrant Shares to or resale of
the Warrant Shares by Holder or (B)&#8239;this Warrant is being exercised via cashless exercise, and otherwise by physical delivery of
a certificate, registered in the Company&rsquo;s share register in the name of the Holder or its designee, for the number of Warrant
Shares to which the Holder is entitled pursuant to such exercise to the address specified by the Holder in the Notice of Exercise by
the date that is the earliest of (i)&#8239;two (2)&#8239;Trading Days after the delivery to the Company of the Notice of Exercise, (ii)&#8239;one
(1)&#8239;Trading Day after delivery of the aggregate Exercise Price to the Company and (iii)&#8239;the number of Trading Days comprising
the Standard Settlement Period after the delivery to the Company of the Notice of Exercise (such date, the &ldquo;<U>Warrant Share Delivery
Date</U>&rdquo;). Upon delivery of the Notice of Exercise, the Holder shall be deemed for all corporate purposes to have become the holder
of record of the Warrant Shares with respect to which this Warrant has been exercised, irrespective of the date of delivery of the Warrant
Shares, provided that payment of the aggregate Exercise Price (other than in the case of a cashless exercise) is received within the
earlier of (i)&#8239;two (2)&#8239;Trading Days and (ii)&#8239;the number of Trading Days comprising the Standard Settlement Period following
delivery of the Notice of Exercise. If the Company fails for any reason to deliver to the Holder the Warrant Shares subject to a Notice
of Exercise by the Warrant Share Delivery Date, the Company shall pay to the Holder, in cash, as liquidated damages and not as a penalty,
for each $1,000 of Warrant Shares subject to such exercise (based on the VWAP of the Common Stock on the date of the applicable Notice
of Exercise), $10 per Trading Day (increasing to $20 per Trading Day on the third Trading Day after the Warrant Share Delivery Date)
for each Trading Day after such Warrant Share Delivery Date until such Warrant Shares are delivered or Holder rescinds such exercise.
The Company agrees to maintain a transfer agent that is a participant in the FAST program so long as this Warrant remains outstanding
and exercisable. As used herein, &ldquo;<U>Standard Settlement Period</U>&rdquo; means the standard settlement period, expressed in a
number of Trading Days, on the Company&rsquo;s primary Trading Market with respect to the Common Stock as in effect on the date of delivery
of the Notice of Exercise. Notwithstanding the foregoing, with respect to any Notice(s)&#8239;of Exercise delivered on or prior to 12:00
p.m.&#8239;(New York City time) on the Initial Exercise Date, which may be delivered at any time after the time of execution of the Purchase
Agreement, the Company agrees to deliver the Warrant Shares subject to such notice(s)&#8239;by 4:00 p.m.&#8239;(New York City time) on
the Initial Exercise Date and the Initial Exercise Date shall be the Warrant Share Delivery Date for purposes hereunder, provided that
payment of the aggregate Exercise Price (other than in the case of a cashless exercise) is received by such Warrant Share Delivery Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">ii.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Delivery
of New Warrants Upon Exercise</U>. If this Warrant shall have been exercised in part, the Company shall, at the request of a Holder and
upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant evidencing
the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in all other
respects be identical with this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Rescission
Rights</U>. If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to Section&#8239;2(d)(i)&#8239;by
the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iv.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Compensation
for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise</U>. In addition to any other rights available to the Holder, if
the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions of Section&#8239;2(d)(i)&#8239;above
pursuant to an exercise on or before the Warrant Share Delivery Date, and if after such date the Holder is required by its broker to
purchase (in an open market transaction or otherwise) or the Holder&rsquo;s brokerage firm otherwise purchases, shares of Common Stock
to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon such exercise (a
 &ldquo;<U>Buy-In</U>&rdquo;), then the Company shall (A)&#8239;pay in cash to the Holder the amount, if any, by which (x)&#8239;the Holder&rsquo;s
total purchase price (including brokerage commissions, if any) for the shares of Common Stock so purchased exceeds (y)&#8239;the amount
obtained by multiplying (1)&#8239;the number of Warrant Shares that the Company was required to deliver to the Holder in connection with
the exercise at issue times (2)&#8239;the price at which the sell order giving rise to such purchase obligation was executed, and (B)&#8239;at
the option of the Holder, either reinstate the portion of the Warrant and equivalent number of Warrant Shares for which such exercise
was not honored (in which case such exercise shall be deemed rescinded) or deliver to the Holder the number of shares of Common Stock
that would have been issued had the Company timely complied with its exercise and delivery obligations hereunder. For example, if the
Holder purchases Common Stock having a total purchase price of $11,000 to cover a Buy-In with respect to an attempted exercise of shares
of Common Stock with an aggregate sale price giving rise to such purchase obligation of $10,000, under clause (A)&#8239;of the immediately
preceding sentence the Company shall be required to pay the Holder $1,000. The Holder shall provide the Company written notice indicating
the amounts payable to the Holder in respect of the Buy-In and, upon request of the Company, evidence of the amount of such loss. Nothing
herein shall limit a Holder&rsquo;s right to pursue any other remedies available to it hereunder, at law or in equity including, without
limitation, a decree of specific performance and/or injunctive relief with respect to the Company&rsquo;s failure to timely deliver shares
of Common Stock upon exercise of the Warrant as required pursuant to the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">v.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>No
Fractional Shares or Scrip</U>. No fractional shares or scrip representing fractional shares shall be issued upon the exercise of this
Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company shall,
at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied by the
Exercise Price or round up to the next whole share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">vi.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Charges,
Taxes and Expenses</U>. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax or other
incidental expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the Company, and
such Warrant Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; <U>provided</U>,
<U>however</U>, that, in the event that Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when
surrendered for exercise shall be accompanied by the Assignment Form&#8239;attached hereto duly executed by the Holder and the Company
may require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto. The Company
shall pay all Transfer Agent fees required for same-day processing of any Notice of Exercise and all fees to the Depository Trust Company
(or another established clearing corporation performing similar functions) required for same-day electronic delivery of the Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">vii.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Closing
of Books</U>. The Company will not close its stockholder books or records in any manner which prevents the timely exercise of this Warrant,
pursuant to the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">e)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
<U>Holder&rsquo;s Exercise Limitations</U>. The Company shall not effect any exercise of this Warrant, and a Holder shall not have the
right to exercise any portion of this Warrant, pursuant to Section&#8239;2 or otherwise, to the extent that after giving effect to such
issuance after exercise as set forth on the applicable Notice of Exercise, the Holder (together with the Holder&rsquo;s Affiliates, and
any other Persons acting as a group together with the Holder or any of the Holder&rsquo;s Affiliates (such Persons, &ldquo;<U>Attribution
Parties</U>&rdquo;)), would beneficially own in excess of the Beneficial Ownership Limitation (as defined below).&#8239; For purposes
of the foregoing sentence, the number of shares of Common Stock beneficially owned by the Holder and its Affiliates and Attribution Parties
shall include the number of shares of Common Stock issuable upon exercise of this Warrant with respect to which such determination is
being made, but shall exclude the number of shares of Common Stock which would be issuable upon (i)&#8239;exercise of the remaining,
nonexercised portion of this Warrant beneficially owned by the Holder or any of its Affiliates or Attribution Parties and (ii)&#8239;exercise
or conversion of the unexercised or nonconverted portion of any other securities of the Company (including, without limitation, any other
Common Stock Equivalents) subject to a limitation on conversion or exercise analogous to the limitation contained herein beneficially
owned by the Holder or any of its Affiliates or Attribution Parties.&#8239; Except as set forth in the preceding sentence, for purposes
of this Section&#8239;2(e), beneficial ownership shall be calculated in accordance with Section&#8239;13(d)&#8239;of the Exchange Act
and the rules&#8239;and regulations promulgated thereunder, it being acknowledged by the Holder that the Company is not representing
to the Holder that such calculation is in compliance with Section&#8239;13(d)&#8239;of the Exchange Act and the Holder is solely responsible
for any schedules required to be filed in accordance therewith. To the extent that the limitation contained in this Section&#8239;2(e)&#8239;applies,
the determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates
and Attribution Parties) and of which portion of this Warrant is exercisable shall be in the sole discretion of the Holder, and the submission
of a Notice of Exercise shall be deemed to be the Holder&rsquo;s determination of whether this Warrant is exercisable (in relation to
other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable,
in each case subject to the Beneficial Ownership Limitation, and the Company shall have no obligation to verify or confirm the accuracy
of such determination. In addition, a determination as to any group status as contemplated above shall be determined in accordance with
Section&#8239;13(d)&#8239;of the Exchange Act and the rules&#8239;and regulations promulgated thereunder. For purposes of this Section&#8239;2(e),
in determining the number of outstanding shares of Common Stock, a Holder may rely on the number of outstanding shares of Common Stock
as reflected in (A)&#8239;the Company&rsquo;s most recent periodic or annual report filed with the Commission, as the case may be, (B)&#8239;a
more recent public announcement by the Company or (C)&#8239;a more recent written notice by the Company or the Transfer Agent setting
forth the number of shares of Common Stock outstanding.&#8239; Upon the written or oral request of a Holder, the Company shall within
one Trading Day confirm orally and in writing to the Holder the number of shares of Common Stock then outstanding.&#8239; In any case,
the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion or exercise of securities
of the Company, including this Warrant, by the Holder or its Affiliates or Attribution Parties since the date as of which such number
of outstanding shares of Common Stock was reported. The &ldquo;<U>Beneficial Ownership Limitation</U>&rdquo; shall be 9.99% of the number
of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock issuable upon exercise
of this Warrant. The Holder, upon notice to the Company, may increase or decrease the Beneficial Ownership Limitation provisions of this
Section&#8239;2(e), provided that the Beneficial Ownership Limitation in no event exceeds 9.99% of the number of shares of the Common
Stock outstanding immediately after giving effect to the issuance of shares of Common Stock upon exercise of this Warrant held by the
Holder and the provisions of this Section&#8239;2(e)&#8239;shall continue to apply. Any increase in the Beneficial Ownership Limitation
will not be effective until the 61<SUP>st</SUP> day after such notice is delivered to the Company. The provisions of this paragraph shall
be construed and implemented in a manner otherwise than in strict conformity with the terms of this Section&#8239;2(e)&#8239;to correct
this paragraph (or any portion hereof) which may be defective or inconsistent with the intended Beneficial Ownership Limitation herein
contained or to make changes or supplements necessary or desirable to properly give effect to such limitation. The limitations contained
in this paragraph shall apply to a successor holder of this Warrant.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><U>Section&#8239;3</U>.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Certain
Adjustments</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Stock
Dividends and Splits</U>. If the Company, at any time while this Warrant is outstanding: (i)&#8239;pays a stock dividend or otherwise
makes a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares
of Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise of this
Warrant), (ii)&#8239;subdivides outstanding shares of Common Stock into a larger number of shares, (iii)&#8239;combines (including by
way of reverse stock split) outstanding shares of Common Stock into a smaller number of shares, or (iv)&#8239;issues by reclassification
of shares of the Common Stock any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by
a fraction of which the numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately
before such event and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event,
and the number of shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price
of this Warrant shall remain unchanged. Any adjustment made pursuant to this Section&#8239;3(a)&#8239;shall become effective immediately
after the record date for the determination of stockholders entitled to receive such dividend or distribution and shall become effective
immediately after the effective date in the case of a subdivision, combination or re-classification.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Subsequent
Rights Offerings</U>. In addition to any adjustments pursuant to Section&#8239;3(a)&#8239;above, if at any time the Company grants, issues
or sells any Common Stock Equivalents or rights to purchase stock, warrants, securities or other property pro rata to the record holders
of any class of shares of Common Stock (the &ldquo;<U>Purchase Rights</U>&rdquo;), then the Holder will be entitled to acquire, upon
the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had held
the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise
hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date on which a record is taken for
the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders of shares
of Common Stock are to be determined for the grant, issue or sale of such Purchase Rights (<U>provided</U>, <U>however</U>, that, to
the extent that the Holder&rsquo;s right to participate in any such Purchase Right would result in the Holder exceeding the Beneficial
Ownership Limitation, then the Holder shall not be entitled to participate in such Purchase Right to such extent (or beneficial ownership
of such shares of Common Stock as a result of such Purchase Right to such extent) and such Purchase Right to such extent shall be held
in abeyance for the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership
Limitation).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Pro
Rata Distributions</U>. During such time as this Warrant is outstanding, if the Company shall declare or make any dividend or other distribution
of its assets (or rights to acquire its assets) to holders of shares of Common Stock, by way of return of capital or otherwise (including,
without limitation, any distribution of cash, stock or other securities, property or options by way of a dividend, spin off, reclassification,
corporate rearrangement, scheme of arrangement or other similar transaction) (a &ldquo;<U>Distribution</U>&rdquo;), at any time after
the issuance of this Warrant, then, in each such case, the Holder shall be entitled to participate in such Distribution to the same extent
that the Holder would have participated therein if the Holder had held the number of shares of Common Stock acquirable upon complete
exercise of this Warrant (without regard to any limitations on exercise hereof, including without limitation, the Beneficial Ownership
Limitation) immediately before the date of which a record is taken for such Distribution, or, if no such record is taken, the date as
of which the record holders of shares of Common Stock are to be determined for the participation in such Distribution (<U>provided</U>,
<U>however</U>, that, to the extent that the Holder's right to participate in any such Distribution would result in the Holder exceeding
the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Distribution to such extent (or in
the beneficial ownership of any shares of Common Stock as a result of such Distribution to such extent) and the portion of such Distribution
shall be held in abeyance for the benefit of the Holder until such time, if ever, as its right thereto would not result in the Holder
exceeding the Beneficial Ownership Limitation). To the extent that this Warrant has not been partially or completely exercised at the
time of such Distribution, such portion of the Distribution shall be held in abeyance for the benefit of the Holder until the Holder
has exercised this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">d)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Fundamental
Transaction</U>. If, at any time while this Warrant is outstanding, (i)&#8239;the Company, directly or indirectly, in one or more related
transactions effects any merger or consolidation of the Company with or into another Person, (ii)&#8239;the Company or any Subsidiary,
directly or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially
all of its assets in one or a series of related transactions, (iii)&#8239;any, direct or indirect, purchase offer, tender offer or exchange
offer (whether by the Company or another Person) is completed pursuant to which holders of Common Stock are permitted to sell, tender
or exchange their shares for other securities, cash or property and has been accepted by the holders of 50% or more of the outstanding
Common Stock or 50% or more of the voting power of the common equity of the Company, (iv)&#8239;the Company, directly or indirectly,
in one or more related transactions effects any reclassification, reorganization or recapitalization of the Common Stock or any compulsory
share exchange pursuant to which the Common Stock is effectively converted into or exchanged for other securities, cash or property,
or (v)&#8239;the Company, directly or indirectly, in one or more related transactions consummates a stock or share purchase agreement
or other business combination (including, without limitation, a reorganization, recapitalization, spin-off, merger or scheme of arrangement)
with another Person or group of Persons whereby such other Person or group acquires 50% or more of the outstanding shares of Common Stock
or 50% or more of the voting power of the common equity of the Company (each a &ldquo;<U>Fundamental Transaction</U>&rdquo;), then, upon
any subsequent exercise of this Warrant, the Holder shall have the right to receive, for each Warrant Share that would have been issuable
upon such exercise immediately prior to the occurrence of such Fundamental Transaction, at the option of the Holder (without regard to
any limitation in Section&#8239;2(e)&#8239;on the exercise of this Warrant), the number of shares of Common Stock of the successor or
acquiring corporation or of the Company, if it is the surviving corporation, and any additional consideration (the &ldquo;<U>Alternate
Consideration</U>&rdquo;) receivable as a result of such Fundamental Transaction by a holder of the number of shares of Common Stock
for which this Warrant is exercisable immediately prior to such Fundamental Transaction (without regard to any limitation in Section&#8239;2(e)&#8239;on
the exercise of this Warrant). For purposes of any such exercise, the determination of the Exercise Price shall be appropriately adjusted
to apply to such Alternate Consideration based on the amount of Alternate Consideration issuable in respect of one share of Common Stock
in such Fundamental Transaction, and the Company shall apportion the Exercise Price among the Alternate Consideration in a reasonable
manner reflecting the relative value of any different components of the Alternate Consideration. If holders of Common Stock are given
any choice as to the securities, cash or property to be received in a Fundamental Transaction, then the Holder shall be given the same
choice as to the Alternate Consideration it receives upon any exercise of this Warrant following such Fundamental Transaction. The Company
shall cause any successor entity in a Fundamental Transaction in which the Company is not the survivor (the &ldquo;<U>Successor Entity</U>&rdquo;)
to assume in writing all of the obligations of the Company under this Warrant and the other Transaction Documents in accordance with
the provisions of this Section&#8239;3(e)&#8239;pursuant to written agreements in form and substance reasonably satisfactory to the Holder
and approved by the Holder (without unreasonable delay) prior to such Fundamental Transaction and shall, at the option of the Holder,
deliver to the Holder in exchange for this Warrant a security of the Successor Entity evidenced by a written instrument substantially
similar in form and substance to this Warrant which is exercisable for a corresponding number of shares of capital stock of such Successor
Entity (or its parent entity) equivalent to the shares of Common Stock acquirable and receivable upon exercise of this Warrant (without
regard to any limitations on the exercise of this Warrant) prior to such Fundamental Transaction, and with an exercise price which applies
the exercise price hereunder to such shares of capital stock (but taking into account the relative value of the shares of Common Stock
pursuant to such Fundamental Transaction and the value of such shares of capital stock, such number of shares of capital stock and such
exercise price being for the purpose of protecting the economic value of this Warrant immediately prior to the consummation of such Fundamental
Transaction), and which is reasonably satisfactory in form and substance to the Holder. Upon the occurrence of any such Fundamental Transaction,
the Successor Entity shall be added to the term &ldquo;Company&rdquo; under this Warrant (so that from and after the occurrence or consummation
of such Fundamental Transaction, each and every provision of this Warrant and the other Transaction Documents referring to the &ldquo;Company&rdquo;
shall refer instead to each of the Company and the Successor Entity or Successor Entities, jointly and severally), and the Successor
Entity or Successor Entities, jointly and severally with the Company, may exercise every right and power of the Company prior thereto
and the Successor Entity or Successor Entities shall assume all of the obligations of the Company prior thereto under this Warrant and
the other Transaction Documents with the same effect as if the Company and such Successor Entity or Successor Entities, jointly and severally,
had been named as the Company herein. For the avoidance of doubt, the Holder shall be entitled to the benefits of the provisions of this
Section&#8239;3(e)&#8239;regardless of (i)&#8239;whether the Company has sufficient authorized shares of Common Stock for the issuance
of Warrant Shares and/or (ii)&#8239;whether a Fundamental Transaction occurs prior to the Initial Exercise Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">e)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Calculations</U>.
All calculations under this Section&#8239;3 shall be made to the nearest cent or the nearest 1/100th of a share, as the case may be.
For purposes of this Section&#8239;3, the number of shares of Common Stock deemed to be issued and outstanding as of a given date shall
be the sum of the number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">f)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Notice
to Holder</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Adjustment
to Exercise Price</U>. Whenever the Exercise Price is adjusted pursuant to any provision of this Section&#8239;3, the Company shall promptly
deliver to the Holder by email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment to the number
of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Notice
to Allow Exercise by Holder</U>. If (A)&#8239;the Company shall declare a dividend (or any other distribution in whatever form) on the
Common Stock, (B)&#8239;the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C)&#8239;the
Company shall authorize the granting to all holders of the Common Stock rights or warrants to subscribe for or purchase any shares of
capital stock of any class or of any rights, (D)&#8239;the approval of any stockholders of the Company shall be required in connection
with any reclassification of the Common Stock, any consolidation or merger to which the Company (or any of its Subsidiaries) is a party,
any sale or transfer of all or substantially all of its assets, or any compulsory share exchange whereby the Common Stock is converted
into other securities, cash or property, or (E)&#8239;the Company shall authorize the voluntary or involuntary dissolution, liquidation
or winding up of the affairs of the Company, then, in each case, the Company shall cause to be delivered by email to the Holder at its
last email address as it shall appear upon the Warrant Register of the Company, at least 20 calendar days prior to the applicable record
or effective date hereinafter specified, a notice stating (x)&#8239;the date on which a record is to be taken for the purpose of such
dividend, distribution, redemption, rights or warrants, or if a record is not to be taken, the date as of which the holders of the Common
Stock of record to be entitled to such dividend, distributions, redemption, rights or warrants are to be determined or (y)&#8239;the
date on which such reclassification, consolidation, merger, sale, transfer or share exchange is expected to become effective or close,
and the date as of which it is expected that holders of the Common Stock of record shall be entitled to exchange their shares of the
Common Stock for securities, cash or other property deliverable upon such reclassification, consolidation, merger, sale, transfer or
share exchange; provided that the failure to deliver such notice or any defect therein or in the delivery thereof shall not affect the
validity of the corporate action required to be specified in such notice. To the extent that any notice provided in this Warrant constitutes,
or contains, material, non-public information regarding the Company or any of the Subsidiaries, the Company shall simultaneously file
such notice with the Commission pursuant to a Current Report on Form&#8239;8-K. The Holder shall remain entitled to exercise this Warrant
during the period commencing on the date of such notice to the effective date of the event triggering such notice except as may otherwise
be expressly set forth herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><U>Section&#8239;4</U>.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Transfer
of Warrant</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Transferability</U>.
This Warrant and all rights hereunder (including, without limitation, any registration rights) are transferable, in whole or in part,
upon surrender of this Warrant at the principal office of the Company or its designated agent, together with a written assignment of
this Warrant substantially in the form attached hereto duly executed by the Holder or its agent or attorney and funds sufficient to pay
any transfer taxes payable upon the making of such transfer. Upon such surrender and, if required, such payment, the Company shall execute
and deliver a new Warrant or Warrants in the name of the assignee or assignees, as applicable, and in the denomination or denominations
specified in such instrument of assignment, and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not
so assigned, and this Warrant shall promptly be cancelled. Notwithstanding anything herein to the contrary, the Holder shall not be required
to physically surrender this Warrant to the Company unless the Holder has assigned this Warrant in full, in which case, the Holder shall
surrender this Warrant to the Company within three (3)&#8239;Trading Days of the date on which the Holder delivers an assignment form
to the Company assigning this Warrant in full. The Warrant, if properly assigned in accordance herewith, may be exercised by a new holder
for the purchase of Warrant Shares without having a new Warrant issued.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>New
Warrants</U>. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of the Company,
together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by the Holder or
its agent or attorney. Subject to compliance with Section&#8239;4(a), as to any transfer which may be involved in such division or combination,
the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided or combined in
accordance with such notice. All Warrants issued on transfers or exchanges shall be dated the initial issuance date of this Warrant and
shall be identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Warrant
Register</U>. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the &ldquo;<U>Warrant
Register</U>&rdquo;), in the name of the record Holder hereof from time to time. The Company may deem and treat the registered Holder
of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder, and for all other
purposes, absent actual notice to the contrary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section&#8239;5</U></FONT><FONT STYLE="font-size: 10pt">.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Miscellaneous</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>No
Rights as Stockholder Until Exercise; No Settlement in Cash</U>. This Warrant does not entitle the Holder to any voting rights, dividends
or other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section&#8239;2(d)(i), except as expressly
set forth in Section&#8239;3. Without limiting any rights of a Holder to receive Warrant Shares on a &ldquo;cashless exercise&rdquo;
pursuant to Section&#8239;2(c)&#8239;or to receive cash payments pursuant to Section&#8239;2(d)(i)&#8239;and Section&#8239;2(d)(iv)&#8239;herein,
in no event shall the Company be required to net cash settle an exercise of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT><FONT STYLE="font-size: 10pt">b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Loss,
Theft, Destruction or Mutilation of Warrant</U>. The Company covenants that upon receipt by the Company of evidence reasonably satisfactory
to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares, and in case
of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant, shall not include
the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the Company will make
and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant or stock certificate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Saturdays,
Sundays, Holidays,&#8239;etc</U>. If the last or appointed day for the taking of any action or the expiration of any right required or
granted herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding Business
Day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Authorized
Shares</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">The Company covenants
that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued Common Stock a sufficient number
of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant. The Company
further covenants that its issuance of this Warrant shall constitute full authority to its officers who are charged with the duty of
issuing the necessary Warrant Shares upon the exercise of the purchase rights under this Warrant. The Company will take all such reasonable
action as may be necessary to assure that such Warrant Shares may be issued as provided herein without violation of any applicable law
or regulation, or of any requirements of the Trading Market upon which the Common Stock may be listed. The Company covenants that all
Warrant Shares which may be issued upon the exercise of the purchase rights represented by this Warrant will, upon exercise of the purchase
rights represented by this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized, validly issued, fully
paid and nonassessable and free from all taxes, liens and charges created by the Company in respect of the issue thereof (other than
taxes in respect of any transfer occurring contemporaneously with such issue).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">Except and to the
extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending its certificate
of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities or
any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant, but will at all
times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary or appropriate
to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality of the foregoing, the
Company will (i)&#8239;not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise immediately
prior to such increase in par value, (ii)&#8239;take all such action as may be necessary or appropriate in order that the Company may
validly and legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii)&#8239;use commercially
reasonable efforts to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof,
as may be, necessary to enable the Company to perform its obligations under this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in; text-align: left">Before taking any action
which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the Exercise Price, the
Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from any public regulatory
body or bodies having jurisdiction thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Jurisdiction</U>.
All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be determined in accordance
with the provisions of the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Restrictions</U>.
The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, and the Holder does not
utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">g)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Nonwaiver
and Expenses</U>. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall operate as
a waiver of such right or otherwise prejudice the Holder&rsquo;s rights, powers or remedies. Without limiting any other provision of
this Warrant or the Purchase Agreement, if the Company willfully and knowingly fails to comply with any provision of this Warrant, which
results in any material damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover any costs
and expenses including, but not limited to, reasonable attorneys&rsquo; fees, including those of appellate proceedings, incurred by the
Holder in collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">h)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Notices</U>.
Any notice, request or other document required or permitted to be given or delivered to the Holder by the Company shall be delivered
in accordance with the notice provisions of the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Limitation
of Liability</U>. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant to purchase Warrant
Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder for the purchase
price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company or by creditors of the
Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">j)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Remedies</U>.
The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will be entitled to specific
performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate compensation for any loss
incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to assert the defense in any
action for specific performance that a remedy at law would be adequate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">k)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Successors
and Assigns</U>. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall inure to the
benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns of Holder.
The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall be enforceable
by the Holder or holder of Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">l)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Amendment</U>.
This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company and the Holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">m)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Severability</U>.
Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid under applicable law,
but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective to the
extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining provisions of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">n)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Headings</U>.
The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed a part of this
Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">********************</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>(Signature Page&#8239;Follows)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-indent: 1in; text-align: justify">IN WITNESS WHEREOF,
the Company has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above indicated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD COLSPAN="2"><FONT STYLE="text-transform: uppercase"><B>T Stamp,&#8239;Inc.</B></FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD COLSPAN="2">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 50%">&nbsp;</TD>
  <TD STYLE="width: 3%">By:</TD>
  <TD STYLE="border-bottom: Black 1pt solid; width: 47%"></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD>
  <TD>Name:</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD>
  <TD>Title:</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOTICE OF EXERCISE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">To:</FONT><FONT STYLE="text-transform: uppercase">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">T
STAMP,&#8239;INC.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)
</FONT><FONT STYLE="font-size: 10pt">The undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the
terms of the attached Warrant (only if exercised in full), and tenders herewith payment of the exercise price in full, together with
all applicable transfer taxes, if any.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)
</FONT><FONT STYLE="font-size: 10pt">Payment shall take the form of (check applicable box):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify"><FONT STYLE="font-family: Wingdings">&#168;
</FONT>in lawful money of the United States; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify"><FONT STYLE="font-family: Wingdings">&#168;
</FONT>if permitted the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection
2(c), to exercise this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure
set forth in subsection 2(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT>&#8239;<FONT STYLE="font-size: 10pt">Please
issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Warrant Shares shall be delivered to the
following DWAC Account Number:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="text-transform: uppercase">[SIGNATURE
OF HOLDER]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 17%">Name of Investing Entity:</TD>
    <TD STYLE="border-bottom: Black 1pt solid; white-space: nowrap; font: 10pt Times New Roman, Times, Serif; width: 83%">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: italic 10pt Times New Roman, Times, Serif; width: 35%">Signature of Authorized Signatory of Investing Entity:</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: italic 10pt Times New Roman, Times, Serif; width: 65%">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 20%">Name of Authorized Signatory:</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 80%">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 20%">Title of Authorized Signatory:</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 80%">&nbsp;</TD></TR>
</TABLE>

<P STYLE="margin: 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%">Date:</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 95%">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif"></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>EXHIBIT&#8239;B</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">ASSIGNMENT FORM</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><I>(To assign the foregoing
Warrant, execute this form and supply required information. Do not use this form to purchase shares.)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="text-indent: -0.25in; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">FOR VALUE RECEIVED,
the foregoing Warrant and all rights evidenced thereby are hereby assigned to</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: justify"></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Please
    Print)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: justify"></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#8239;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P></TD>
    <TD><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(Please Print)</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2">Phone Number:</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2">Email Address:</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated:
    _______________ __, ______</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify">&#8239;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; text-align: justify; width: 13%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s
    Signature:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: justify; width: 37%">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: justify; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s
    Address:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 17; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.2
<SEQUENCE>4
<FILENAME>tm2317786d1_ex4-2.htm
<DESCRIPTION>EXHIBIT 4.2
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Exhibit 4.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">NEITHER THIS SECURITY NOR THE SECURITIES FOR
WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY
STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE &ldquo;SECURITIES ACT&rdquo;),
AND, ACCORDINGLY, MAY&#8239;NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR
PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND
IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS SECURITY MAY&#8239;BE
PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>COMMON STOCK PURCHASE WARRANT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="text-transform: uppercase"><B>T
Stamp,&#8239;Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant Shares: _______</FONT></TD>
  <TD STYLE="width: 50%"> Issue Date: June&#8239;1, 2023</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">THIS COMMON STOCK PURCHASE
WARRANT (the &ldquo;<U>Warrant</U>&rdquo;) certifies that, for value received, Armistice Capital Master Fund Ltd. or its assigns (the
 &ldquo;<U>Holder</U>&rdquo;) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set
forth, at any time on or after the date hereof (the &ldquo;<U>Initial Exercise Date</U>&rdquo;) and on or prior to 5:00 p.m.&#8239;(New
York City time) on the date that is the five year anniversary of the Closing Date (the &ldquo;<U>Termination Date</U>&rdquo;) but not
thereafter, to subscribe for and purchase from T Stamp Inc., a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;), up to _______
shares (as subject to adjustment hereunder, the &ldquo;<U>Warrant Shares</U>&rdquo;) of Common Stock. The purchase price of one share
of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section&#8239;2(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section&#8239;1</U></FONT><FONT STYLE="font-size: 10pt">.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Definitions</U>.
Capitalized terms used and not otherwise defined herein shall have the meanings set forth in that certain Securities Purchase Agreement
(the &ldquo;<U>Purchase Agreement</U>&rdquo;), dated June&#8239;1, 2023, among the Company and the purchaser signatory thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section&#8239;2</U></FONT><FONT STYLE="font-size: 10pt">.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Exercise</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Exercise
of Warrant</U>. Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time or times on
or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company of a duly executed facsimile copy
or PDF copy submitted by e-mail (or e-mail attachment) of the Notice of Exercise in the form annexed hereto (the &ldquo;<U>Notice of
Exercise</U>&rdquo;). Within the earlier of (i)&#8239;two (2)&#8239;Trading Days and (ii)&#8239;the number of Trading Days comprising
the Standard Settlement Period (as defined in Section&#8239;2(d)(i)&#8239;herein) following the date of exercise as aforesaid, the Holder
shall deliver the aggregate Exercise Price for the Warrant Shares specified in the applicable Notice of Exercise by wire transfer or
cashier&rsquo;s check drawn on a United States bank unless the cashless exercise procedure specified in Section&#8239;2(c)&#8239;below
is specified in the applicable Notice of Exercise. No ink-original Notice of Exercise shall be required, nor shall any medallion guarantee
(or other type of guarantee or notarization) of any Notice of Exercise be required. Notwithstanding anything herein to the contrary,
the Holder shall not be required to physically surrender this Warrant to the Company until the Holder has purchased all of the Warrant
Shares available hereunder and the Warrant has been exercised in full, in which case, the Holder shall surrender this Warrant to the
Company for cancellation within three (3)&#8239;Trading Days of the date on which the final Notice of Exercise is delivered to the Company.
Partial exercises of this Warrant resulting in purchases of a portion of the total number of Warrant Shares available hereunder shall
have the effect of lowering the outstanding number of Warrant Shares purchasable hereunder in an amount equal to the applicable number
of Warrant Shares purchased. The Holder and the Company shall maintain records showing the number of Warrant Shares purchased and the
date of such purchases. The Company shall deliver any objection to any Notice of Exercise within one (1)&#8239;Trading Day of receipt
of such notice. <B>The Holder and any assignee, by acceptance of this Warrant, acknowledge and agree that, by reason of the provisions
of this paragraph, following the purchase of a portion of the Warrant Shares hereunder, the number of Warrant Shares available for purchase
hereunder at any given time may be less than the amount stated on the face hereof.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Exercise
Price</U>. The exercise price per share of Common Stock under this Warrant shall be $___, subject to adjustment hereunder (the &ldquo;<U>Exercise
Price</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Cashless
Exercise</U>. If at any time after the six month anniversary of the Issue Date there is no effective registration statement registering,
or the prospectus contained therein is not available for the resale of the Warrant Shares by the Holder, then this Warrant may also be
exercised, in whole or in part, at such time by means of a &ldquo;cashless exercise&rdquo; in which the Holder shall be entitled to receive
a number of Warrant Shares equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in; text-align: left">(A) &#8239;=</TD><TD STYLE="text-align: justify"> as applicable:
(i)&#8239;the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise if such Notice of Exercise
is (1)&#8239;both executed and delivered pursuant to Section&#8239;2(a)&#8239;hereof on a day that is not a Trading Day or (2)&#8239;both
executed and delivered pursuant to Section&#8239;2(a)&#8239;hereof on a Trading Day prior to the opening of &ldquo;regular trading hours&rdquo;
(as defined in Rule&#8239;600(b)&#8239;of Regulation NMS promulgated under the federal securities laws) on such Trading Day, (ii)&#8239;at
the option of the Holder, either (y)&#8239;the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise
or (z)&#8239;the Bid Price of the Common Stock on the principal Trading Market as reported by Bloomberg L.P. (&ldquo;<U>Bloomberg</U>&rdquo;)
as of the time of the Holder&rsquo;s execution of the applicable Notice of Exercise if such Notice of Exercise is executed during &ldquo;regular
trading hours&rdquo; on a Trading Day and is delivered within two (2)&#8239;hours thereafter (including until two (2)&#8239;hours after
the close of &ldquo;regular trading hours&rdquo; on a Trading Day) pursuant to Section&#8239;2(a)&#8239;hereof or (iii)&#8239;the VWAP
on the date of the applicable Notice of Exercise if the date of such Notice of Exercise is a Trading Day and such Notice of Exercise
is both executed and delivered pursuant to Section&#8239;2(a)&#8239;hereof after the close of &ldquo;regular trading hours&rdquo; on
such Trading Day;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in; text-align: left">(B) &#8239;=</TD><TD STYLE="text-align: justify"> the Exercise
Price of this Warrant, as adjusted hereunder; and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in; text-align: left">(X) &#8239;=</TD><TD STYLE="text-align: justify"> the number
of Warrant Shares that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant if such exercise
were by means of a cash exercise rather than a cashless exercise.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">If Warrant Shares
are issued in such a cashless exercise, the parties acknowledge and agree that in accordance with Section&#8239;3(a)(9)&#8239;of the
Securities Act, the Warrant Shares shall take on the characteristics of the Warrants being exercised, and the holding period of the Warrant
Shares being issued may be tacked on to the holding period of this Warrant.&#8239;&#8239;The Company agrees not to take any position
contrary to this Section&#8239;2(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Bid Price</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a)&#8239;if the Common Stock is then listed
on the Nasdaq Stock Market, the bid price of the Common Stock for the time in question (or the nearest preceding date) on the Trading
Market on which the Common Stock is then listed or quoted as reported by Bloomberg (based on a Trading Day from 9:30 a.m.&#8239;(New
York City time) to 4:02 p.m.&#8239;(New York City time)), (b)&#8239; if the Common Stock is not then listed or quoted on Nasdaq Stock
Market and OTCQB or OTCQX is not a Trading Market, the volume weighted average price of the Common Stock for such date (or the nearest
preceding date) on OTCQB or OTCQX as applicable, (c)&#8239;if the Common Stock is not then listed or quoted for trading on Nasdaq Stock
Market or the OTCQB or OTCQX and if prices for the Common Stock are then reported on The Pink Open Market (or a similar organization
or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common Stock so reported, or (d)&#8239;in
all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in good faith by
the Holders of a majority in interest of the Securities then outstanding and reasonably acceptable to the Company, the fees and expenses
of which shall be paid by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>VWAP</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a)&#8239;if the Common Stock is then listed
or quoted on the Nasdaq Stock Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding
date) as reported by Bloomberg (based on a Trading Day from 9:30 a.m.&#8239;(New York City time) to 4:02 p.m.&#8239;(New York City time)),
(b)&#8239; if none of Nasdaq Stock Market nor OTCQB or OTCQX are not a Trading Market, the volume weighted average price of the Common
Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c)&#8239;if the Common Stock is not then listed
or quoted for trading on Nasdaq Stock Market or OTCQB or OTCQX and if prices for the Common Stock are then reported on The Pink Open
Market (or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of
the Common Stock so reported, or (d)&#8239;in all other cases, the fair market value of a share of Common Stock as determined by an independent
appraiser selected in good faith by the Holder and reasonably acceptable to the Company, the fees and expenses of which shall be paid
by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">d)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
<U>Mechanics of Exercise</U>.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Delivery
of Warrant Shares Upon Exercise</U>. The Company shall cause the Warrant Shares purchased hereunder to be transmitted by the Transfer
Agent to the Holder by crediting the account of the Holder&rsquo;s or its designee&rsquo;s balance account with The Depository Trust
Company through its Deposit or Withdrawal at Custodian system (&ldquo;<U>DWAC</U>&rdquo;) if the Company is then a participant in such
system and either (A)&#8239;there is an effective registration statement permitting the issuance of the Warrant Shares to or resale of
the Warrant Shares by the Holder or (B)&#8239;the Warrant Shares are eligible for resale by the Holder without volume or manner-of-sale
limitations pursuant to Rule&#8239;144 (assuming cashless exercise of the Warrants), and otherwise by physical delivery of a certificate,
registered in the Company&rsquo;s share register in the name of the Holder or its designee, for the number of Warrant Shares to which
the Holder is entitled pursuant to such exercise to the address specified by the Holder in the Notice of Exercise by the date that is
the earliest of (i)&#8239;two (2)&#8239;Trading Days after the delivery to the Company of the Notice of Exercise, (ii)&#8239;one (1)&#8239;Trading
Day after delivery of the aggregate Exercise Price to the Company and (iii)&#8239;the number of Trading Days comprising the Standard
Settlement Period after the delivery to the Company of the Notice of Exercise (such date, the &ldquo;<U>Warrant Share Delivery Date</U>&rdquo;).
Upon delivery of the Notice of Exercise, the Holder shall be deemed for all corporate purposes to have become the holder of record of
the Warrant Shares with respect to which this Warrant has been exercised, irrespective of the date of delivery of the Warrant Shares,
provided that payment of the aggregate Exercise Price (other than in the case of a cashless exercise) is received within the earlier
of (i)&#8239;two (2)&#8239;Trading Days and (ii)&#8239;the number of Trading Days comprising the Standard Settlement Period following
delivery of the Notice of Exercise. If the Company fails, for reasons within its control, to deliver to the Holder the Warrant Shares
subject to a Notice of Exercise by the Warrant Share Delivery Date, the Company shall pay to the Holder, in cash, as liquidated damages
and not as a penalty, for each $1,000 of Warrant Shares subject to such exercise (based on the VWAP of the Common Stock on the date of
the applicable Notice of Exercise), $10 per Trading Day for each Trading Day after such Warrant Share Delivery Date until such Warrant
Shares are delivered or Holder rescinds such exercise. The Company agrees to maintain a transfer agent that is a participant in the FAST
program so long as this Warrant remains outstanding and exercisable. As used herein, &ldquo;<U>Standard Settlement Period</U>&rdquo;
means the standard settlement period, expressed in a number of Trading Days, on the Company&rsquo;s primary Trading Market with respect
to the Common Stock as in effect on the date of delivery of the Notice of Exercise. Nothing herein shall limit a Holder&rsquo;s right
to pursue any other remedies available to it hereunder, at law or in equity including, without limitation, a decree of specific performance
and/or injunctive relief with respect to the Company&rsquo;s failure to timely deliver shares of Common Stock upon exercise of the Warrant
as required pursuant to the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Delivery
of New Warrants Upon Exercise</U>. If this Warrant shall have been exercised in part, the Company shall, at the request of a Holder and
upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant evidencing
the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in all other
respects be identical with this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Rescission
Rights</U>. If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to Section&#8239;2(d)(i)&#8239;by
the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iv.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>No
Fractional Shares or Scrip</U>. No fractional shares or scrip representing fractional shares shall be issued upon the exercise of this
Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company shall,
at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied by the
Exercise Price or round up to the next whole share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">v.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Charges,
Taxes and Expenses</U>. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax or other
incidental expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the Company, and
such Warrant Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; <U>provided</U>,
<U>however</U>, that, in the event that Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when
surrendered for exercise shall be accompanied by the Assignment Form&#8239;attached hereto duly executed by the Holder and the Company
may require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto. The Company
shall pay all Transfer Agent fees required for same-day processing of any Notice of Exercise and all fees to the Depository Trust Company
(or another established clearing corporation performing similar functions) required for same-day electronic delivery of the Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">vi.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Closing
of Books</U>. The Company will not close its stockholder books or records in any manner which prevents the timely exercise of this Warrant,
pursuant to the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Holder&rsquo;s
Exercise Limitations</U>. The Company shall not effect any exercise of this Warrant, and a Holder shall not have the right to exercise
any portion of this Warrant, pursuant to Section&#8239;2 or otherwise, to the extent that after giving effect to such issuance after
exercise as set forth on the applicable Notice of Exercise, the Holder (together with the Holder&rsquo;s Affiliates, and any other Persons
acting as a group together with the Holder or any of the Holder&rsquo;s Affiliates (such Persons, &ldquo;<U>Attribution Parties</U>&rdquo;)),
would beneficially own in excess of the Beneficial Ownership Limitation (as defined below).&#8239; For purposes of the foregoing sentence,
the number of shares of Common Stock beneficially owned by the Holder and its Affiliates and Attribution Parties shall include the number
of shares of Common Stock issuable upon exercise of this Warrant with respect to which such determination is being made, but shall exclude
the number of shares of Common Stock which would be issuable upon (i)&#8239;exercise of the remaining, nonexercised portion of this Warrant
beneficially owned by the Holder or any of its Affiliates or Attribution Parties and (ii)&#8239;exercise or conversion of the unexercised
or nonconverted portion of any other securities of the Company (including, without limitation, any other Common Stock Equivalents) subject
to a limitation on conversion or exercise analogous to the limitation contained herein beneficially owned by the Holder or any of its
Affiliates or Attribution Parties.&#8239; Except as set forth in the preceding sentence, for purposes of this Section&#8239;2(e), beneficial
ownership shall be calculated in accordance with Section&#8239;13(d)&#8239;of the Exchange Act and the rules&#8239;and regulations promulgated
thereunder, it being acknowledged by the Holder that the Company is not representing to the Holder that such calculation is in compliance
with Section&#8239;13(d)&#8239;of the Exchange Act and the Holder is solely responsible for any schedules required to be filed in accordance
therewith. To the extent that the limitation contained in this Section&#8239;2(e)&#8239;applies, the determination of whether this Warrant
is exercisable (in relation to other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which
portion of this Warrant is exercisable shall be in the sole discretion of the Holder, and the submission of a Notice of Exercise shall
be deemed to be the Holder&rsquo;s determination of whether this Warrant is exercisable (in relation to other securities owned by the
Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable, in each case subject
to the Beneficial Ownership Limitation, and the Company shall have no obligation to verify or confirm the accuracy of such determination.
In addition, a determination as to any group status as contemplated above shall be determined in accordance with Section&#8239;13(d)&#8239;of
the Exchange Act and the rules&#8239;and regulations promulgated thereunder. For purposes of this Section&#8239;2(e), in determining
the number of outstanding shares of Common Stock, a Holder may rely on the number of outstanding shares of Common Stock as reflected
in (A)&#8239;the Company&rsquo;s most recent periodic or annual report filed with the Commission, as the case may be, (B)&#8239;a more
recent public announcement by the Company or (C)&#8239;a more recent written notice by the Company or the Transfer Agent setting forth
the number of shares of Common Stock outstanding.&#8239; Upon the written or oral request of a Holder, the Company shall within one Trading
Day confirm orally and in writing to the Holder the number of shares of Common Stock then outstanding.&#8239; In any case, the number
of outstanding shares of Common Stock shall be determined after giving effect to the conversion or exercise of securities of the Company,
including this Warrant, by the Holder or its Affiliates or Attribution Parties since the date as of which such number of outstanding
shares of Common Stock was reported. The &ldquo;<U>Beneficial Ownership Limitation</U>&rdquo; shall be 4.99% of the number of shares
of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock issuable upon exercise of this
Warrant. The Holder, upon notice to the Company, may increase or decrease the Beneficial Ownership Limitation provisions of this Section&#8239;2(e),
provided that the Beneficial Ownership Limitation in no event exceeds 9.99% of the number of shares of the Common Stock outstanding immediately
after giving effect to the issuance of shares of Common Stock upon exercise of this Warrant held by the Holder and the provisions of
this Section&#8239;2(e)&#8239;shall continue to apply. Any increase in the Beneficial Ownership Limitation will not be effective until
the 61<SUP>st</SUP> day after such notice is delivered to the Company. The provisions of this paragraph shall be construed and implemented
in a manner otherwise than in strict conformity with the terms of this Section&#8239;2(e)&#8239;to correct this paragraph (or any portion
hereof) which may be defective or inconsistent with the intended Beneficial Ownership Limitation herein contained or to make changes
or supplements necessary or desirable to properly give effect to such limitation. The limitations contained in this paragraph shall apply
to a successor holder of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section&#8239;3</U></FONT><FONT STYLE="font-size: 10pt">.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Certain
Adjustments</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Stock
Dividends and Splits</U>. If the Company, at any time while this Warrant is outstanding: (i)&#8239;pays a stock dividend or otherwise
makes a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares
of Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise of this
Warrant), (ii)&#8239;subdivides outstanding shares of Common Stock into a larger number of shares, (iii)&#8239;combines (including by
way of reverse stock split) outstanding shares of Common Stock into a smaller number of shares, or (iv)&#8239;issues by reclassification
of shares of the Common Stock any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by
a fraction of which the numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately
before such event and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event,
and the number of shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price
of this Warrant shall remain unchanged. Any adjustment made pursuant to this Section&#8239;3(a)&#8239;shall become effective immediately
after the record date for the determination of stockholders entitled to receive such dividend or distribution and shall become effective
immediately after the effective date in the case of a subdivision, combination or re-classification.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Subsequent
Rights Offerings</U>. In addition to any adjustments pursuant to Section&#8239;3(a)&#8239;above, if at any time the Company grants, issues
or sells any Common Stock Equivalents or rights to purchase stock, warrants, securities or other property pro rata to the record holders
of any class of shares of Common Stock (the &ldquo;<U>Purchase Rights</U>&rdquo;), then the Holder will be entitled to acquire, upon
the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had held
the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise
hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date on which a record is taken for
the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders of shares
of Common Stock are to be determined for the grant, issue or sale of such Purchase Rights (<U>provided</U>, <U>however</U>, that, to
the extent that the Holder&rsquo;s right to participate in any such Purchase Right would result in the Holder exceeding the Beneficial
Ownership Limitation, then the Holder shall not be entitled to participate in such Purchase Right to such extent (or beneficial ownership
of such shares of Common Stock as a result of such Purchase Right to such extent) and such Purchase Right to such extent shall be held
in abeyance for the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership
Limitation).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Pro
Rata Distributions</U>. During such time as this Warrant is outstanding, if the Company shall declare or make any dividend or other distribution
of its assets (or rights to acquire its assets) to holders of shares of Common Stock, by way of return of capital or otherwise (including,
without limitation, any distribution of cash, stock or other securities, property or options by way of a dividend, spin off, reclassification,
corporate rearrangement, scheme of arrangement or other similar transaction) (a &ldquo;<U>Distribution</U>&rdquo;), at any time after
the issuance of this Warrant, then, in each such case, the Holder shall within five trading days of such dividend, distribution or right
being declared or made be entitled to complete exercise of this Warrant and participate in such Distribution to the same extent that
the Holder would have participated therein if the Holder had held the number of shares of Common Stock in respect of which exercise is
made immediately before the date of which a record is taken for such Distribution, or, if no such record is taken, the date as of which
the record holders of shares of Common Stock are to be determined for the participation in such Distribution (<U>provided</U>, <U>however</U>,
that, to the extent that the Holder's right to participate in any such Distribution would result in the Holder exceeding the Beneficial
Ownership Limitation, then the Holder shall not be entitled to participate in such Distribution to such extent (or in the beneficial
ownership of any shares of Common Stock as a result of such Distribution to such extent) and the portion of such Distribution shall be
held in abeyance for the benefit of the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding
the Beneficial Ownership Limitation).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Fundamental
Transaction</U>. If, at any time while this Warrant is outstanding, (i)&#8239;the Company, directly or indirectly, in one or more related
transactions effects any merger or consolidation of the Company with or into another Person (excluding a merger effected solely to change
the Company&rsquo;s name), (ii)&#8239;the Company (and all of its Subsidiaries, taken as a whole), directly or indirectly, effects any
sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially all of its assets in one or a series
of related transactions, (iii)&#8239;any, direct or indirect, purchase offer, tender offer or exchange offer (whether by the Company
or another Person) is completed pursuant to which holders of Common Stock are permitted to sell, tender or exchange their shares for
other securities, cash or property and has been accepted by the holders of 50% or more of the outstanding Common Stock, (iv)&#8239;the
Company, directly or indirectly, in one or more related transactions effects any reclassification, reorganization or recapitalization
of the Common Stock or any compulsory share exchange pursuant to which the Common Stock is effectively converted into or exchanged for
other securities, cash or property, or (v)&#8239;the Company, directly or indirectly, in one or more related transactions consummates
a stock or share purchase agreement or other business combination (including, without limitation, a reorganization, recapitalization,
spin-off, merger or scheme of arrangement) with another Person or group of Persons whereby such other Person or group acquires more than
50% of the outstanding shares of Common Stock or 50% or more of the voting power of the common equity of the Company (each a &ldquo;<U>Fundamental
Transaction) </U>then if holders of Common Stock are given any choice as to the securities, cash or property to be received in a Fundamental
Transaction, then the Holder shall be given the same choice as to the Alternate Consideration it receives upon any exercise of this Warrant
following such Fundamental Transaction. Notwithstanding anything to the contrary, in the event of a Fundamental Transaction, the Company
or any Successor Entity (as defined below) shall, at the Holder&rsquo;s option, exercisable at any time concurrently with, or within
30 days after, the consummation of the Fundamental Transaction (or, if later, the date of the public announcement of the applicable Fundamental
Transaction), purchase this Warrant from the Holder by paying to the Holder an amount of cash equal to the Black Scholes Value (as defined
below) of the remaining unexercised portion of this Warrant on the date of the consummation of such Fundamental Transaction; provided,
however, that if the Fundamental Transaction is not within the Company's control, including not approved by the Company's Board of Directors,
Holder shall only be entitled to receive from the Company or any Successor Entity the same type or form of consideration (and in the
same proportion), at the Black Scholes Value of the unexercised portion of this Warrant, that is being offered and paid to the holders
of Common Stock of the Company in connection with the Fundamental Transaction, whether that consideration be in the form of cash, stock
or any combination thereof, or whether the holders of Common Stock are given the choice to receive from among alternative forms of consideration
in connection with the Fundamental Transaction; provided, further, that if holders of Common Stock of the Company are not offered or
paid any consideration in such Fundamental Transaction, such holders of Common Stock will be deemed to have received common stock of
the Successor Entity (which Entity may be the Company following such Fundamental Transaction) in such Fundamental Transaction. &ldquo;<U>Black
Scholes Value</U>&rdquo; means the value of this Warrant based on the Black Scholes Option Pricing Model obtained from the &ldquo;OV&rdquo;
function on Bloomberg determined as of the day of consummation of the applicable Fundamental Transaction for pricing purposes and reflecting
(A)&#8239;a risk-free interest rate corresponding to the U.S. Treasury rate for a period equal to the time between the date of the public
announcement of the applicable Fundamental Transaction and the Termination Date, (B)&#8239;an expected volatility equal to the 100 day
volatility obtained from the HVT function on Bloomberg (determined utilizing a 365-day annualization factor) as of the Trading Day immediately
following the public announcement of the applicable Fundamental Transaction, (C)&#8239;the underlying price per share used in such calculation
shall be the greater of (i)&#8239;the sum of the price per share being offered in cash, if any, plus the value of any non-cash consideration,
if any, being offered in such Fundamental Transaction and (ii)&#8239;the highest VWAP during the period beginning on the Trading Day
immediately preceding the announcement of the applicable Fundamental Transaction (or the consummation of the applicable Fundamental Transaction,
if earlier) and ending on the Trading Day of the Holder&rsquo;s request pursuant to this Section&#8239;3(d)&#8239;and (D)&#8239;a remaining
option time equal to the time between the date of the public announcement of the applicable Fundamental Transaction and the Termination
Date and (E)&#8239;a zero cost of borrow. The payment of the Black Scholes Value will be made by wire transfer of immediately available
funds (or such other consideration) within the later of five (5)&#8239;Trading Days of the Holder&rsquo;s election.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Calculations</U>.
All calculations under this Section&#8239;3 shall be made to the nearest cent or the nearest 1/100th of a share, as the case may be.
For purposes of this Section&#8239;3, the number of shares of Common Stock deemed to be issued and outstanding as of a given date shall
be the sum of the number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Notice
to Holder</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Adjustment
to Exercise Price</U>. Whenever the Exercise Price is adjusted pursuant to any provision of this Section&#8239;3, the Company shall promptly
deliver to the Holder by email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment to the number
of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Notice
to Allow Exercise by Holder</U>. If (A)&#8239;the Company shall declare a dividend (or any other distribution in whatever form) on the
Common Stock, (B)&#8239;the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C)&#8239;the
Company shall authorize the granting to all holders of the Common Stock rights or warrants to subscribe for or purchase any shares of
capital stock of any class or of any rights, (D)&#8239;the approval of any stockholders of the Company shall be required in connection
with any reclassification of the Common Stock, any consolidation or merger to which the Company (or any of its Subsidiaries) is a party,
any sale or transfer of all or substantially all of its assets, or any compulsory share exchange whereby the Common Stock is converted
into other securities, cash or property, or (E)&#8239;the Company shall authorize the voluntary or involuntary dissolution, liquidation
or winding up of the affairs of the Company, then, in each case, the Company shall cause to be delivered by email to the Holder at its
last email address as it shall appear upon the Warrant Register of the Company, at least 20 calendar days prior to the applicable record
or effective date hereinafter specified, a notice stating (x)&#8239;the date on which a record is to be taken for the purpose of such
dividend, distribution, redemption, rights or warrants, or if a record is not to be taken, the date as of which the holders of the Common
Stock of record to be entitled to such dividend, distributions, redemption, rights or warrants are to be determined or (y)&#8239;the
date on which such reclassification, consolidation, merger, sale, transfer or share exchange is expected to become effective or close,
and the date as of which it is expected that holders of the Common Stock of record shall be entitled to exchange their shares of the
Common Stock for securities, cash or other property deliverable upon such reclassification, consolidation, merger, sale, transfer or
share exchange; provided that the failure to deliver such notice or any defect therein or in the delivery thereof shall not affect the
validity of the corporate action required to be specified in such notice. To the extent that any notice provided in this Warrant constitutes,
or contains, material, non-public information regarding the Company or any of the Subsidiaries, the Company shall simultaneously file
such notice with the Commission pursuant to a Current Report on Form&#8239;8-K. The Holder shall remain entitled to exercise this Warrant
during the period commencing on the date of such notice to the effective date of the event triggering such notice except as may otherwise
be expressly set forth herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section&#8239;4</U></FONT><FONT STYLE="font-size: 10pt">.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Transfer
of Warrant</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Transferability</U>.
Subject to compliance with any applicable securities laws and the conditions set forth in Section&#8239;4(d)&#8239;hereof and to the
provisions of Section&#8239;4.1 of the Purchase Agreement, this Warrant and all rights hereunder (including, without limitation, any
registration rights) are transferable, in whole or in part, upon surrender of this Warrant at the principal office of the Company or
its designated agent, together with a written assignment of this Warrant substantially in the form attached hereto duly executed by the
Holder or its agent or attorney and funds sufficient to pay any transfer taxes payable upon the making of such transfer. Upon such surrender
and, if required, such payment, the Company shall execute and deliver a new Warrant or Warrants in the name of the assignee or assignees,
as applicable, and in the denomination or denominations specified in such instrument of assignment, and shall issue to the assignor a
new Warrant evidencing the portion of this Warrant not so assigned, and this Warrant shall promptly be cancelled. Notwithstanding anything
herein to the contrary, the Holder shall not be required to physically surrender this Warrant to the Company unless the Holder has assigned
this Warrant in full, in which case, the Holder shall surrender this Warrant to the Company within three (3)&#8239;Trading Days of the
date on which the Holder delivers an assignment form to the Company assigning this Warrant in full. The Warrant, if properly assigned
in accordance herewith, may be exercised by a new holder for the purchase of Warrant Shares without having a new Warrant issued.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>New
Warrants</U>. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of the Company,
together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by the Holder or
its agent or attorney. Subject to compliance with Section&#8239;4(a), as to any transfer which may be involved in such division or combination,
the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided or combined in
accordance with such notice. All Warrants issued on transfers or exchanges shall be dated the original Issue Date and shall be identical
with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Warrant
Register</U>. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the &ldquo;<U>Warrant
Register</U>&rdquo;), in the name of the record Holder hereof from time to time. The Company may deem and treat the registered Holder
of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder, and for all other
purposes, absent actual notice to the contrary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Transfer
Restrictions</U>. If, at the time of the surrender of this Warrant in connection with any transfer of this Warrant, the transfer of this
Warrant shall not be either (i)&#8239;registered pursuant to an effective registration statement under the Securities Act and under applicable
state securities or blue sky laws or (ii)&#8239;eligible for resale without volume or manner-of-sale restrictions or current public information
requirements pursuant to Rule&#8239;144, the Company may require, as a condition of allowing such transfer, that the Holder or transferee
of this Warrant, as the case may be, comply with the provisions of Section&#8239;5.7 of the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Representation
by the Holder</U>. The Holder, by the acceptance hereof, represents and warrants that it is acquiring this Warrant and, upon any exercise
hereof, will acquire the Warrant Shares issuable upon such exercise, for its own account and not with a view to or for distributing or
reselling such Warrant Shares or any part thereof in violation of the Securities Act or any applicable state securities law, except pursuant
to sales registered or exempted under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section&#8239;5</U></FONT><FONT STYLE="font-size: 10pt">.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Miscellaneous</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>No
Rights as Stockholder Until Exercise; No Settlement in Cash</U>. This Warrant does not entitle the Holder to any voting rights, dividends
or other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section&#8239;2(d)(i), except as expressly
set forth in Section&#8239;3. Without limiting any rights of a Holder to receive Warrant Shares on a &ldquo;cashless exercise&rdquo;
pursuant to Section&#8239;2(c)&#8239;or to receive cash payments pursuant to Section&#8239;2(d)(i)&#8239;and Section&#8239;2(d)(iv)&#8239;herein,
in no event shall the Company be required to net cash settle an exercise of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Loss,
Theft, Destruction or Mutilation of Warrant</U>. The Company covenants that upon receipt by the Company of evidence reasonably satisfactory
to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares, and in case
of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant, shall not include
the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the Company will make
and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant or stock certificate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Saturdays,
Sundays, Holidays,&#8239;etc</U>. If the last or appointed day for the taking of any action or the expiration of any right required or
granted herein shall not be a Trading Day, then such action may be taken or such right may be exercised on the next succeeding Trading
Day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Authorized
Shares</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">The Company covenants
that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued Common Stock a sufficient number
of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant. The Company
further covenants that its issuance of this Warrant shall constitute full authority to its officers who are charged with the duty of
issuing the necessary Warrant Shares upon the exercise of the purchase rights under this Warrant. The Company will take all such reasonable
action as may be necessary to assure that such Warrant Shares may be issued as provided herein without violation of any applicable law
or regulation, or of any requirements of the Trading Market upon which the Common Stock may be listed. The Company covenants that all
Warrant Shares which may be issued upon the exercise of the purchase rights represented by this Warrant will, upon exercise of the purchase
rights represented by this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized, validly issued, fully
paid and nonassessable and free from all taxes, liens and charges created by the Company in respect of the issue thereof (other than
taxes in respect of any transfer occurring contemporaneously with such issue).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">Except and to the
extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending its certificate
of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities or
any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant, but will at all
times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary or appropriate
to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality of the foregoing, the
Company will (i)&#8239;not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise immediately
prior to such increase in par value, (ii)&#8239;take all such action as may be necessary or appropriate in order that the Company may
validly and legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii)&#8239;use commercially
reasonable efforts to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof,
as may be, necessary to enable the Company to perform its obligations under this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">Before taking any
action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the Exercise Price,
the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from any public regulatory
body or bodies having jurisdiction thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Jurisdiction</U>.
All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be determined in accordance
with the provisions of the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Restrictions</U>.
The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, and the Holder does not
utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">g)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Nonwaiver
and Expenses</U>. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall operate as
a waiver of such right or otherwise prejudice the Holder&rsquo;s rights, powers or remedies. Without limiting any other provision of
this Warrant or the Purchase Agreement, if the Company willfully and knowingly fails to comply with any provision of this Warrant, which
results in any material damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover any costs
and expenses including, but not limited to, reasonable attorneys&rsquo; fees, including those of appellate proceedings, incurred by the
Holder in collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">h)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Notices</U>.
Any notice, request or other document required or permitted to be given or delivered to the Holder by the Company shall be delivered
in accordance with the notice provisions of the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Limitation
of Liability</U>. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant to purchase Warrant
Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder for the purchase
price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company or by creditors of the
Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">j)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Remedies</U>.
The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will be entitled to specific
performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate compensation for any loss
incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to assert the defense in any
action for specific performance that a remedy at law would be adequate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">k)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Successors
and Assigns</U>. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall inure to the
benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns of Holder.
The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall be enforceable
by the Holder or holder of Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">l)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Amendment</U>.
This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company and the Holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">m)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Severability</U>.
Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid under applicable law,
but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective to the
extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining provisions of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">n)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Headings</U>.
The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed a part of this
Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">********************</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>(Signature Page&#8239;Follows)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">IN WITNESS WHEREOF, the Company
has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above indicated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD COLSPAN="2"><FONT STYLE="text-transform: uppercase"><B>T Stamp,&#8239;Inc.</B></FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD COLSPAN="2">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 50%">&nbsp;</TD>
  <TD STYLE="width: 3%">By:</TD>
  <TD STYLE="border-bottom: Black 1pt solid; width: 47%"></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD>
  <TD>Name:</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD>
  <TD>Title:</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOTICE OF EXERCISE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">To:</FONT><FONT STYLE="text-transform: uppercase">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">t
stamp Inc.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)
</FONT><FONT STYLE="font-size: 10pt">The undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the
terms of the attached Warrant (only if exercised in full), and tenders herewith payment of the exercise price in full, together with
all applicable transfer taxes, if any.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)
</FONT><FONT STYLE="font-size: 10pt">Payment shall take the form of (check applicable box):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify"><FONT STYLE="font-family: Wingdings">&#168;
</FONT>in lawful money of the United States; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify"><FONT STYLE="font-family: Wingdings">&#168;
</FONT>if permitted the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection
2(c), to exercise this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure
set forth in subsection 2(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)
</FONT><FONT STYLE="font-size: 10pt">Please issue said Warrant Shares in the name of the undersigned or in such other name as is specified
below:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Warrant Shares shall be delivered to the
following DWAC Account Number:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(4)&#8239;<U>Accredited Investor</U>.
The undersigned is an &ldquo;accredited investor&rdquo; as defined in Regulation D promulgated under the Securities Act of 1933, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="text-transform: uppercase">[SIGNATURE
OF HOLDER]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 17%">Name of Investing Entity:</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 83%">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: italic 10pt Times New Roman, Times, Serif; width: 35%">Signature of Authorized Signatory of Investing Entity:</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: italic 10pt Times New Roman, Times, Serif; width: 65%">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 20%">Name of Authorized Signatory:</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 80%">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 20%">Title of Authorized Signatory:</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 80%">&nbsp;</TD></TR>
</TABLE>

<P STYLE="margin: 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%">Date:</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 95%">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXHIBIT&#8239;B</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">ASSIGNMENT FORM</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><I>(To assign the foregoing Warrant, execute
this form and supply required information. Do not use this form to purchase shares.)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">FOR VALUE RECEIVED, the foregoing Warrant and all rights evidenced
thereby are hereby assigned to</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: justify"></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Please
    Print)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: justify"></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#8239;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P></TD>
    <TD><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(Please Print)</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2">Phone Number:</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2">Email Address:</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated:
    _______________ __, ______</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify">&#8239;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; text-align: justify; width: 13%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s
    Signature:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: justify; width: 37%">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: justify; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s
    Address:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 16; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8239;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>5
<FILENAME>tm2317786d1_ex5-1.htm
<DESCRIPTION>EXHIBIT 5.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>Exhibit 5.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><IMG SRC="tm2317786d1_ex5-1img001.jpg" ALT="Graphic" STYLE="height: 157px; width: 346px"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">June 5, 2023</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Board of Directors</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">3017 Bolling Way NE, Floors 1 and 2,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Atlanta, Georgia, 30305, USA</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">To the Board of Directors:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are acting as counsel
to T Stamp Inc., a Delaware corporation (the &ldquo;<B><I>Company</I></B>&rdquo;), in connection with the issuance and sale of (i) 736,400
shares (the &ldquo;<B><I>Shares</I></B>&rdquo;) of the Company&rsquo;s Class A Common Stock, par value $0.01 per share (the &ldquo;<B><I>Class
A Common Stock</I></B>&rdquo;), (ii) pre-funded warrants (the &ldquo;<B><I>Pre-Funded Warrants</I></B>&rdquo;) to purchase up to 543,300
shares (the &ldquo;<B><I>Pre-Funded Warrant Shares</I></B>&rdquo;) of Class A Common Stock pursuant to the Registration Statement on
Form S-3 (File No. 333-271091), filed with the Securities and Exchange Commission (the &ldquo;<B><I>SEC</I></B>&rdquo;) under the Securities
Act of 1933, as amended (the &ldquo;<B><I>Act</I></B>&rdquo;), on April 3, 2023 (the &ldquo;<B><I>Registration Statement</I></B>&rdquo;)
and which became effective on April 12, 2023, the related base prospectus, dated April 3, 2023 (the &ldquo;<B><I>Base Prospectus</I></B>&rdquo;),
and the prospectus supplement, dated June 1, 2023 (the &ldquo;<B><I>Prospectus Supplement</I></B>&rdquo; and together with the Base Prospectus,
the &ldquo;<B><I>Prospectus</I></B>&rdquo;), filed with the SEC pursuant to Rule 424(b) under the Act. Herein, we refer to the Shares,
Pre-Funded Warrants, and Pre-Funded Warrant Shares as the &ldquo;<B><I>Securities</I></B>.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In connection with this opinion
letter, we have examined the Registration Statement, the Prospectus, the Securities Purchase Agreement dated June 1, 2023 (the &ldquo;<B><I>Purchase
Agreement</I></B>&rdquo;) by and between the Company and the purchaser party thereto (the &ldquo;<B><I>Purchaser</I></B>&rdquo;), the
form of Pre-Funded Warrants, the amended and restated certificate of incorporation of the Company, as amended, the bylaws of the Company,
and such other documents or records necessary in our estimation to render an opinion. In our examination, we have assumed the legal capacity
of all natural persons, the genuineness of all signatures, the authenticity of all documents submitted to us as originals, the conformity
to original documents of all documents submitted to us as certified or photostatic copies and the authenticity of the originals of such
copies.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have further assumed that
the Securities will be issued and sold in the manner stated in the Registration Statement and the Prospectus, and in compliance with
the applicable provisions of the Act and the rules and regulations of the SEC thereunder and the securities or blue sky laws of various
states and the terms and conditions of the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Based on and subject to the
foregoing and the other limitations, qualifications and assumptions set forth herein, we are of the opinion that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Securities have been
    duly authorized for issuance by the Company.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Shares, when duly registered
    on the books of the transfer agent and registrar in the name and on behalf of the Purchaser and when issued and sold by the Company
    and delivered against payment therefor in accordance with the terms of the Purchase Agreement, will be validly issued, fully paid
    and non-assessable.</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Pre-Funded Warrants,
    when issued and sold by the Company and delivered against payment therefor in accordance with the terms of the Purchase Agreement,
    such Pre-Funded Warrants will be valid and binding obligations of the Company, enforceable against the Company in accordance with
    their terms.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Pre-Funded Warrant
    Shares, when duly registered on the books of the transfer agent and registrar in the name and on behalf of the holders and when issued
    and delivered by the Company upon exercise and payment of the applicable exercise price of the Pre-Funded Warrants, will be validly
    issued, fully paid and non-assessable.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have assumed that, at
the time of the issuance, sale and delivery of the Pre-Funded Warrant Shares: (i) the authorization thereof by the Company will not have
been modified or rescinded, and there will not have occurred any change in law affecting the validity thereof; (ii) the amended and restated
certificate of incorporation, as amended, of the Company and the bylaws of the Company, each as currently in effect, will not have been
modified or amended and will be in full force and effect; and (iii) there will be a sufficient number of shares of Class A Common Stock
authorized and then available for issuance under the certificate of incorporation of the Company as then in effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our opinions are subject
to bankruptcy, insolvency, reorganization, moratorium, fraudulent conveyance, fraudulent transfer and other similar laws relating to
or affecting creditors&rsquo; rights generally and to general equitable principles (regardless of whether considered in a proceeding
in equity or at law), including concepts of commercial reasonableness, good faith and fair dealing and the possible unavailability of
specific performance or injunctive relief.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">With respect to each instrument
or agreement referred to in or otherwise relevant to the opinions set forth herein (each, an &ldquo;<B><I>Instrument</I></B>&rdquo;),
we have assumed, to the extent relevant to the opinions set forth herein, that (i) each party to such Instrument (if not a natural person)
was duly organized or formed, as the case may be, and at all relevant times was, is and will be validly existing and in good standing
under the laws of its jurisdiction of organization or formation, as the case may be, and at all relevant times had, has and will have
full right, power and authority to execute, deliver and perform its obligations under such Instrument; (ii) such Instrument has been
duly authorized, executed and delivered by each party thereto; and (iii) such Instrument at all relevant times was, is and will be a
valid, binding and enforceable agreement or obligation, as the case may be, of, each party thereto; provided, that we make no assumption
insofar as such assumption relates to the Company and is expressly covered by our opinions set forth herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are opining herein as
to the effect on the subject transactions only of the laws of the State of Delaware, and we express no opinion with respect to the applicability
thereto, or the effect thereon, of the laws of any other jurisdiction, including federal law.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">No opinion is being rendered
hereby with respect to the truth and accuracy, or completeness of the Registration Statement, Prospectus, or any portion thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We further consent to the use of this opinion
as an exhibit to the Registration Statement and to the reference to our firm under the caption &ldquo;Legal Matters&rdquo; in the Prospectus.
In giving such consent, we do not hereby admit that we are within the category of persons whose consent is required under Section 7 of
the Securities Act or the rules or regulations of the Commission thereunder.</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 50%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Yours truly,</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P></TD>
    <TD STYLE="width: 50%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>/s/ CrowdCheck Law, LLP</I></P></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">AS/GA</FONT></TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>6
<FILENAME>tm2317786d1_ex10-1.htm
<DESCRIPTION>EXHIBIT 10.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: right; margin: 0"><B>Exhibit 10.1</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>SECURITIES
PURCHASE AGREEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Securities Purchase Agreement
(this &ldquo;<U>Agreement</U>&rdquo;) is dated as of June&nbsp;1, 2023, between T Stamp Inc., a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;),
and each purchaser identified on the signature pages&nbsp;hereto (each, including its successors and assigns, a &ldquo;<U>Purchaser</U>&rdquo;
and collectively the &ldquo;<U>Purchasers</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, subject to the terms
and conditions set forth in this Agreement and pursuant to (i)&nbsp;an effective registration statement under the Securities Act (as defined
below) as to the Shares and Prefunded Warrants and (ii)&nbsp;an exemption from the registration requirements of Section&nbsp;5 of the
Securities Act contained in Section&nbsp;4(a)(2)&nbsp;thereof and/or Regulation D thereunder as to the Warrants, the Company desires to
issue and sell to each Purchaser, and each Purchaser, severally and not jointly, desires to purchase from the Company, securities of the
Company as more fully described in this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">NOW, THEREFORE,&nbsp;IN CONSIDERATION
of the mutual covenants contained in this Agreement, and for other good and valuable consideration the receipt and adequacy of which are
hereby acknowledged, the Company and each Purchaser agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>ARTICLE&nbsp;I.</B></FONT><BR>
DEFINITIONS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Definitions</U>.
In addition to the terms defined elsewhere in this Agreement, for all purposes of this Agreement, the following terms have the meanings
set forth in this Section&nbsp;1.1:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<U>Acquiring Person</U>&rdquo;
shall have the meaning ascribed to such term in Section&nbsp;4.5.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Action</U>&rdquo;
shall have the meaning ascribed to such term in Section&nbsp;3.1(j).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Affiliate</U>&rdquo;
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control
with a Person as such terms are used in and construed under Rule&nbsp;405 under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Board
of Directors</U>&rdquo; means the board of directors of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Business
Day</U>&rdquo; means any day other than Saturday, Sunday or other day on which commercial banks in The City of New York are authorized
or required by law to remain closed; <U>provided</U>, <U>however</U>, for clarification, commercial banks shall not be deemed to be authorized
or required by law to remain closed due to &ldquo;stay at home&rdquo;, &ldquo;shelter-in-place&rdquo;, &ldquo;non-essential employee&rdquo;&nbsp;
or any other similar orders or restrictions or the closure of any physical branch locations at the direction of any governmental authority
so long as the electronic funds transfer systems (including for wire transfers) of commercial banks in The City of New York generally
are open for use by customers on such day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Closing</U>&rdquo;
means the closing of the purchase and sale of the Securities pursuant to Section&nbsp;2.1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Closing
Date</U>&rdquo; means the Trading Day on which all of the Transaction Documents have been executed and delivered by the applicable parties
thereto, and all conditions precedent to (i)&nbsp;the Purchasers&rsquo; obligations to pay the Subscription Amount and (ii)&nbsp;the Company&rsquo;s
obligations to deliver the Securities, in each case, have been satisfied or waived, but in no event later than the second (2<SUP>nd</SUP>)
Trading Day following the date hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Commission</U>&rdquo;
means the United States Securities and Exchange Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Common
Stock</U>&rdquo; means the Class&nbsp;A common stock of the Company, par value $0.01 per share, and any other class of securities into
which such securities may hereafter be reclassified or changed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Common
Stock Equivalents</U>&rdquo; means any securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire
at any time Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument that is
at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Company
Counsel</U>&rdquo; means CrowdCheck Law LLP.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Disclosure
Schedules</U>&rdquo; means the Disclosure Schedules of the Company delivered concurrently herewith.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Disclosure
Time</U>&rdquo; means, (i)&nbsp;if this Agreement is signed on a day that is not a Trading Day or after 9:00 a.m.&nbsp;(New York City
time) and before midnight (New York City time) on any Trading Day, 9:01 a.m.&nbsp;(New York City time) on the Trading Day immediately
following the date hereof, unless otherwise instructed as to an earlier time by the Placement Agent, and (ii)&nbsp;if this Agreement is
signed between midnight (New York City time) and 9:00 a.m.&nbsp;(New York City time) on any Trading Day, no later than 9:01 a.m.&nbsp;(New
York City time) on the date hereof, unless otherwise instructed as to an earlier time by the Placement Agent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>EGS</U>&rdquo;
means Ellenoff Grossman&nbsp;&amp; Schole LLP, with offices located at 1345 Avenue of the Americas, New York, New York 10105-0302.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Evaluation
Date</U>&rdquo; shall have the meaning ascribed to such term in Section&nbsp;3.1(s).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Exchange
Act</U>&rdquo; means the Securities Exchange Act of 1934, as amended, and the rules&nbsp;and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Exempt
Issuance</U>&rdquo; means the issuance of (a)&nbsp;shares of Common Stock or options to employees, officers or directors of the Company
pursuant to any stock or option plan duly adopted for such purpose, by a majority of the non-employee members of the Board of Directors
or a majority of the members of a committee of non-employee directors established for such purpose for services rendered to the Company,
(b)&nbsp;securities upon the exercise or exchange of or conversion of any Securities issued hereunder, warrants to the Placement Agent
in connection with the transactions pursuant to this Agreement and any securities upon exercise of warrants to the Placement Agent and/or
other securities exercisable or exchangeable for or convertible into shares of Common Stock issued and outstanding on the date of this
Agreement, provided that such securities have not been amended since the date of this Agreement to increase the number of such securities
or to decrease the exercise price, exchange price or conversion price of such securities (other than in connection with stock splits or
combinations) or to extend the term of such securities, and (c)&nbsp;securities issued pursuant to acquisitions or strategic transactions
approved by a majority of the disinterested directors of the Company, provided that such securities are issued as &ldquo;restricted securities&rdquo;
(as defined in Rule&nbsp;144) and carry no registration rights that require or permit the filing of any registration statement in connection
therewith during the prohibition period in Section&nbsp;4.12(a)&nbsp;herein, and provided that any such issuance shall only be to a Person
(or to the equityholders of a Person) which is, itself or through its subsidiaries, an operating company or an owner of an asset in a
business synergistic with the business of the Company and shall provide to the Company additional benefits in addition to the investment
of funds, but shall not include a transaction in which the Company is issuing securities primarily for the purpose of raising capital
or to an entity whose primary business is investing in securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>FCPA</U>&rdquo;
means the Foreign Corrupt Practices Act of 1977, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>FDA</U>&rdquo;
shall have the meaning ascribed to such term in Section&nbsp;3.1(hh).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>FDCA</U>&rdquo;
shall have the meaning ascribed to such term in Section&nbsp;3.1(hh).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>GAAP</U>&rdquo;
shall have the meaning ascribed to such term in Section&nbsp;3.1(h).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Indebtedness</U>&rdquo;
shall have the meaning ascribed to such term in Section&nbsp;3.1(aa).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Intellectual
Property Rights</U>&rdquo; shall have the meaning ascribed to such term in Section&nbsp;3.1(p).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Legend
Removal Date</U>&rdquo; shall have the meaning ascribed to such term in Section&nbsp;4.1(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Liens</U>&rdquo;
means a lien, charge, pledge, security interest, encumbrance, right of first refusal, preemptive right or other restriction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Lock-Up
Agreement</U>&rdquo; means the Lock-Up Agreement, dated as of the date hereof, by and among the Company and the directors and officers,
in the form of <U>Exhibit&nbsp;B</U> attached hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Material
Adverse Effect</U>&rdquo; shall have the meaning assigned to such term in Section&nbsp;3.1(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Material
Permits</U>&rdquo; shall have the meaning ascribed to such term in Section&nbsp;3.1(n).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Per Share
Purchase Price</U>&rdquo; equals $2.30, subject to adjustment for reverse and forward stock splits, stock dividends, stock combinations
and other similar transactions of the Common Stock that occur after the date of this Agreement, provided that the purchase price per Prefunded
Warrant shall be the Per Share Purchase Price minus $0.001.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Person</U>&rdquo;
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability company,
joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Pharmaceutical
Product</U>&rdquo; shall have the meaning ascribed to such term in Section&nbsp;3.1(hh).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Placement
Agent</U>&rdquo; means Maxim Group LLC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Prefunded
Warrant</U>&rdquo; means, collectively, the Prefunded Common Stock purchase warrants delivered to the Purchasers at the Closing in accordance
with Section&nbsp;2.2(a)&nbsp;hereof, which Prefunded Warrants shall be exercisable immediately and shall expire when exercised in full,
in the form of <U>Exhibit&nbsp;C</U> attached hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Prefunded
Warrant Shares</U>&rdquo; means the shares of Common Stock issuable upon exercise of the Prefunded Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Proceeding</U>&rdquo;
means an action, claim, suit, investigation or proceeding (including, without limitation, an informal investigation or partial proceeding,
such as a deposition), whether commenced or threatened.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Prospectus</U>&rdquo;
means the final prospectus filed for the Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Prospectus
Supplement</U>&rdquo; means the supplement to the Prospectus complying with Rule&nbsp;424(b)&nbsp;of the Securities Act that is filed
with the Commission and delivered by the Company to each Purchaser at the Closing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Purchaser
Party</U>&rdquo; shall have the meaning ascribed to such term in Section&nbsp;4.8.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Registration
Statement</U>&rdquo; means the effective registration statement with Commission file No.&nbsp;333-271091 which registers the sale of the
Shares and the Prefunded Warrants to the Purchasers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Required
Approvals</U>&rdquo; shall have the meaning ascribed to such term in Section&nbsp;3.1(e).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Rule&nbsp;144</U>&rdquo;
means Rule&nbsp;144 promulgated by the Commission pursuant to the Securities Act, as such Rule&nbsp;may be amended or interpreted from
time to time, or any similar rule&nbsp;or regulation hereafter adopted by the Commission having substantially the same purpose and effect
as such Rule.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Rule&nbsp;424</U>&rdquo;
means Rule&nbsp;424 promulgated by the Commission pursuant to the Securities Act, as such Rule&nbsp;may be amended or interpreted from
time to time, or any similar rule&nbsp;or regulation hereafter adopted by the Commission having substantially the same purpose and effect
as such Rule.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>SEC Reports</U>&rdquo;
shall have the meaning ascribed to such term in Section&nbsp;3.1(h).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Securities</U>&rdquo;
means the Shares, the Warrants and the Warrant Shares and the Prefunded Warrants and Prefunded Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Securities
Act</U>&rdquo; means the Securities Act of 1933, as amended, and the rules&nbsp;and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Shares</U>&rdquo;
means the shares of Common Stock issued or issuable to each Purchaser pursuant to this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Short
Sales</U>&rdquo; means all &ldquo;short sales&rdquo; as defined in Rule&nbsp;200 of Regulation SHO under the Exchange Act (but shall not
be deemed to include locating and/or borrowing shares of Common Stock).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Subscription
Amount</U>&rdquo; means, as to each Purchaser, the aggregate amount to be paid for Shares and Warrants and Prefunded Warrants purchased
hereunder as specified below such Purchaser&rsquo;s name on the signature page&nbsp;of this Agreement and next to the heading &ldquo;Subscription
Amount,&rdquo; in United States dollars and in immediately available funds (minus, if applicable, a Purchaser&rsquo;s aggregate exercise
price of the Prefunded Warrants, which amounts shall be paid as and when such Prefunded Warrants are exercised).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Subsidiary</U>&rdquo;
means any subsidiary of the Company as set forth on <U>Schedule 3.1(a)</U>, and shall, where applicable, also include any direct or indirect
subsidiary of the Company formed or acquired after the date hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Trading
Day</U>&rdquo; means a day on which the principal Trading Market is open for trading.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Trading
Market</U>&rdquo; means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date
in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, the New York Stock
Exchange, the Pink Market, OTCQB or the OTCQX (or any successors to any of the foregoing).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Transaction
Documents</U>&rdquo; means this Agreement, the Warrants, the Prefunded Warrants, all exhibits and schedules thereto and hereto and any
other documents or agreements executed in connection with the transactions contemplated hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Transfer
Agent</U>&rdquo; means Colonial Stock Transfer, the current transfer agent of the Company, and any successor transfer agent of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Variable
Rate Transaction</U>&rdquo; shall have the meaning ascribed to such term in Section&nbsp;4.12(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>VWAP</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a)&nbsp;if the Common Stock is then listed
or quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30
a.m.&nbsp;(New York City time) to 4:02 p.m.&nbsp;(New York City time)), (b)&nbsp; if the OTCQB Venture Market (&ldquo;<U>OTCQB</U>&rdquo;)
or the OTCQX Best Market (&ldquo;<U>OTCQX</U>&rdquo;) is not a Trading Market, the volume weighted average price of the Common Stock for
such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c)&nbsp;if the Common Stock is not then listed or quoted for
trading on OTCQB or OTCQX and if prices for the Common Stock are then reported in the Pink Open Market (&ldquo;<U>Pink Market</U>&rdquo;)
operated by OTC Markets,&nbsp;Inc. (or a similar organization or agency succeeding to its functions of reporting prices), the most recent
bid price per share of the Common Stock so reported, or (d)&nbsp;in all other cases, the fair market value of a share of Common Stock
as determined by an independent appraiser selected in good faith by the Purchasers of a majority in interest of the Securities then outstanding
and reasonably acceptable to the Company, the fees and expenses of which shall be paid by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Warrants</U>&rdquo;
means, collectively, the Common Stock purchase warrants delivered to the Purchasers at the Closing in accordance with Section&nbsp;2.2(a)&nbsp;hereof,
which Warrants shall be exercisable immediately and have a term of exercise equal to 5 years, in the form of <U>Exhibit&nbsp;A</U> attached
hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Warrant
Shares</U>&rdquo; means the shares of Common Stock issuable upon exercise of the Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>ARTICLE&nbsp;II.</B></FONT><BR>
PURCHASE AND SALE</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Closing</U>.
On the Closing Date, upon the terms and subject to the conditions set forth herein, the Company agrees to sell, and the Purchasers, severally
and not jointly, agree to purchase, up to an aggregate of $2,943,310.00 of Shares and Warrants; <U>provided</U>, <U>howeve</U>r, that,
to the extent that a Purchaser determines, in its sole discretion, that such Purchaser (together with such Purchaser&rsquo;s Affiliates,
and any Person acting as a group together with such purchaser or any of such Purchaser&rsquo;s Affiliates) would beneficially own in excess
of the Beneficial Ownership Limitation, or as such Purchaser may otherwise choose, in lieu of purchasing Shares such Purchaser may elect
to purchase Prefunded Warrants in lieu of Shares in such manner to result in the same aggregate purchase price being paid by such Purchaser
to the Company. The &ldquo;<U>Beneficial Ownership Limitation</U>&rdquo; shall be 4.99% (or, at the election of the Purchaser at Closing,
9.99%) of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of the Securities on the
Closing Date.] Each Purchaser&rsquo;s Subscription Amount as set forth on the signature page&nbsp;hereto executed by such Purchaser shall
be made available for &ldquo;Delivery Versus Payment&rdquo; settlement with the Company or its designee. The Company shall deliver to
each Purchaser its respective Shares and a Warrant as determined pursuant to Section&nbsp;2.2(a), and the Company and each Purchaser shall
deliver the other items set forth in Section&nbsp;2.2 deliverable at the Closing. Upon satisfaction of the covenants and conditions set
forth in Sections 2.2 and 2.3, the Closing shall take place remotely by electronic transfer of the Closing documentation. Notwithstanding
anything herein to the contrary, if at any time on or after the time of execution of this Agreement by the Company and an applicable Purchaser,
through, and including the time immediately prior to the Closing (the &ldquo;<U>Pre-Settlement Period</U>&rdquo;), such Purchaser sells
to any Person all, or any portion, of the Shares to be issued hereunder to such Purchaser at the Closing (collectively, the &ldquo;<U>Pre-Settlement
Shares</U>&rdquo;), such Purchaser shall, automatically hereunder (without any additional required actions by such Purchaser or the Company),
be deemed to be unconditionally bound to purchase, such Pre-Settlement Shares at the Closing; provided, that the Company shall not be
required to deliver any Pre-Settlement Shares to such Purchaser prior to the Company&rsquo;s receipt of the purchase price of such Pre-Settlement
Shares hereunder; and provided further that the Company hereby acknowledges and agrees that the forgoing shall not constitute a representation
or covenant by such Purchaser as to whether or not during the Pre-Settlement Period such Purchaser shall sell any shares of Common Stock
to any Person and that any such decision to sell any shares of Common Stock by such Purchaser shall solely be made at the time such Purchaser
elects to effect any such sale, if any. Unless otherwise directed by the Placement Agent, settlement of the Shares shall occur via &ldquo;Delivery
Versus Payment&rdquo; (&ldquo;<U>DVP</U>&rdquo;) (i.e., on the Closing Date, the Company shall issue the Shares registered in the Purchasers&rsquo;
names and addresses and released by the Transfer Agent directly to the account(s)&nbsp;at the Placement Agent identified by each Purchaser;
upon receipt of such Shares, the Placement Agent shall promptly electronically deliver such Shares to the applicable Purchaser, and payment
therefor shall be made by the Placement Agent (or its clearing firm) by wire transfer to the Company). Notwithstanding the foregoing,
with respect to any Notice(s)&nbsp;of Exercise (as defined in the Prefunded Warrants) delivered on or prior to 12:00 p.m.&nbsp;(New York
City time) on the Closing Date, which may be delivered at any time after the time of execution of this Agreement, the Company agrees to
deliver the Prefunded Warrant Shares subject to such notice(s)&nbsp;by 4:00 p.m.&nbsp;(New York City time) on the Closing Date and the
Closing Date shall be the Warrant Share Delivery Date (as defined in the Prefunded Warrants) for purposes hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.2</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Deliveries</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">On
or prior to the Closing Date (except as indicated below), the Company shall deliver or cause to be delivered to each Purchaser the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">this
Agreement duly executed by the Company;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">a
legal opinion of Company Counsel, substantially in the form acceptable to the Placement Agent and the Purchasers;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">subject
to the last sentence of Section&nbsp;2.1, the Company shall have provided each Purchaser with the Company&rsquo;s wire instructions, on
Company letterhead and executed by the Chief Executive Officer or Chief Financial Officer;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Subject
to the last sentence of Section&nbsp;2.1, a copy of the irrevocable instructions to the Transfer Agent instructing the Transfer Agent
to deliver on an expedited basis via The Depository Trust Company Deposit or Withdrawal at Custodian system (&ldquo;<U>DWAC</U>&rdquo;)
Shares equal to such Purchaser&rsquo;s Subscription Amount divided by the Per Share Purchase Price, registered in the name of such Purchaser;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">a
Warrant registered in the name of such Purchaser to purchase up to a number of shares of Common Stock equal to 100% of such Purchaser&rsquo;s
Shares and Prefunded Warrants, with an exercise price equal to $2.30, subject to adjustment therein;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">for
each Purchaser of Prefunded Warrants pursuant to Section&nbsp;2.1, a Prefunded Warrant registered in the name of such Purchaser to purchase
up to a number of shares of Common Stock equal to the portion of such Purchaser&rsquo;s Subscription Amount applicable to Prefunded Warrant
divided by the Per Share Purchase Price minus $0.001, with an exercise price equal to $0.001 per share, subject to adjustment therein;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vii)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">on
the date hereof, the duly executed Lock-Up Agreements; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(viii)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">the
Prospectus and Prospectus Supplement (which may be delivered in accordance with Rule&nbsp;172 under the Securities Act).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">On
or prior to the Closing Date, each Purchaser shall deliver or cause to be delivered to the Company the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">this
Agreement duly executed by such Purchaser; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">such
Purchaser&rsquo;s Subscription Amount, which shall be made available for &ldquo;Delivery Versus Payment&rdquo; settlement with the Company
or its designee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.3</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Closing
Conditions</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
obligations of the Company hereunder in connection with the Closing are subject to the following conditions being met:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">the
accuracy in all material respects (or, to the extent representations or warranties are qualified by materiality, in all respects) on the
Closing Date of the representations and warranties of the Purchasers contained herein (unless as of a specific date therein in which case
they shall be accurate in all material respects (or, to the extent representations or warranties are qualified by materiality, in all
respects) as of such date);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">all
obligations, covenants and agreements of each Purchaser required to be performed at or prior to the Closing Date shall have been performed;
and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">the
delivery by each Purchaser of the items set forth in Section&nbsp;2.2(b)&nbsp;of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
respective obligations of the Purchasers hereunder in connection with the Closing are subject to the following conditions being met:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">the
accuracy in all material respects (or, to the extent representations or warranties are qualified by materiality or Material Adverse Effect,
in all respects) when made and on the Closing Date of the representations and warranties of the Company contained herein (unless as of
a specific date therein in which case they shall be accurate in all respects or, to the extent representations or warranties are qualified
by materiality or Material Adverse Effect, in all respects) as of such date);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">all
obligations, covenants and agreements of the Company required to be performed at or prior to the Closing Date shall have been performed;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">the
delivery by the Company of the items set forth in Section&nbsp;2.2(a)&nbsp;of this Agreement;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">there
shall have been no Material Adverse Effect with respect to the Company;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">from
the date hereof to the Closing Date, trading in the Common Stock shall not have been suspended by the Commission or the Company&rsquo;s
principal Trading Market, and, at any time prior to the Closing Date, trading in securities generally as reported by Bloomberg L.P. shall
not have been suspended or limited, or minimum prices shall not have been established on securities whose trades are reported by such
service, or on any Trading Market, nor shall a banking moratorium have been declared either by the United States or New York State authorities
nor shall there have occurred any material outbreak or escalation of hostilities or other national or international calamity of such magnitude
in its effect on, or any material adverse change in, any financial market which, in each case, in the reasonable judgment of such Purchaser,
makes it impracticable or inadvisable to purchase the Securities at the Closing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>ARTICLE&nbsp;III.</B></FONT><BR>
REPRESENTATIONS AND WARRANTIES</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Representations
and Warranties of the Company</U>. Except as set forth in the Disclosure Schedules, which Disclosure Schedules shall be deemed a part
hereof and shall qualify any representation or otherwise made herein to the extent of the disclosure contained in the corresponding section
of the Disclosure Schedules, the Company hereby makes the following representations and warranties to each Purchaser:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Subsidiaries</U>.
All of the direct and indirect subsidiaries of the Company are set forth on <U>Schedule 3.1(a)</U>. The Company owns, directly or indirectly,
all of the capital stock or other equity interests of each Subsidiary free and clear of any Liens, and all of the issued and outstanding
shares of capital stock of each Subsidiary are validly issued and are fully paid, non-assessable and free of preemptive and similar rights
to subscribe for or purchase securities. If the Company has no subsidiaries, all other references to the Subsidiaries or any of them in
the Transaction Documents shall be disregarded.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Organization
and Qualification</U>. The Company and each of the Subsidiaries is an entity duly incorporated or otherwise organized, validly existing
and in good standing under the laws of the jurisdiction of its incorporation or organization, with the requisite power and authority to
own and use its properties and assets and to carry on its business as currently conducted. Neither the Company nor any Subsidiary is in
violation nor default of any of the provisions of its respective certificate or articles of incorporation, bylaws or other organizational
or charter documents. Each of the Company and the Subsidiaries is duly qualified to conduct business and is in good standing as a foreign
corporation or other entity in each jurisdiction in which the nature of the business conducted or property owned by it makes such qualification
necessary, except where the failure to be so qualified or in good standing, as the case may be, could not have or reasonably be expected
to result in: (i)&nbsp;a material adverse effect on the legality, validity or enforceability of any Transaction Document, (ii)&nbsp;a
material adverse effect on the results of operations, assets, business, prospects or condition (financial or otherwise) of the Company
and the Subsidiaries, taken as a whole, or (iii)&nbsp;a material adverse effect on the Company&rsquo;s ability to perform in any material
respect on a timely basis its obligations under any Transaction Document (any of (i), (ii)&nbsp;or (iii), a &ldquo;<U>Material Adverse
Effect</U>&rdquo;) and no Proceeding has been instituted in any such jurisdiction revoking, limiting or curtailing or seeking to revoke,
limit or curtail such power and authority or qualification.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Authorization;
Enforcement</U>. The Company has the requisite corporate power and authority to enter into and to consummate the transactions contemplated
by this Agreement and each of the other Transaction Documents and otherwise to carry out its obligations hereunder and thereunder. The
execution and delivery of this Agreement and each of the other Transaction Documents by the Company and the consummation by it of the
transactions contemplated hereby and thereby have been duly authorized by all necessary action on the part of the Company and no further
action is required by the Company, the Board of Directors or the Company&rsquo;s stockholders in connection herewith or therewith other
than in connection with the Required Approvals. This Agreement and each other Transaction Document to which it is a party has been (or
upon delivery will have been) duly executed by the Company and, when delivered in accordance with the terms hereof and thereof, will constitute
the valid and binding obligation of the Company enforceable against the Company in accordance with its terms, except (i)&nbsp;as limited
by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general application
affecting enforcement of creditors&rsquo; rights generally, (ii)&nbsp;as limited by laws relating to the availability of specific performance,
injunctive relief or other equitable remedies and (iii)&nbsp;insofar as indemnification and contribution provisions may be limited by
applicable law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>No
Conflicts</U>. The execution, delivery and performance by the Company of this Agreement and the other Transaction Documents to which it
is a party, the issuance and sale of the Securities and the consummation by it of the transactions contemplated hereby and thereby do
not and will not (i)&nbsp;conflict with or violate any provision of the Company&rsquo;s or any Subsidiary&rsquo;s certificate or articles
of incorporation, bylaws or other organizational or charter documents, or (ii)&nbsp;conflict with, or constitute a default (or an event
that with notice or lapse of time or both would become a default) under, result in the creation of any Lien upon any of the properties
or assets of the Company or any Subsidiary, or give to others any rights of termination, amendment, anti-dilution or similar adjustments,
acceleration or cancellation (with or without notice, lapse of time or both) of, any agreement, credit facility, debt or other instrument
(evidencing a Company or Subsidiary debt or otherwise) or other understanding to which the Company or any Subsidiary is a party or by
which any property or asset of the Company or any Subsidiary is bound or affected, or (iii)&nbsp;subject to the Required Approvals, conflict
with or result in a violation of any law, rule, regulation, order, judgment, injunction, decree or other restriction of any court or governmental
authority to which the Company or a Subsidiary is subject (including federal and state securities laws and regulations), or by which any
property or asset of the Company or a Subsidiary is bound or affected; except in the case of each of clauses (ii)&nbsp;and (iii), such
as could not have or reasonably be expected to result in a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Filings,
Consents and Approvals</U>. The Company is not required to obtain any consent, waiver, authorization or order of, give any notice to,
or make any filing or registration with, any court or other federal, state, local or other governmental authority or other Person in connection
with the execution, delivery and performance by the Company of the Transaction Documents, other than: (i)&nbsp;the filings required pursuant
to Section&nbsp;4.4 of this Agreement, (ii)&nbsp;the filing with the Commission of the Prospectus Supplement, (iii)&nbsp;application(s)&nbsp;to
each applicable Trading Market for the listing of the Shares and Warrant Shares and Prefunded Warrant Shares for trading thereon in the
time and manner required thereby, and (iv)&nbsp;the filing of Form&nbsp;D with the Commission and such filings as are required to be made
under applicable state securities laws (collectively, the &ldquo;<U>Required Approvals</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Issuance
of the Securities; Registration</U>. The Securities are duly authorized and, when issued and paid for in accordance with the applicable
Transaction Documents, will be duly and validly issued, fully paid and nonassessable, free and clear of all Liens imposed by the Company.
The Warrant Shares and Prefunded Warrant Shares, when issued in accordance with the terms of the Warrants and Prefunded Warrants, will
be validly issued, fully paid and nonassessable, free and clear of all Liens imposed by the Company. The Company has reserved from its
duly authorized capital stock the maximum number of shares of Common Stock issuable pursuant to this Agreement and the Warrants and Prefunded
Warrants. The Company has prepared and filed the Registration Statement in conformity with the requirements of the Securities Act, which
became effective on&nbsp;April&nbsp;12, 2023 (the &ldquo;<U>Effective Date</U>&rdquo;), including the Prospectus, and such amendments
and supplements thereto as may have been required to the date of this Agreement. The Registration Statement is effective under the Securities
Act and no stop order preventing or suspending the effectiveness of the Registration Statement or suspending or preventing the use of
the Prospectus has been issued by the Commission and no proceedings for that purpose have been instituted or, to the knowledge of the
Company, are threatened by the Commission. The Company, if required by the rules&nbsp;and regulations of the Commission, shall file the
Prospectus with the Commission pursuant to Rule&nbsp;424(b). At the time the Registration Statement and any amendments thereto became
effective, at the date of this Agreement and at the Closing Date, the Registration Statement and any amendments thereto conformed and
will conform in all material respects to the requirements of the Securities Act and did not and will not contain any untrue statement
of a material fact or omit to state any material fact required to be stated therein or necessary to make the statements therein not misleading;
and the Prospectus and any amendments or supplements thereto, at the time the Prospectus or any amendment or supplement thereto was issued
and at the Closing Date, conformed and will conform in all material respects to the requirements of the Securities Act and did not and
will not contain an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein,
in the light of the circumstances under which they were made, not misleading. The Company was at the time of the filing of the Registration
Statement eligible to use Form&nbsp;S-3. The Company is eligible to use Form&nbsp;S-3 under the Securities Act and it meets the transaction
requirements with respect to the aggregate market value of securities being sold pursuant to this offering and during the twelve (12)
months prior to this offering, as set forth in General Instruction I.B.6 of Form&nbsp;S-3.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Capitalization</U>.
The capitalization of the Company as of the date hereof is as set forth on <U>Schedule 3.1(g)</U>, which <U>Schedule 3.1(g)</U>&nbsp;shall
also include the number of shares of Common Stock owned beneficially, and of record, by Affiliates of the Company as of the date hereof.
The Company has not issued any capital stock since its most recently filed periodic report under the Exchange Act, other than pursuant
to the exercise of employee stock options under the Company&rsquo;s stock option plans, the issuance of shares of Common Stock to employees
pursuant to the Company&rsquo;s employee stock purchase plans and pursuant to the conversion and/or exercise of Common Stock Equivalents
outstanding as of the date of the most recently filed periodic report under the Exchange Act. No Person has any right of first refusal,
preemptive right, right of participation, or any similar right to participate in the transactions contemplated by the Transaction Documents.
Except as a result of the purchase and sale of the Securities and as set forth on <U>Schedule 3.1(g)</U>, there are no outstanding options,
warrants, scrip rights to subscribe to, calls or commitments of any character whatsoever relating to, or securities, rights or obligations
convertible into or exercisable or exchangeable for, or giving any Person any right to subscribe for or acquire, any shares of Common
Stock or the capital stock of any Subsidiary, or contracts, commitments, understandings or arrangements by which the Company or any Subsidiary
is or may become bound to issue additional shares of Common Stock or Common Stock Equivalents or capital stock of any Subsidiary. The
issuance and sale of the Securities will not obligate the Company or any Subsidiary to issue shares of Common Stock or other securities
to any Person (other than the Purchasers). There are no outstanding securities or instruments of the Company or any Subsidiary with any
provision that adjusts the exercise, conversion, exchange or reset price of such security or instrument upon an issuance of securities
by the Company or any Subsidiary. There are no outstanding securities or instruments of the Company or any Subsidiary that contain any
redemption or similar provisions, and there are no contracts, commitments, understandings or arrangements by which the Company or any
Subsidiary is or may become bound to redeem a security of the Company or such Subsidiary. The Company does not have any stock appreciation
rights or &ldquo;phantom stock&rdquo; plans or agreements or any similar plan or agreement. All of the outstanding shares of capital stock
of the Company are duly authorized, validly issued, fully paid and nonassessable, have been issued in compliance with all federal and
state securities laws, and none of such outstanding shares was issued in violation of any preemptive rights or similar rights to subscribe
for or purchase securities. No further approval or authorization of any stockholder, the Board of Directors or others is required for
the issuance and sale of the Securities. There are no stockholders agreements, voting agreements or other similar agreements with respect
to the Company&rsquo;s capital stock to which the Company is a party or, to the knowledge of the Company, between or among any of the
Company&rsquo;s stockholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>SEC
Reports; Financial Statements</U>. The Company has filed all reports, schedules, forms, statements and other documents required to be
filed by the Company under the Securities Act and the Exchange Act, including pursuant to Section&nbsp;13(a)&nbsp;or 15(d)&nbsp;thereof,
for the two years preceding the date hereof (or such shorter period as the Company was required by law or regulation to file such material)
(the foregoing materials, including the exhibits thereto and documents incorporated by reference therein, together with the Prospectus
and the Prospectus Supplement, being collectively referred to herein as the &ldquo;<U>SEC Reports</U>&rdquo;) on a timely basis or has
received a valid extension of such time of filing and has filed any such SEC Reports prior to the expiration of any such extension. As
of their respective dates, the SEC Reports complied in all material respects with the requirements of the Securities Act and the Exchange
Act, as applicable, and none of the SEC Reports, when filed, contained any untrue statement of a material fact or omitted to state a material
fact required to be stated therein or necessary in order to make the statements therein, in the light of the circumstances under which
they were made, not misleading. The Company has never been an issuer subject to Rule&nbsp;144(i)&nbsp;under the Securities Act. The financial
statements of the Company included in the SEC Reports comply in all material respects with applicable accounting requirements and the
rules&nbsp;and regulations of the Commission with respect thereto as in effect at the time of filing. Such financial statements have been
prepared in accordance with United States generally accepted accounting principles applied on a consistent basis during the periods involved
(&ldquo;<U>GAAP</U>&rdquo;), except as may be otherwise specified in such financial statements or the notes thereto and except that unaudited
financial statements may not contain all footnotes required by GAAP, and fairly present in all material respects the financial position
of the Company and its consolidated Subsidiaries as of and for the dates thereof and the results of operations and cash flows for the
periods then ended, subject, in the case of unaudited statements, to normal, immaterial, year-end audit adjustments.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Material
Changes; Undisclosed Events, Liabilities or Developments</U>. Since the date of the latest audited financial statements included within
the SEC Reports, except as set forth on <U>Schedule 3.1(i)</U>, (i)&nbsp;there has been no event, occurrence or development that has had
or that could reasonably be expected to result in a Material Adverse Effect, (ii)&nbsp;the Company has not incurred any liabilities (contingent
or otherwise) other than (A)&nbsp;trade payables and accrued expenses incurred in the ordinary course of business consistent with past
practice and (B)&nbsp;liabilities not required to be reflected in the Company&rsquo;s financial statements pursuant to GAAP or disclosed
in filings made with the Commission, (iii)&nbsp;the Company has not altered its method of accounting, (iv)&nbsp;the Company has not declared
or made any dividend or distribution of cash or other property to its stockholders or purchased, redeemed or made any agreements to purchase
or redeem any shares of its capital stock and (v)&nbsp;the Company has not issued any equity securities to any officer, director or Affiliate,
except pursuant to existing Company stock option plans. The Company does not have pending before the Commission any request for confidential
treatment of information. Except for the issuance of the Securities contemplated by this Agreement or as set forth on <U>Schedule 3.1(i)</U>,
no event, liability, fact, circumstance, occurrence or development has occurred or exists or is reasonably expected to occur or exist
with respect to the Company or its Subsidiaries or their respective businesses, prospects, properties, operations, assets or financial
condition that would be required to be disclosed by the Company under applicable securities laws at the time this representation is made
or deemed made that has not been publicly disclosed at least 1 Trading Day prior to the date that this representation is made.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Litigation</U>.
Except as set forth on <U>Schedule 3.1(j)</U>, there is no action, suit, inquiry, notice of violation, proceeding or investigation pending
or, to the knowledge of the Company, threatened against or affecting the Company, any Subsidiary or any of their respective properties
before or by any court, arbitrator, governmental or administrative agency or regulatory authority (federal, state, county, local or foreign)
(collectively, an &ldquo;<U>Action</U>&rdquo;). None of the Actions set forth on <U>Schedule 3.1(j)</U>, (i)&nbsp;adversely affects or
challenges the legality, validity or enforceability of any of the Transaction Documents or the Securities or (ii)&nbsp;could, if there
were an unfavorable decision, have or reasonably be expected to result in a Material Adverse Effect. Neither the Company nor any Subsidiary,
nor any director or officer thereof, is or has been the subject of any Action involving a claim of violation of or liability under federal
or state securities laws or a claim of breach of fiduciary duty. There has not been, and to the knowledge of the Company, there is not
pending or contemplated, any investigation by the Commission involving the Company or any current or former director or officer of the
Company. The Commission has not issued any stop order or other order suspending the effectiveness of any registration statement filed
by the Company or any Subsidiary under the Exchange Act or the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Labor
Relations</U>. No labor dispute exists or, to the knowledge of the Company, is imminent with respect to any of the employees of the Company,
which could reasonably be expected to result in a Material Adverse Effect. None of the Company&rsquo;s or its Subsidiaries&rsquo; employees
is a member of a union that relates to such employee&rsquo;s relationship with the Company or such Subsidiary, and neither the Company
nor any of its Subsidiaries is a party to a collective bargaining agreement, and the Company and its Subsidiaries believe that their relationships
with their employees are good. To the knowledge of the Company, no executive officer of the Company or any Subsidiary, is, or is now expected
to be, in violation of any material term of any employment contract, confidentiality, disclosure or proprietary information agreement
or non-competition agreement, or any other contract or agreement or any restrictive covenant in favor of any third party, and the continued
employment of each such executive officer does not subject the Company or any of its Subsidiaries to any liability with respect to any
of the foregoing matters. The Company and its Subsidiaries are in compliance with all U.S. federal, state, local and foreign laws and
regulations relating to employment and employment practices, terms and conditions of employment and wages and hours, except where the
failure to be in compliance could not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Compliance</U>.
Neither the Company nor any Subsidiary: (i)&nbsp;is in default under or in violation of (and no event has occurred that has not been waived
that, with notice or lapse of time or both, would result in a default by the Company or any Subsidiary under), nor has the Company or
any Subsidiary received notice of a claim that it is in default under or that it is in violation of, any indenture, loan or credit agreement
or any other agreement or instrument to which it is a party or by which it or any of its properties is bound (whether or not such default
or violation has been waived), (ii)&nbsp;is in violation of any judgment, decree or order of any court, arbitrator or other governmental
authority or (iii)&nbsp;is or has been in violation of any statute, rule, ordinance or regulation of any governmental authority, including
without limitation all foreign, federal, state and local laws relating to taxes, environmental protection, occupational health and safety,
product quality and safety and employment and labor matters, except in each case as could not have or reasonably be expected to result
in a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Environmental
Laws</U>.</FONT> <FONT STYLE="font-size: 10pt">The Company and its Subsidiaries (i)&nbsp;are in compliance
with all federal, state, local and foreign laws relating to pollution or protection of human health or the environment (including ambient
air, surface water, groundwater, land surface or subsurface strata), including laws relating to emissions, discharges, releases or threatened
releases of chemicals, pollutants, contaminants, or toxic or hazardous substances or wastes (collectively, &ldquo;<U>Hazardous Materials</U>&rdquo;)
into the environment, or otherwise relating to the manufacture, processing, distribution, use, treatment, storage, disposal, transport
or handling of Hazardous Materials, as well as all authorizations, codes, decrees, demands, or demand letters, injunctions, judgments,
licenses, notices or notice letters, orders, permits, plans or regulations, issued, entered, promulgated or approved thereunder (&ldquo;<U>Environmental
Laws</U>&rdquo;); (ii)&nbsp;have received all permits licenses or other approvals required of them under applicable Environmental Laws
to conduct their respective businesses; and (iii)&nbsp;are in compliance with all terms and conditions of any such permit, license or
approval where in each clause (i), (ii)&nbsp;and (iii), the failure to so comply could be reasonably expected to have, individually or
in the aggregate, a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(n)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Regulatory
Permits</U>. The Company and the Subsidiaries possess all certificates, authorizations and permits issued by the appropriate federal,
state, local or foreign regulatory authorities necessary to conduct their respective businesses as described in the SEC Reports, except
where the failure to possess such permits could not reasonably be expected to result in a Material Adverse Effect (&ldquo;<U>Material
Permits</U>&rdquo;), and neither the Company nor any Subsidiary has received any notice of proceedings relating to the revocation or modification
of any Material Permit.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(o)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Title
to Assets</U>. The Company and the Subsidiaries have good and marketable title in fee simple to all real property owned by them and good
and marketable title in all personal property owned by them that is material to the business of the Company and the Subsidiaries, in each
case free and clear of all Liens, except for (i)&nbsp;Liens as do not materially affect the value of such property and do not materially
interfere with the use made and proposed to be made of such property by the Company and the Subsidiaries and (ii)&nbsp;Liens for the payment
of federal, state or other taxes, for which appropriate reserves have been made therefor in accordance with GAAP and, the payment of which
is neither delinquent nor subject to penalties. Any real property and facilities held under lease by the Company and the Subsidiaries
are held by them under valid, subsisting and enforceable leases with which the Company and the Subsidiaries are in compliance.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(p)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Intellectual
Property</U>. The Company and the Subsidiaries have, or have rights to use, all patents, patent applications, trademarks, trademark applications,
service marks, trade names, trade secrets, inventions, copyrights, licenses and other intellectual property rights and similar rights
necessary or required for use in connection with their respective businesses as described in the SEC Reports and which the failure to
so have could have a Material Adverse Effect (collectively, the &ldquo;<U>Intellectual Property Rights</U>&rdquo;). None of, and neither
the Company nor any Subsidiary has received a notice (written or otherwise) that any of, the Intellectual Property Rights has expired,
terminated or been abandoned, or is expected to expire or terminate or be abandoned, within two (2)&nbsp;years from the date of this Agreement.
Neither the Company nor any Subsidiary has received, since the date of the latest audited financial statements included within the SEC
Reports, a written notice of a claim or otherwise has any knowledge that the Intellectual Property Rights violate or infringe upon the
rights of any Person, except as could not have or reasonably be expected to not have a Material Adverse Effect. To the knowledge of the
Company, all such Intellectual Property Rights are enforceable and there is no existing infringement by another Person of any of the Intellectual
Property Rights. The Company and its Subsidiaries have taken reasonable security measures to protect the secrecy, confidentiality and
value of all of their intellectual properties, except where failure to do so could not, individually or in the aggregate, reasonably be
expected to have a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(q)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Insurance</U>.
The Company and the Subsidiaries are insured by insurers of recognized financial responsibility against such losses and risks and in such
amounts as are prudent and customary in the businesses in which the Company and the Subsidiaries are engaged, including, but not limited
to, directors and officers insurance coverage at least equal to the aggregate Subscription Amount. Neither the Company nor any Subsidiary
has any reason to believe that it will not be able to renew its existing insurance coverage as and when such coverage expires or to obtain
similar coverage from similar insurers as may be necessary to continue its business without a significant increase in cost.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(r)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Transactions
With Affiliates and Employees</U>. Except as set forth on <U>Schedule 3.1(r)</U>, none of the officers or directors of the Company or
any Subsidiary and, to the knowledge of the Company, none of the employees of the Company or any Subsidiary is presently a party to any
transaction with the Company or any Subsidiary (other than for services as employees, officers and directors), including any contract,
agreement or other arrangement providing for the furnishing of services to or by, providing for rental of real or personal property to
or from, providing for the borrowing of money from or lending of money to or otherwise requiring payments to or from any officer, director
or such employee or, to the knowledge of the Company, any entity in which any officer, director, or any such employee has a substantial
interest or is an officer, director, trustee, stockholder, member or partner, in each case in excess of $120,000 other than for (i)&nbsp;payment
of salary or consulting fees for services rendered, (ii)&nbsp;reimbursement for expenses incurred on behalf of the Company and (iii)&nbsp;other
employee benefits, including stock option agreements under any stock option plan of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(s)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Sarbanes-Oxley;
Internal Accounting Controls</U>. The Company and the Subsidiaries are in compliance with any and all applicable requirements of the Sarbanes-Oxley
Act of 2002, as amended, that are effective as of the date hereof, and any and all applicable rules&nbsp;and regulations promulgated by
the Commission thereunder that are effective as of the date hereof and as of the Closing Date. The Company and the Subsidiaries maintain
a system of internal accounting controls sufficient to provide reasonable assurance that: (i)&nbsp;transactions are executed in accordance
with management&rsquo;s general or specific authorizations, (ii)&nbsp;transactions are recorded as necessary to permit preparation of
financial statements in conformity with GAAP and to maintain asset accountability, (iii)&nbsp;access to assets is permitted only in accordance
with management&rsquo;s general or specific authorization, and (iv)&nbsp;the recorded accountability for assets is compared with the existing
assets at reasonable intervals and appropriate action is taken with respect to any differences. The Company and the Subsidiaries have
established disclosure controls and procedures (as defined in Exchange Act Rules&nbsp;13a-15(e)&nbsp;and 15d-15(e)) for the Company and
the Subsidiaries and designed such disclosure controls and procedures to ensure that information required to be disclosed by the Company
in the reports it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified
in the Commission&rsquo;s rules&nbsp;and forms. The Company&rsquo;s certifying officers have evaluated the effectiveness of the disclosure
controls and procedures of the Company and the Subsidiaries as of the end of the period covered by the most recently filed periodic report
under the Exchange Act (such date, the &ldquo;<U>Evaluation Date</U>&rdquo;). The Company presented in its most recently filed periodic
report under the Exchange Act the conclusions of the certifying officers about the effectiveness of the disclosure controls and procedures
based on their evaluations as of the Evaluation Date. Since the Evaluation Date, there have been no changes in the internal control over
financial reporting (as such term is defined in the Exchange Act) of the Company and its Subsidiaries that have materially affected, or
is reasonably likely to materially affect, the internal control over financial reporting of the Company and its Subsidiaries.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(t)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Certain
Fees</U>. Except for fees payable by the Company to the Placement Agent, no brokerage or finder&rsquo;s fees or commissions are or will
be payable by the Company or any Subsidiary to any broker, financial advisor or consultant, finder, placement agent, investment banker,
bank or other Person with respect to the transactions contemplated by the Transaction Documents. The Purchasers shall have no obligation
with respect to any fees or with respect to any claims made by or on behalf of other Persons for fees of a type contemplated in this Section&nbsp;that
may be due in connection with the transactions contemplated by the Transaction Documents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(u)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Investment
Company</U>. The Company is not, and is not an Affiliate of, and immediately after receipt of payment for the Securities, will not be
or be an Affiliate of, an &ldquo;investment company&rdquo; within the meaning of the Investment Company Act of 1940, as amended. The Company
shall conduct its business in a manner so that it will not become an &ldquo;investment company&rdquo; subject to registration under the
Investment Company Act of 1940, as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Registration
Rights</U>. No Person has any right to cause the Company or any Subsidiary to effect the registration under the Securities Act of any
securities of the Company or any Subsidiary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(w)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Listing
and Maintenance Requirements</U>. The Common Stock is registered pursuant to Section&nbsp;12(b)&nbsp;or 12(g)&nbsp;of the Exchange Act,
and the Company has taken no action designed to, or which to its knowledge is likely to have the effect of, terminating the registration
of the Common Stock under the Exchange Act nor has the Company received any notification that the Commission is contemplating terminating
such registration. The Company has not, in the 12 months preceding the date hereof, received notice from any Trading Market on which the
Common Stock is or has been listed or quoted to the effect that the Company is not in compliance with the listing or maintenance requirements
of such Trading Market. The Company is, and has no reason to believe that it will not in the foreseeable future continue to be, in compliance
with all such listing and maintenance requirements. The Common Stock is currently eligible for electronic transfer through the Depository
Trust Company or another established clearing corporation and the Company is current in payment of the fees to the Depository Trust Company
(or such other established clearing corporation) in connection with such electronic transfer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(x)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Application
of Takeover Protections</U>. The Company and the Board of Directors have taken all necessary action, if any, in order to render inapplicable
any control share acquisition, business combination, poison pill (including any distribution under a rights agreement) or other similar
anti-takeover provision under the Company&rsquo;s certificate of incorporation (or similar charter documents) or the laws of its state
of incorporation that is or could become applicable to the Purchasers as a result of the Purchasers and the Company fulfilling their obligations
or exercising their rights under the Transaction Documents, including without limitation as a result of the Company&rsquo;s issuance of
the Securities and the Purchasers&rsquo; ownership of the Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(y)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Disclosure</U>.
Except with respect to the material terms and conditions of the transactions contemplated by the Transaction Documents, the Company confirms
that neither it nor any other Person acting on its behalf has provided any of the Purchasers or their agents or counsel with any information
that it believes constitutes or might constitute material, non-public information which is not otherwise disclosed in the Prospectus Supplement.
The Company understands and confirms that the Purchasers will rely on the foregoing representation in effecting transactions in securities
of the Company. All of the disclosure furnished by or on behalf of the Company to the Purchasers regarding the Company and its Subsidiaries,
their respective businesses and the transactions contemplated hereby, including the Disclosure Schedules to this Agreement, is true and
correct and does not contain any untrue statement of a material fact or omit to state any material fact necessary in order to make the
statements made therein, in the light of the circumstances under which they were made, not misleading. The press releases disseminated
by the Company during the twelve months preceding the date of this Agreement taken as a whole do not contain any untrue statement of a
material fact or omit to state a material fact required to be stated therein or necessary in order to make the statements therein, in
the light of the circumstances under which they were made and when made, not misleading. The Company acknowledges and agrees that no Purchaser
makes or has made any representations or warranties with respect to the transactions contemplated hereby other than those specifically
set forth in Section&nbsp;3.2 hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(z)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>No
Integrated Offering</U>. Assuming the accuracy of the Purchasers&rsquo; representations and warranties set forth in Section&nbsp;3.2,
neither the Company, nor any of its Affiliates, nor any Person acting on its or their behalf has, directly or indirectly, made any offers
or sales of any security or solicited any offers to buy any security, under circumstances that would cause this offering of the Securities
to be integrated with prior offerings by the Company for purposes of (i)&nbsp;the Securities Act which would require the registration
of the Warrants or Warrant Shares under the Securities Act, or (ii)&nbsp;any applicable shareholder approval provisions of any Trading
Market on which any of the securities of the Company are listed or designated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(aa)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Solvency</U>.
Based on the consolidated financial condition of the Company as of the Closing Date, after giving effect to the receipt by the Company
of the proceeds from the sale of the Securities hereunder, (i)&nbsp;the fair saleable value of the Company&rsquo;s assets exceeds the
amount that will be required to be paid on or in respect of the Company&rsquo;s existing debts and other liabilities (including known
contingent liabilities) as they mature, (ii)&nbsp;the Company&rsquo;s assets do not constitute unreasonably small capital to carry on
its business as now conducted and as proposed to be conducted including its capital needs taking into account the particular capital requirements
of the business conducted by the Company, consolidated and projected capital requirements and capital availability thereof, and (iii)&nbsp;the
current cash flow of the Company, together with the proceeds the Company would receive, were it to liquidate all of its assets, after
taking into account all anticipated uses of the cash, would be sufficient to pay all amounts on or in respect of its liabilities when
such amounts are required to be paid. The Company does not intend to incur debts beyond its ability to pay such debts as they mature (taking
into account the timing and amounts of cash to be payable on or in respect of its debt). The Company has no knowledge of any facts or
circumstances which lead it to believe that it will file for reorganization or liquidation under the bankruptcy or reorganization laws
of any jurisdiction within one year from the Closing Date. <U>Schedule 3.1(aa)</U> sets forth as of the date hereof all outstanding secured
and unsecured Indebtedness of the Company or any Subsidiary, or for which the Company or any Subsidiary has commitments. For the purposes
of this Agreement, &ldquo;<U>Indebtedness</U>&rdquo; means (x)&nbsp;any liabilities for borrowed money or amounts owed in excess of $50,000
(other than trade accounts payable incurred in the ordinary course of business), (y)&nbsp;all guaranties, endorsements and other contingent
obligations in respect of indebtedness of others, whether or not the same are or should be reflected in the Company&rsquo;s consolidated
balance sheet (or the notes thereto), except guaranties by endorsement of negotiable instruments for deposit or collection or similar
transactions in the ordinary course of business; and (z)&nbsp;the present value of any lease payments in excess of $50,000 due under leases
required to be capitalized in accordance with GAAP. Neither the Company nor any Subsidiary is in default with respect to any Indebtedness.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(bb)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Tax
Status</U>. Except for matters that would not, individually or in the aggregate, have or reasonably be expected to result in a Material
Adverse Effect, the Company and its Subsidiaries each (i)&nbsp;has made or filed all United States federal, state and local income and
all foreign income and franchise tax returns, reports and declarations required by any jurisdiction to which it is subject, (ii)&nbsp;has
paid all taxes and other governmental assessments and charges that are material in amount, shown or determined to be due on such returns,
reports and declarations and (iii)&nbsp;has set aside on its books provision reasonably adequate for the payment of all material taxes
for periods subsequent to the periods to which such returns, reports or declarations apply. There are no unpaid taxes in any material
amount claimed to be due by the taxing authority of any jurisdiction, and the officers of the Company or of any Subsidiary know of no
basis for any such claim.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(cc)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Foreign
Corrupt Practices</U>. Neither the Company nor any Subsidiary, nor to the knowledge of the Company or any Subsidiary, any agent or other
person acting on behalf of the Company or any Subsidiary, has (i)&nbsp;directly or indirectly, used any funds for unlawful contributions,
gifts, entertainment or other unlawful expenses related to foreign or domestic political activity, (ii)&nbsp;made any unlawful payment
to foreign or domestic government officials or employees or to any foreign or domestic political parties or campaigns from corporate funds,
(iii)&nbsp;failed to disclose fully any contribution made by the Company or any Subsidiary (or made by any person acting on its behalf
of which the Company is aware) which is in violation of law, or (iv)&nbsp;violated in any material respect any provision of FCPA.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(dd)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Accountants</U>.
The Company&rsquo;s accounting firm is set forth on <U>Schedule 3.1(dd)</U> of the Disclosure Schedules. To the knowledge and belief of
the Company, such accounting firm (i)&nbsp;is a registered public accounting firm as required by the Exchange Act and (ii)&nbsp;shall
express its opinion with respect to the financial statements to be included in the Company&rsquo;s Annual Report for the fiscal year ending
December&nbsp;31, 2023.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ee)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Acknowledgment
Regarding Purchasers&rsquo; Purchase of Securities</U>. The Company acknowledges and agrees that each of the Purchasers is acting solely
in the capacity of an arm&rsquo;s length purchaser with respect to the Transaction Documents and the transactions contemplated thereby.
The Company further acknowledges that no Purchaser is acting as a financial advisor or fiduciary of the Company (or in any similar capacity)
with respect to the Transaction Documents and the transactions contemplated thereby and any advice given by any Purchaser or any of their
respective representatives or agents in connection with the Transaction Documents and the transactions contemplated thereby is merely
incidental to the Purchasers&rsquo; purchase of the Securities. The Company further represents to each Purchaser that the Company&rsquo;s
decision to enter into this Agreement and the other Transaction Documents has been based solely on the independent evaluation of the transactions
contemplated hereby by the Company and its representatives.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 20 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ff)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Acknowledgment
Regarding Purchaser&rsquo;s Trading Activity</U>. Anything in this Agreement or elsewhere herein to the contrary notwithstanding (except
for Sections 3.2(f)&nbsp;and 4.14 hereof), it is understood and acknowledged by the Company that: (i)&nbsp;none of the Purchasers has
been asked by the Company to agree, nor has any Purchaser agreed, to desist from purchasing or selling, long and/or short, securities
of the Company, or &ldquo;derivative&rdquo; securities based on securities issued by the Company or to hold the Securities for any specified
term; (ii)&nbsp;past or future open market or other transactions by any Purchaser, specifically including, without limitation, Short Sales
or &ldquo;derivative&rdquo; transactions, before or after the closing of this or future private placement transactions, may negatively
impact the market price of the Company&rsquo;s publicly-traded securities; (iii)&nbsp;any Purchaser, and counter-parties in &ldquo;derivative&rdquo;
transactions to which any such Purchaser is a party, directly or indirectly, presently may have a &ldquo;short&rdquo; position in the
Common Stock, and (iv)&nbsp;each Purchaser shall not be deemed to have any affiliation with or control over any arm&rsquo;s length counter-party
in any &ldquo;derivative&rdquo; transaction. </FONT><FONT STYLE="font-size: 10pt">The Company further understands and acknowledges that
(y)&nbsp;one or more Purchasers may engage in hedging activities at various times during the period that the Securities are outstanding,
including, without limitation, during the periods that the value of the Warrant Shares deliverable with respect to Securities are being
determined, and (z)&nbsp;such hedging activities (if any) could reduce the value of the existing stockholders' equity interests in the
Company at and after the time that the hedging activities are being conducted.&nbsp; The Company acknowledges that such aforementioned
hedging activities do not constitute a breach of any of the Transaction Documents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(gg)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Regulation
M Compliance</U>.&nbsp; The Company has not, and to its knowledge no one acting on its behalf has, (i)&nbsp;taken, directly or indirectly,
any action designed to cause or to result in the stabilization or manipulation of the price of any security of the Company to facilitate
the sale or resale of any of the Securities, (ii)&nbsp;sold, bid for, purchased, or, paid any compensation for soliciting purchases of,
any of the Securities, or (iii)&nbsp;paid or agreed to pay to any Person any compensation for soliciting another to purchase any other
securities of the Company, other than, in the case of clauses (ii)&nbsp;and (iii), compensation paid to the Placement Agent in connection
with the placement of the Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 21 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(hh)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>FDA</U>.
As to each product subject to the jurisdiction of the U.S. Food and Drug Administration (&ldquo;<U>FDA</U>&rdquo;) under the Federal Food,
Drug and Cosmetic Act, as amended, and the regulations thereunder (&ldquo;<U>FDCA</U>&rdquo;) that is manufactured, packaged, labeled,
tested, distributed, sold, and/or marketed by the Company or any of its Subsidiaries (each such product, a &ldquo;<U>Pharmaceutical Product</U>&rdquo;),
such Pharmaceutical Product is being manufactured, packaged, labeled, tested, distributed, sold and/or marketed by the Company in compliance
with all applicable requirements under FDCA and similar laws, rules&nbsp;and regulations relating to registration, investigational use,
premarket clearance, licensure, or application approval, good manufacturing practices, good laboratory practices, good clinical practices,
product listing, quotas, labeling, advertising, record keeping and filing of reports, except where the failure to be in compliance would
not have a Material Adverse Effect. There is no pending, completed or, to the Company's knowledge, threatened, action (including any lawsuit,
arbitration, or legal or administrative or regulatory proceeding, charge, complaint, or investigation) against the Company or any of its
Subsidiaries, and none of the Company or any of its Subsidiaries has received any notice, warning letter or other communication from the
FDA or any other governmental entity, which (i)&nbsp;contests the premarket clearance, licensure, registration, or approval of, the uses
of, the distribution of, the manufacturing or packaging of, the testing of, the sale of, or the labeling and promotion of any Pharmaceutical
Product, (ii)&nbsp;withdraws its approval of, requests the recall, suspension, or seizure of, or withdraws or orders the withdrawal of
advertising or sales promotional materials relating to, any Pharmaceutical Product, (iii)&nbsp;imposes a clinical hold on any clinical
investigation by the Company or any of its Subsidiaries, (iv)&nbsp;enjoins production at any facility of the Company or any of its Subsidiaries,
(v)&nbsp;enters or proposes to enter into a consent decree of permanent injunction with the Company or any of its Subsidiaries, or (vi)&nbsp;otherwise
alleges any violation of any laws, rules&nbsp;or regulations by the Company or any of its Subsidiaries, and which, either individually
or in the aggregate, would have a Material Adverse Effect. The properties, business and operations of the Company have been and are being
conducted in all material respects in accordance with all applicable laws, rules&nbsp;and regulations of the FDA.&nbsp; The Company has
not been informed by the FDA that the FDA will prohibit the marketing, sale, license or use in the United States of any product proposed
to be developed, produced or marketed by the Company nor has the FDA expressed any concern as to approving or clearing for marketing any
product being developed or proposed to be developed by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Stock
Option Plans</U>. Each stock option granted by the Company under the Company&rsquo;s stock option plan was granted (i)&nbsp;in accordance
with the terms of the Company&rsquo;s stock option plan and (ii)&nbsp;with an exercise price at least equal to the fair market value of
the Common Stock on the date such stock option would be considered granted under GAAP and applicable law. No stock option granted under
the Company&rsquo;s stock option plan has been backdated. The Company has not knowingly granted, and there is no and has been no Company
policy or practice to knowingly grant, stock options prior to, or otherwise knowingly coordinate the grant of stock options with, the
release or other public announcement of material information regarding the Company or its Subsidiaries or their financial results or prospects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(jj)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Cybersecurity</U>.&nbsp;
(i)(x)&nbsp;There has been no security breach or other compromise of or relating to any of the Company&rsquo;s or any Subsidiary&rsquo;s
information technology and computer systems, networks, hardware, software, data (including the data of its respective customers, employees,
suppliers, vendors and any third party data maintained by or on behalf of it), equipment or technology (collectively, &ldquo;<U>IT Systems
and Data</U>&rdquo;) and (y)&nbsp;the Company and the Subsidiaries have not been notified of, and has no knowledge of any event or condition
that would reasonably be expected to result in, any security breach or other compromise to its IT Systems and Data; (ii)&nbsp;the Company
and the Subsidiaries are presently in compliance with all applicable laws or statutes and all judgments, orders, rules&nbsp;and regulations
of any court or arbitrator or governmental or regulatory authority, internal policies and contractual obligations relating to the privacy
and security of IT Systems and Data and to the protection of such IT Systems and Data from unauthorized use, access, misappropriation
or modification, except as would not, individually or in the aggregate, have a Material Adverse Effect; (iii)&nbsp;the Company and the
Subsidiaries have implemented and maintained commercially reasonable safeguards to maintain and protect its material confidential information
and the integrity, continuous operation, redundancy and security of all IT Systems and Data; and (iv)&nbsp;the Company and the Subsidiaries
have implemented backup and disaster recovery technology consistent with industry standards and practices.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 22 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(kk)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Office
of Foreign Assets Control</U>. Neither the Company nor any Subsidiary nor, to the Company's knowledge, any director, officer, agent, employee
or affiliate of the Company or any Subsidiary is currently subject to any U.S. sanctions administered by the Office of Foreign Assets
Control of the U.S. Treasury Department (&ldquo;<U>OFAC</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ll)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>U.S.
Real Property Holding Corporation</U>. The Company is not and has never been a U.S. real property holding corporation within the meaning
of Section&nbsp;897 of the Internal Revenue Code of 1986, as amended, and the Company shall so certify upon Purchaser&rsquo;s request.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(mm)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Bank
Holding Company Act</U>. Neither the Company nor any of its Subsidiaries or Affiliates is subject to the Bank Holding Company Act of 1956,
as amended (the &ldquo;<U>BHCA</U>&rdquo;) and to regulation by the Board of Governors of the Federal Reserve System (the &ldquo;<U>Federal
Reserve</U>&rdquo;). Neither the Company nor any of its Subsidiaries or Affiliates owns or controls, directly or indirectly, five percent
(5%) or more of the outstanding shares of any class of voting securities or twenty-five percent or more of the total equity of a bank
or any entity that is subject to the BHCA and to regulation by the Federal Reserve. Neither the Company nor any of its Subsidiaries or
Affiliates exercises a controlling influence over the management or policies of a bank or any entity that is subject to the BHCA and to
regulation by the Federal Reserve.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(nn)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Money
Laundering</U>. The operations of the Company and its Subsidiaries are and have been conducted at all times in compliance with applicable
financial record-keeping and reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970, as amended, applicable
money laundering statutes and applicable rules&nbsp;and regulations thereunder (collectively, the &ldquo;<U>Money Laundering Laws</U>&rdquo;),
and no Action or Proceeding by or before any court or governmental agency, authority or body or any arbitrator involving the Company or
any Subsidiary with respect to the Money Laundering Laws is pending or, to the knowledge of the Company or any Subsidiary, threatened.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(oo)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Private
Placement</U>. Assuming the accuracy of the Purchasers&rsquo; representations and warranties set forth in Section&nbsp;3.2, no registration
under the Securities Act is required for the offer and sale of the Warrants or the Warrant Shares by the Company to the Purchasers as
contemplated hereby.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(pp)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>No
General Solicitation</U>. Neither the Company nor any Person acting on behalf of the Company has offered or sold any of the Warrant or
Warrant Shares by any form of general solicitation or general advertising. The Company has offered the Warrants and Warrant Shares for
sale only to the Purchasers and certain other &ldquo;accredited investors&rdquo; within the meaning of Rule&nbsp;501 under the Securities
Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 23 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(qq)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>No
Disqualification Events</U>. With respect to the Warrant and Warrant Shares to be offered and sold hereunder in reliance on Rule&nbsp;506
under the Securities Act, none of the Company, any of its predecessors, any affiliated issuer, any director, executive officer, other
officer of the Company participating in the offering hereunder, any beneficial owner of 20% or more of the Company&rsquo;s outstanding
voting equity securities, calculated on the basis of voting power, nor any promoter (as that term is defined in Rule&nbsp;405 under the
Securities Act) connected with the Company in any capacity at the time of sale (each, an &ldquo;<U>Issuer Covered Person</U>&rdquo;) is
subject to any of the &ldquo;Bad Actor&rdquo; disqualifications described in Rule&nbsp;506(d)(1)(i)&nbsp;to (viii)&nbsp;under the Securities
Act (a &ldquo;<U>Disqualification Event</U>&rdquo;), except for a Disqualification Event covered by Rule&nbsp;506(d)(2)&nbsp;or (d)(3).
The Company has exercised reasonable care to determine whether any Issuer Covered Person is subject to a Disqualification Event. The Company
has complied, to the extent applicable, with its disclosure obligations under Rule&nbsp;506(e), and has furnished to the Purchasers a
copy of any disclosures provided thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(rr)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Other
Covered Persons</U>. Other than the Placement Agent, the Company is not aware of any person (other than any Issuer Covered Person) that
has been or will be paid (directly or indirectly) remuneration for solicitation of purchasers in connection with the sale of any Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ss)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Notice
of Disqualification Events</U>. The Company will notify the Purchasers in writing, prior to the Closing Date of (i)&nbsp;any Disqualification
Event relating to any Issuer Covered Person and (ii)&nbsp;any event that would, with the passage of time, reasonably be expected to become
a Disqualification Event relating to any Issuer Covered Person, in each case of which it is aware.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Representations
and Warranties of the Purchasers</U>. Each Purchaser, for itself and for no other Purchaser, hereby represents and warrants as of the
date hereof and as of the Closing Date to the Company as follows (unless as of a specific date therein, in which case they shall be accurate
as of such date):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Organization;
Authority</U>. Such Purchaser is either an individual or an entity duly incorporated or formed, validly existing and in good standing
under the laws of the jurisdiction of its incorporation or formation with full right, corporate, partnership, limited liability company
or similar power and authority to enter into and to consummate the transactions contemplated by the Transaction Documents and otherwise
to carry out its obligations hereunder and thereunder. The execution and delivery of the Transaction Documents and performance by such
Purchaser of the transactions contemplated by the Transaction Documents have been duly authorized by all necessary corporate, partnership,
limited liability company or similar action, as applicable, on the part of such Purchaser. Each Transaction Document to which it is a
party has been duly executed by such Purchaser, and when delivered by such Purchaser in accordance with the terms hereof, will constitute
the valid and legally binding obligation of such Purchaser, enforceable against it in accordance with its terms, except: (i)&nbsp;as limited
by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general application
affecting enforcement of creditors&rsquo; rights generally, (ii)&nbsp;as limited by laws relating to the availability of specific performance,
injunctive relief or other equitable remedies and (iii)&nbsp;insofar as indemnification and contribution provisions may be limited by
applicable law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 24 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Understandings
or Arrangements</U>. Such Purchaser is acquiring the Securities as principal for its own account and has no direct or indirect arrangement
or understandings with any other persons to distribute or regarding the distribution of such Securities (this representation and warranty
not limiting such Purchaser&rsquo;s right to sell the Securities pursuant to the Registration Statement or otherwise in compliance with
applicable federal and state securities laws). Such Purchaser is acquiring the Securities hereunder in the ordinary course of its business.
Such Purchaser understands that the Warrants and the Warrant Shares are &ldquo;restricted securities&rdquo; and have not been registered
under the Securities Act or any applicable state securities law and is acquiring such Securities as principal for his, her or its own
account and not with a view to or for distributing or reselling such Securities or any part thereof in violation of the Securities Act
or any applicable state securities law, has no present intention of distributing any of such Securities in violation of the Securities
Act or any applicable state securities law and has no direct or indirect arrangement or understandings with any other persons to distribute
or regarding the distribution of such Securities in violation of the Securities Act or any applicable state securities law (this representation
and warranty not limiting such Purchaser&rsquo;s right to sell such Securities pursuant to a registration statement or otherwise in compliance
with applicable federal and state securities laws).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Purchaser
Status</U>. At the time such Purchaser was offered the Securities, it was, and as of the date hereof it is, and on each date on which
it exercises any Warrants, it will be an &ldquo;accredited investor&rdquo; as defined in Rule&nbsp;501(a)(1), (a)(2), (a)(3), (a)(7),
(a)(8), (a)(9), (a)(12) or (a)(13) under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Experience
of Such Purchaser</U>. Such Purchaser, either alone or together with its representatives, has such knowledge, sophistication and experience
in business and financial matters so as to be capable of evaluating the merits and risks of the prospective investment in the Securities,
and has so evaluated the merits and risks of such investment. Such Purchaser is able to bear the economic risk of an investment in the
Securities and, at the present time, is able to afford a complete loss of such investment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Access
to Information</U>. Such Purchaser acknowledges that it has had the opportunity to review the Transaction Documents (including all exhibits
and schedules thereto) and the SEC Reports and has been afforded, (i)&nbsp;the opportunity to ask such questions as it has deemed necessary
of, and to receive answers from, representatives of the Company concerning the terms and conditions of the offering of the Securities
and the merits and risks of investing in the Securities; (ii)&nbsp;access to information about the Company and its financial condition,
results of operations, business, properties, management and prospects sufficient to enable it to evaluate its investment; and (iii)&nbsp;the
opportunity to obtain such additional information that the Company possesses or can acquire without unreasonable effort or expense that
is necessary to make an informed investment decision with respect to the investment.&nbsp; Such Purchaser acknowledges and agrees that
neither the Placement Agent nor any Affiliate of the Placement Agent has provided such Purchaser with any information or advice with respect
to the Securities nor is such information or advice necessary or desired.&nbsp; Neither the Placement Agent nor any Affiliate has made
or makes any representation as to the Company or the quality of the Securities and the Placement Agent and any Affiliate may have acquired
non-public information with respect to the Company which such Purchaser agrees need not be provided to it.&nbsp; In connection with the
issuance of the Securities to such Purchaser, neither the Placement Agent nor any of its Affiliates has acted as a financial advisor or
fiduciary to such Purchaser.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 25 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Certain
Transactions and Confidentiality</U>. Other than consummating the transactions contemplated hereunder, such Purchaser has not, nor has
any Person acting on behalf of or pursuant to any understanding with such Purchaser, directly or indirectly executed any purchases or
sales, including Short Sales,&nbsp;of the securities of the Company during the period commencing as of the time that such Purchaser first
received a term sheet (written or oral) from the Company or any other Person representing the Company setting forth the material pricing
terms of the transactions contemplated hereunder and ending immediately prior to the execution hereof. Notwithstanding the foregoing,
in the case of a Purchaser that is a multi-managed investment vehicle whereby separate portfolio managers manage separate portions of
such Purchaser&rsquo;s assets and the portfolio managers have no direct knowledge of the investment decisions made by the portfolio managers
managing other portions of such Purchaser&rsquo;s assets, the representation set forth above shall only apply with respect to the portion
of assets managed by the portfolio manager that made the investment decision to purchase the Securities covered by this Agreement. Other
than to other Persons party to this Agreement or to such Purchaser&rsquo;s representatives, including, without limitation, its officers,
directors, partners, legal and other advisors, employees, agents and Affiliates, such Purchaser has maintained the confidentiality of
all disclosures made to it in connection with this transaction (including the existence and terms of this transaction). Notwithstanding
the foregoing, for the avoidance of doubt, nothing contained herein shall constitute a representation or warranty, or preclude any actions,
with respect to locating or borrowing shares in order to effect Short Sales or similar transactions in the future.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>General
Solicitation</U>. Such Purchaser is not purchasing the Securities as a result of any advertisement, article, notice or other communication
regarding the Securities published in any newspaper, magazine or similar media or broadcast over television or radio or presented at any
seminar or, to the knowledge of such Purchaser, any other general solicitation or general advertisement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
Company acknowledges and agrees that the representations contained in </FONT>this Section&nbsp;3.2 shall not modify, amend or affect such
Purchaser&rsquo;s right to rely on the Company&rsquo;s representations and warranties contained in this Agreement or any representations
and warranties contained in any other Transaction Document or any other document or instrument executed and/or delivered in connection
with this Agreement or the consummation of the transactions contemplated hereby. Notwithstanding the foregoing, for the avoidance of doubt,
nothing contained herein shall constitute a representation or warranty, or preclude any actions, with respect to locating or borrowing
shares in order to effect Short Sales or similar transactions in the future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 26 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>ARTICLE&nbsp;IV.</B></FONT><BR>
OTHER AGREEMENTS OF THE PARTIES</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Removal
of Legends</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Warrants and Warrant Shares may only be disposed of in compliance with state and federal securities laws. In connection with any transfer
of Warrants or Warrant Shares other than pursuant to an effective registration statement or Rule&nbsp;144, to the Company or to an Affiliate
of a Purchaser or in connection with a pledge as contemplated in Section&nbsp;4.1(b), the Company may require the transferor thereof to
provide to the Company an opinion of counsel selected by the transferor and reasonably acceptable to the Company, the form and substance
of which opinion shall be reasonably satisfactory to the Company, to the effect that such transfer does not require registration of such
transferred Warrant under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Purchasers agree to the imprinting, so long as is required by this Section&nbsp;4.1, of a legend on any of the Warrants or Warrant Shares
in the following form:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">NEITHER THIS SECURITY NOR THE SECURITIES
INTO WHICH THIS SECURITY IS EXERCISABLE HAS BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF
ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE &ldquo;SECURITIES ACT&rdquo;),
AND, ACCORDINGLY, MAY&nbsp;NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT
TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE
WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS SECURITY MAY&nbsp;BE PLEDGED IN
CONNECTION WITH A BONA FIDE MARGIN ACCOUNT WITH A REGISTERED BROKER-DEALER OR OTHER LOAN WITH A FINANCIAL INSTITUTION THAT IS AN &ldquo;ACCREDITED
INVESTOR&rdquo; AS DEFINED IN RULE 501(a)&nbsp;UNDER THE SECURITIES ACT OR OTHER LOAN SECURED BY SUCH SECURITIES.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">The Company acknowledges
and agrees that a Purchaser may from time to time pledge pursuant to a bona fide margin agreement with a registered broker-dealer or grant
a security interest in some or all of the Warrants or Warrant Shares to a financial institution that is an &ldquo;accredited investor&rdquo;
as defined in Rule&nbsp;501(a)&nbsp;under the Securities Act and, if required under the terms of such arrangement, such Purchaser may
transfer pledged or secured Warrants or Warrant Shares to the pledgees or secured parties. Such a pledge or transfer would not be subject
to approval of the Company and no legal opinion of legal counsel of the pledgee, secured party or pledgor shall be required in connection
therewith. Further, no notice shall be required of such pledge. At the appropriate Purchaser&rsquo;s expense, the Company will execute
and deliver such reasonable documentation as a pledgee or secured party of Warrants and Warrant Shares may reasonably request in connection
with a pledge or transfer of the Warrants or Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 27 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Certificates
evidencing the Warrant Shares shall not contain any legend (including the legend set forth in Section&nbsp;4.1(b)&nbsp;hereof): (i)&nbsp;while
a registration statement covering the resale of such security is effective under the Securities Act, or (ii)&nbsp;following any sale of
such Warrant Shares pursuant to Rule&nbsp;144 (assuming cashless exercise of the Warrants), or (iii)&nbsp;if such Warrant Shares are eligible
for sale under Rule&nbsp;144 (assuming cashless exercise of the Warrants), or (iv)&nbsp;if such legend is not required under applicable
requirements of the Securities Act (including judicial interpretations and pronouncements issued by the staff of the Commission). The
Company shall cause its counsel to issue a legal opinion to the Transfer Agent or the Purchaser promptly if required by the Transfer Agent
to effect the removal of the legend hereunder, or if requested by a Purchaser, respectively. If all or any portion of a Warrant is exercised
at a time when there is an effective registration statement to cover the resale of the Warrant Shares, or if such Warrant Shares may be
sold under Rule&nbsp;144 (assuming cashless exercise of the Warrants) or if such legend is not otherwise required under applicable requirements
of the Securities Act (including judicial interpretations and pronouncements issued by the staff of the Commission) then such Warrant
Shares shall be issued free of all legends. The Company agrees that following such time as such legend is no longer required under this
Section&nbsp;4.1(c), the Company will, no later than the earlier of (i)&nbsp;two (2)&nbsp;Trading Days and (ii)&nbsp;the number of Trading
Days comprising the Standard Settlement Period (as defined below) following the delivery by a Purchaser to the Company or the Transfer
Agent of a certificate representing Warrant Shares, as applicable, issued with a restrictive legend (such date, the &ldquo;<U>Legend Removal
Date</U>&rdquo;), deliver or cause to be delivered to such Purchaser a certificate representing such shares that is free from all restrictive
and other legends. The Company may not make any notation on its records or give instructions to the Transfer Agent that enlarge the restrictions
on transfer set forth in this Section&nbsp;4. Warrant Shares subject to legend removal hereunder shall be transmitted by the Transfer
Agent to the Purchaser by crediting the account of the Purchaser&rsquo;s prime broker with the Depository Trust Company System as directed
by such Purchaser. As used herein, &ldquo;<U>Standard Settlement Period</U>&rdquo; means the standard settlement period, expressed in
a number of Trading Days, on the Company&rsquo;s primary Trading Market with respect to the Common Stock as in effect on the date of delivery
of a certificate representing Warrant Shares issued with a restrictive legend.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">In
addition to such Purchaser&rsquo;s other available remedies, the Company shall pay to a Purchaser, in cash, (i)&nbsp;as partial liquidated
damages and not as a penalty, for each $1,000 of Warrant Shares (based on the VWAP of the Common Stock on the date such Securities are
submitted to the Transfer Agent) delivered for removal of the restrictive legend and subject to Section&nbsp;4.1(c), $10 per Trading Day
(increasing to $20 per Trading Day five (5)&nbsp;Trading Days after such damages have begun to accrue) for each Trading Day after the
Legend Removal Date until such certificate is delivered without a legend and (ii)&nbsp;if the Company fails to (a)&nbsp;issue and deliver
(or cause to be delivered) to a Purchaser by the Legend Removal Date a certificate representing the Securities so delivered to the Company
by such Purchaser that is free from all restrictive and other legends and (b)&nbsp;if after the Legend Removal Date such Purchaser purchases
(in an open market transaction or otherwise) shares of Common Stock to deliver in satisfaction of a sale by such Purchaser of all or any
portion of the number of shares of Common Stock, or a sale of a number of shares of Common Stock equal to all or any portion of the number
of shares of Common Stock, that such Purchaser anticipated receiving from the Company without any restrictive legend, then an amount equal
to the excess of such Purchaser&rsquo;s total purchase price (including brokerage commissions and other out-of-pocket expenses, if any)
for the shares of Common Stock so purchased (including brokerage commissions and other out-of-pocket expenses, if any) (the &ldquo;<U>Buy-In
Price</U>&rdquo;) over the product of (A)&nbsp;such number of Warrant Shares that the Company was required to deliver to such Purchaser
by the Legend Removal Date multiplied by (B)&nbsp;the lowest closing sale price of the Common Stock on any Trading Day during the period
commencing on the date of the delivery by such Purchaser to the Company of the applicable Warrant Shares (as the case may be) and ending
on the date of such delivery and payment under this Section&nbsp;4.1(d).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 28 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Shares, Prefunded Warrants, and Prefunded Warrant Shares shall be issued free of legends. If all or any portion of a Prefunded Warrant
is exercised at a time when there is an effective registration statement to cover the issuance or resale of the Prefunded Warrant Shares
or if the Prefunded Warrant is exercised via cashless exercise, the Prefunded Warrant Shares issued pursuant to any such exercise shall
be issued free of all legends. If at any time following the date hereof the Registration Statement (or any subsequent registration statement
registering the sale or resale of the Prefunded Warrant Shares) is not effective or is not otherwise available for the sale or resale
of the Prefunded Warrant Shares, the Company shall immediately notify the holders of the Prefunded Warrants in writing that such registration
statement is not then effective and thereafter shall promptly notify such holders when the registration statement is effective again and
available for the sale or resale of the Prefunded Warrant Shares (it being understood and agreed that the foregoing shall not limit the
ability of the Company to issue, or any Purchaser to sell, any of the Prefunded Warrant Shares in compliance with applicable federal and
state securities laws). The Company shall use best efforts to keep a registration statement (including the Registration Statement) registering
the issuance or resale of the Prefunded Warrant Shares effective during the term of the Prefunded Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Furnishing
of Information</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Until
the earlier of the time that (i)&nbsp;no Purchaser owns Securities or (ii)&nbsp;the Warrants have expired, the Company covenants to timely
file (or obtain extensions in respect thereof and file within the applicable grace period) all reports required to be filed by the Company
after the date hereof pursuant to the Exchange Act even if the Company is not then subject to the reporting requirements of the Exchange
Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 29 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">At
any time during the period commencing from the six (6)&nbsp;month anniversary of the date hereof and ending at such time that all of the
Warrant Shares (assuming cashless exercise) may be sold without the requirement for the Company to be in compliance with Rule&nbsp;144(c)(1)&nbsp;and
otherwise without restriction or limitation pursuant to Rule&nbsp;144, if the Company (i)&nbsp;shall fail for any reason to satisfy the
current public information requirement under Rule&nbsp;144(c)&nbsp;or (ii)&nbsp;has ever been an issuer described in Rule&nbsp;144(i)(1)(i)&nbsp;or
becomes an issuer in the future, and the Company shall fail to satisfy any condition set forth in Rule&nbsp;144(i)(2)&nbsp;(a &ldquo;<U>Public
Information Failure</U>&rdquo;) then, in addition to such Purchaser&rsquo;s other available remedies, the Company shall pay to a Purchaser,
in cash, as partial liquidated damages and not as a penalty, by reason of any such delay in or reduction of its ability to sell the Warrant
Shares, an amount in cash equal to two percent (2.0%) of the aggregate Exercise Price of such Purchaser&rsquo;s Warrants on the day of
a Public Information Failure and on every thirtieth (30<SUP>th</SUP>) day (pro rated for periods totaling less than thirty days) thereafter
until the earlier of (a)&nbsp;the date such Public Information Failure is cured and (b)&nbsp;such time that such public information is
no longer required&nbsp; for the Purchasers to transfer the Warrant Shares pursuant to Rule&nbsp;144.&nbsp; The payments to which a Purchaser
shall be entitled pursuant to this Section&nbsp;4.2(b)&nbsp;are referred to herein as &ldquo;<U>Public Information Failure Payments</U>.&rdquo;&nbsp;
Public Information Failure Payments shall be paid on the earlier of (i)&nbsp;the last day of the calendar month during which such Public
Information Failure Payments are incurred and (ii)&nbsp;the third (3<SUP>rd</SUP>) Business Day after the event or failure giving rise
to the Public Information Failure Payments is cured.&nbsp; In the event the Company fails to make Public Information Failure Payments
in a timely manner, such Public Information Failure Payments shall bear interest at the rate of 1.5% per month (prorated for partial months)
until paid in full. Nothing herein shall limit such Purchaser&rsquo;s right to pursue actual damages for the Public Information Failure,
and such Purchaser shall have the right to pursue all remedies available to it at law or in equity including, without limitation, a decree
of specific performance and/or injunctive relief.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Integration</U>.
The Company shall not sell, offer for sale or solicit offers to buy or otherwise negotiate in respect of any security (as defined in Section&nbsp;2
of the Securities Act) that would be integrated with the offer or sale of the Securities in a manner that would require the registration
under the Securities Act of the sale of the Warrants or Warrant Shares or that would be integrated with the offer or sale of the Securities
for purposes of the rules&nbsp;and regulations of any Trading Market such that it would require shareholder approval prior to the closing
of such other transaction unless shareholder approval is obtained before the closing of such subsequent transaction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.4</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Securities
Laws Disclosure; Publicity</U>. The Company shall (a)&nbsp;by the Disclosure Time, issue a press release disclosing the material terms
of the transactions contemplated hereby, and (b)&nbsp;file a Current Report on Form&nbsp;8-K, including the Transaction Documents as exhibits
thereto, with the Commission within the time required by the Exchange Act. From and after the issuance of such press release, the Company
represents to the Purchasers that it shall have publicly disclosed all material, non-public information delivered to any of the Purchasers
by the Company or any of its Subsidiaries, or any of their respective officers, directors, employees, Affiliates or agents, including,
without limitation, the Placement Agent, in connection with the transactions contemplated by the Transaction Documents. In addition, effective
upon the issuance of such press release, the Company acknowledges and agrees that any and all confidentiality or similar obligations under
any agreement, whether written or oral, between the Company, any of its Subsidiaries or any of their respective officers, directors, employees,
Affiliates or agents, including, without limitation, the Placement Agent, on the one hand, and any of the Purchasers or any of their Affiliates
on the other hand, shall terminate and be no further force or effect. The Company understands and confirms that each Purchaser shall be
relying on the foregoing covenant in effecting transactions in securities of the Company. The Company and each Purchaser shall consult
with each other in issuing any other press releases with respect to the transactions contemplated hereby, and neither the Company nor
any Purchaser shall issue any such press release nor otherwise make any such public statement without the prior consent of the Company,
with respect to any press release of any Purchaser, or without the prior consent of each Purchaser, with respect to any press release
of the Company, which consent shall not unreasonably be withheld or delayed, except if such disclosure is required by law, in which case
the disclosing party shall promptly provide the other party with prior notice of such public statement or communication. Notwithstanding
the foregoing, the Company shall not publicly disclose the name of any Purchaser, or include the name of any Purchaser in any filing with
the Commission or any regulatory agency or Trading Market, without the prior written consent of such Purchaser, except (a)&nbsp;as required
by federal securities law in connection with the filing of final Transaction Documents with the Commission and (b)&nbsp;to the extent
such disclosure is required by law or Trading Market regulations, in which case the Company shall provide the Purchasers with prior notice
of such disclosure permitted under this clause (b)&nbsp;and reasonably cooperate with such Purchaser regarding such disclosure.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 30 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.5</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Shareholder
Rights Plan</U>. No claim will be made or enforced by the Company or, with the consent of the Company, any other Person, that any Purchaser
is an &ldquo;<U>Acquiring Person</U>&rdquo; under any control share acquisition, business combination, poison pill (including any distribution
under a rights agreement) or similar anti-takeover plan or arrangement in effect or hereafter adopted by the Company, or that any Purchaser
could be deemed to trigger the provisions of any such plan or arrangement, by virtue of receiving Securities under the Transaction Documents
or under any other agreement between the Company and the Purchasers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.6</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Non-Public
Information</U>. Except with respect to the material terms and conditions of the transactions contemplated by the Transaction Documents,
which shall be disclosed pursuant to Section&nbsp;4.4, the Company covenants and agrees that neither it, nor any other Person acting on
its behalf will provide any Purchaser or its agents or counsel with any information that constitutes, or the Company reasonably believes
constitutes, material non-public information, unless prior thereto such Purchaser shall have consented in writing to the receipt of such
information and agreed in writing with the Company to keep such information confidential. The Company understands and confirms that each
Purchaser shall be relying on the foregoing covenant in effecting transactions in securities of the Company. To the extent that the Company,
any of its Subsidiaries, or any of their respective officers, directors, agents, employees or Affiliates delivers any material, non-public
information to a Purchaser without such Purchaser&rsquo;s consent, the Company hereby covenants and agrees that such Purchaser shall not
have any duty of confidentiality to the Company, any of its Subsidiaries, or any of their respective officers, directors, employees, Affiliates
or agents, including, without limitation, the Placement Agent, or a duty to the Company, any of its Subsidiaries or any of their respective
officers, directors, employees, Affiliates or agents, including, without limitation, the Placement Agent, not to trade on the basis of,
such material, non-public information, provided that the Purchaser shall remain subject to applicable law. To the extent that any notice
provided pursuant to any Transaction Document constitutes, or contains, material, non-public information regarding the Company or any
Subsidiaries, the Company shall simultaneously with the delivery of such notice file such notice with the Commission pursuant to a Current
Report on Form&nbsp;8-K. The Company understands and confirms that each Purchaser shall be relying on the foregoing covenant in effecting
transactions in securities of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 31 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.7</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Use
of Proceeds</U>. Except as set forth on <U>Schedule 4.7</U> attached hereto, the Company shall use the net proceeds from the sale of the
Securities hereunder for working capital purposes and shall not use such proceeds: (a)&nbsp;for the satisfaction of any portion of the
Company&rsquo;s debt (other than payment of trade payables in the ordinary course of the Company&rsquo;s business and prior practices),
(b)&nbsp;for the redemption of any Common Stock or Common Stock Equivalents, (c)&nbsp;for the settlement of any outstanding litigation
or (d)&nbsp;in violation of FCPA or OFAC regulations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.8</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Indemnification
of Purchasers</U>. Subject to the provisions of this Section&nbsp;4.8, the Company will indemnify and hold each Purchaser and its directors,
officers, shareholders, members, partners, employees and agents (and any other Persons with a functionally equivalent role of a Person
holding such titles notwithstanding a lack of such title or any other title), each Person who controls such Purchaser (within the meaning
of Section&nbsp;15 of the Securities Act and Section&nbsp;20 of the Exchange Act), and the directors, officers, shareholders, agents,
members, partners or employees (and any other Persons with a functionally equivalent role of a Person holding such titles notwithstanding
a lack of such title or any other title) of such controlling persons (each, a &ldquo;Purchaser Party&rdquo;) harmless from any and all
losses, liabilities, obligations, claims, contingencies, damages, costs and expenses, including all judgments, amounts paid in settlements,
court costs and reasonable attorneys&rsquo; fees and costs of investigation that any such Purchaser Party may suffer or incur as a result
of or relating to (a)&nbsp;any breach of any of the representations, warranties, covenants or agreements made by the Company in this Agreement
or in the other Transaction Documents or (b)&nbsp;any action instituted against the Purchaser Parties in any capacity, or any of them
or their respective Affiliates, by any stockholder of the Company who is not an Affiliate of such Purchaser Party, with respect to any
of the transactions contemplated by the Transaction Documents (unless such action is solely based upon a material breach of such Purchaser
Party&rsquo;s representations, warranties or covenants under the Transaction Documents or any agreements or understandings such Purchaser
Party may have with any such stockholder or any violations by such Purchaser Party of state or federal securities laws or any conduct
by such Purchaser Party which is finally judicially determined to constitute fraud, gross negligence or willful misconduct. If any action
shall be brought against any Purchaser Party in respect of which indemnity may be sought pursuant to this Agreement, such Purchaser Party
shall promptly notify the Company in writing, and, the Company shall have the right to assume the defense thereof with counsel of its
own choosing reasonably acceptable to the Purchaser Party. Any Purchaser Party shall have the right to employ separate counsel in any
such action and participate in the defense thereof, but the fees and expenses of such counsel shall be at the expense of such Purchaser
Party except to the extent that (i)&nbsp;the employment thereof has been specifically authorized by the Company in writing, (ii)&nbsp;the
Company has failed after a reasonable period of time to assume such defense and to employ counsel or (iii)&nbsp;in such action there is,
in the reasonable opinion of counsel a material conflict on any material issue between the position of the Company and the position of
such Purchaser Party, in which case the Company shall be responsible for the reasonable fees and expenses of no more than one such separate
counsel. The Company will not be liable to any Purchaser Party under this Agreement (y)&nbsp;for any settlement by a Purchaser Party effected
without the Company&rsquo;s prior written consent, which shall not be unreasonably withheld or delayed; or (z)&nbsp;to the extent, but
only to the extent that a loss, claim, damage or liability is attributable to any Purchaser Party&rsquo;s breach of any of the representations,
other Transaction Documents. The indemnification required by this Section&nbsp;4.8 shall be made by periodic payments of the amount thereof
during the course of the investigation or defense, as and when bills are received or are incurred. The indemnity agreements contained
herein shall be in addition to any cause of action or similar right of any Purchaser Party against the Company or others and any liabilities
the Company may be subject to pursuant to law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 32 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.9</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Reservation
of Common Stock</U>. As of the date hereof, the Company has reserved and the Company shall continue to reserve and keep available at all
times, free of preemptive rights, a sufficient number of shares of Common Stock for the purpose of enabling the Company to issue Shares
pursuant to this Agreement and Warrant Shares and Prefunded Warrant Shares pursuant to any exercise of the Warrants and Prefunded Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.10</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Listing
of Common Stock</U>. The Company hereby agrees to use best efforts to maintain the listing or quotation of the Common Stock on the Trading
Market on which it is currently listed, and concurrently with the Closing, the Company shall apply to list or quote all of the Shares
and Warrant Shares and Prefunded Warrant Shares on such Trading Market and promptly secure the listing of all of the Shares and Warrant
Shares and Prefunded Warrant Shares on such Trading Market. The Company further agrees, if the Company applies to have the Common Stock
traded on any other Trading Market, it will then include in such application all of the Shares and Warrant Shares and Prefunded Warrant
Shares, and will take such other action as is necessary to cause all of the Shares and Warrant Shares and Prefunded Warrant Shares to
be listed or quoted on such other Trading Market as promptly as possible. The Company will then take all action reasonably necessary to
continue the listing and trading of its Common Stock on a Trading Market and will comply in all respects with the Company&rsquo;s reporting,
filing and other obligations under the bylaws or rules&nbsp;of the Trading Market. The Company agrees to maintain the eligibility of the
Common Stock for electronic transfer through the Depository Trust Company or another established clearing corporation, including, without
limitation, by timely payment of fees to the Depository Trust Company or such other established clearing corporation in connection with
such electronic transfer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.11</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Intentionally
omitted</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.12</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Subsequent
Equity Sales</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">From
the date hereof until 75 days after the Closing Date, neither the Company nor any Subsidiary shall (i)&nbsp;issue, enter into any agreement
to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents or (ii)&nbsp;file any
registration statement or any amendment or supplement thereto, other than the Prospectus Supplement or as contemplated pursuant to Section&nbsp;4.18
herein or filing a registration statement on Form&nbsp;S-8 in connection with any employee benefit plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 33 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">From
the date hereof until 6 months after the Closing Date, the Company shall be prohibited from effecting or entering into an agreement to
effect any issuance by the Company or any of its Subsidiaries of Common Stock or Common Stock Equivalents (or a combination of units thereof)
involving a Variable Rate Transaction. &ldquo;<U>Variable Rate Transaction</U>&rdquo; means a transaction in which the Company (i)&nbsp;issues
or sells any debt or equity securities that are convertible into, exchangeable or exercisable for, or include the right to receive additional
shares of Common Stock either (A)&nbsp;at a conversion price, exercise price or exchange rate or other price that is based upon and/or
varies with the trading prices of or quotations for the shares of Common Stock at any time after the initial issuance of such debt or
equity securities, or (B)&nbsp;with a conversion, exercise or exchange price that is subject to being reset at some future date after
the initial issuance of such debt or equity security or upon the occurrence of specified or contingent events directly or indirectly related
to the business of the Company or the market for the Common Stock or (ii)&nbsp;enters into, or effects a transaction under, any agreement,
including, but not limited to, an equity line of credit or an &ldquo;at-the-market offering&rdquo;, whereby the Company may issue securities
at a future determined price regardless of whether shares pursuant to such agreement have actually been issued and regardless of whether
such agreement is subsequently canceled. Any Purchaser shall be entitled to obtain injunctive relief against the Company to preclude any
such issuance, which remedy shall be in addition to any right to collect damages.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Notwithstanding
the foregoing, this Section&nbsp;4.12 shall not apply in respect of an Exempt Issuance, except that no Variable Rate Transaction shall
be an Exempt Issuance.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.13</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Equal
Treatment of Purchasers</U>. No consideration (including any modification of any Transaction Document) shall be offered or paid to any
Person to amend or consent to a waiver or modification of any provision of the Transaction Documents unless the same consideration is
also offered to all of the parties to the Transaction Documents. For clarification purposes, this provision constitutes a separate right
granted to each Purchaser by the Company and negotiated separately by each Purchaser, and is intended for the Company to treat the Purchasers
as a class and shall not in any way be construed as the Purchasers acting in concert or as a group with respect to the purchase, disposition
or voting of Securities or otherwise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.14</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Certain
Transactions and Confidentiality</U>. Each Purchaser, severally and not jointly with the other Purchasers, covenants that neither it nor
any Affiliate acting on its behalf or pursuant to any understanding with it will execute any purchases or sales, including Short Sales
of any of the Company&rsquo;s securities during the period commencing with the execution of this Agreement and ending at such time that
the transactions contemplated by this Agreement are first publicly announced pursuant to the initial press release as described in Section&nbsp;4.4.<FONT>&nbsp;
</FONT>Each Purchaser, severally and not jointly with the other Purchasers, covenants that until such time as the transactions contemplated
by this Agreement are publicly disclosed by the Company pursuant to the initial press release as described in Section&nbsp;4.4, such Purchaser
will maintain the confidentiality of the existence and terms of this transaction and the information included in the Disclosure Schedules
(other than as disclosed to its legal and other representatives).&nbsp; N<FONT>otwithstanding the foregoing
and notwithstanding anything contained in this Agreement to the contrary, the Company expressly acknowledges and agrees that (i)&nbsp;no
Purchaser makes any representation, warranty or covenant hereby that it will not engage in effecting transactions in any securities of
the Company after the time that the transactions contemplated by this Agreement are first publicly announced pursuant to the initial press
release as described in Section&nbsp;4.4, (ii)&nbsp;no Purchaser shall be restricted or prohibited from effecting any transactions in
any securities of the Company in accordance with applicable securities laws from and after the time that the transactions contemplated
by this Agreement are first publicly announced pursuant to the initial press release as described in Section&nbsp;4.4 and (iii)&nbsp;no
Purchaser shall have any duty of confidentiality or duty not to trade in the securities of the Company to the Company, any of its Subsidiaries,
or any of their respective officers, directors, employees, Affiliates or agent, including, without limitation, the Placement Agent, after
the issuance of the initial press release as described in Section&nbsp;4.4.&nbsp; </FONT>Notwithstanding the foregoing, in the case of
a Purchaser that is a multi-managed investment vehicle whereby separate portfolio managers manage separate portions of such Purchaser&rsquo;s
assets and the portfolio managers have no direct knowledge of the investment decisions made by the portfolio managers managing other portions
of such Purchaser&rsquo;s assets, the covenant set forth above shall only apply with respect to the portion of assets managed by the portfolio
manager that made the investment decision to purchase the Securities covered by this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 34 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.15</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Capital
Changes</U>. Until the one year anniversary of the Closing Date, the Company shall not undertake a reverse or forward stock split or reclassification
of the Common Stock without the prior written consent of the Purchasers holding a majority in interest of the Shares other than a reverse
stock split that is required, in the good faith determination of the Board of Directors, to maintain the listing of the Common Stock on
the Trading Market.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.16</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Exercise
Procedures</U>. The form of Notice of Exercise included in the Warrants and Prefunded Warrants set forth the totality of the procedures
required of the Purchasers in order to exercise the Warrants and Prefunded Warrants. No additional legal opinion, other information or
instructions shall be required of the Purchasers to exercise their Warrants and Prefunded Warrants. Without limiting the preceding sentences,
no ink-original Notice of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of
any Notice of Exercise form be required in order to exercise the Warrants and Prefunded Warrants. The Company shall honor exercises of
the Warrants and Prefunded Warrants and shall deliver Warrant Shares and Prefunded Warrant Shares in accordance with the terms, conditions
and time periods set forth in the Transaction Documents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.17</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Form&nbsp;D;
Blue Sky Filings</U>. The Company agrees to timely file a Form&nbsp;D with respect to the Warrant and Warrant Shares as required under
Regulation D and to provide a copy thereof, promptly upon request of any Purchaser. The Company shall take such action as the Company
shall reasonably determine is necessary in order to obtain an exemption for, or to qualify the Warrant and Warrant Shares for, sale to
the Purchasers at the Closing under applicable securities or &ldquo;Blue Sky&rdquo; laws of the states of the United States, and shall
provide evidence of such actions promptly upon request of any Purchaser.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.18</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Registration
Statement</U>. As soon as practicable (and in any event within 45 calendar days of the date of this Agreement), the Company shall file
a registration statement on Form&nbsp;S-1 (or other appropriate form if the Company is not then S-1 eligible) providing for the resale
by the Purchasers of the Warrant Shares issued and issuable upon exercise of the Warrants.&nbsp; The Company shall use commercially reasonable
efforts to cause such registration statement to become effective within 181 days following the Closing Date and to keep such registration
statement effective at all times until no Purchaser owns any Warrants or Warrant Shares issuable upon exercise thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 35 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.19</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Lock-Up
Agreements</U>. The Company shall not amend, modify, waive or terminate any provision of any of the Lock-Up Agreements except to extend
the term of the lock-up period and shall enforce the provisions of each Lock-Up Agreement in accordance with its terms. If any party to
a Lock-Up Agreement breaches any provision of a Lock-Up Agreement, the Company shall promptly use its best efforts to seek specific performance
of the terms of such Lock-Up Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>ARTICLE&nbsp;V.</B></FONT><BR>
MISCELLANEOUS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Termination</U>.&nbsp;
This Agreement may be terminated by any Purchaser, as to such Purchaser&rsquo;s obligations hereunder only and without any effect whatsoever
on the obligations between the Company and the other Purchasers, by written notice to the other parties, if the Closing has not been consummated
on or before the fifth (5<SUP>th</SUP>) Trading Day following the date hereof by reason of the Company not meeting its obligations hereunder;
<U>provided</U>, <U>however</U>, that no such termination will affect the right of any party to sue for any breach by any other party
(or parties).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.2</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Fees
and Expenses</U>. Except as expressly set forth in the Transaction Documents to the contrary, each party shall pay the fees and expenses
of its advisers, counsel, accountants and other experts, if any, and all other expenses incurred by such party incident to the negotiation,
preparation, execution, delivery and performance of this Agreement. The Company shall pay all Transfer Agent fees (including, without
limitation, any fees required for same-day processing of any instruction letter delivered by the Company and any exercise notice delivered
by a Purchaser), stamp taxes and other taxes and duties levied in connection with the delivery of any Securities to the Purchasers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.3</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Entire
Agreement</U>. The Transaction Documents, together with the exhibits and schedules thereto, the Prospectus and the Prospectus Supplement,
contain the entire understanding of the parties with respect to the subject matter hereof and thereof and supersede all prior agreements
and understandings, oral or written, with respect to such matters, which the parties acknowledge have been merged into such documents,
exhibits and schedules.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.4</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Notices</U>.
Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall be in writing and shall
be deemed given and effective on the earliest of: (a)&nbsp;the time of transmission, if such notice or communication is delivered via
email attachment at the email address as set forth on the signature pages&nbsp;attached hereto at or prior to 5:30 p.m.&nbsp;(New York
City time) on a Trading Day, (b)&nbsp;the next Trading Day after the time of transmission, if such notice or communication is delivered
via email attachment at the email address as set forth on the signature pages&nbsp;attached hereto on a day that is not a Trading Day
or later than 5:30 p.m.&nbsp;(New York City time) on any Trading Day, (c)&nbsp;the second (2<SUP>nd</SUP>) Trading Day following the date
of mailing, if sent by U.S. nationally recognized overnight courier service or (d)&nbsp;upon actual receipt by the party to whom such
notice is required to be given. The address for such notices and communications shall be as set forth on the signature pages&nbsp;attached
hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 36 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.5</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Amendments;
Waivers</U>. No provision of this Agreement may be waived, modified, supplemented or amended except in a written instrument signed, in
the case of an amendment, by the Company and Purchasers which purchased at least 50.1% in interest of the Shares and Prefunded Warrants
based on the initial Subscription Amounts hereunder (or, prior to the Closing, the Company and each Purchaser) or, in the case of a waiver,
by the party against whom enforcement of any such waived provision is sought, provided that if any amendment, modification or waiver disproportionately
and adversely impacts a Purchaser (or group of Purchasers), the consent of such disproportionately impacted Purchaser (or group of Purchasers)
shall also be required. No waiver of any default with respect to any provision, condition or requirement of this Agreement shall be deemed
to be a continuing waiver in the future or a waiver of any subsequent default or a waiver of any other provision, condition or requirement
hereof, nor shall any delay or omission of any party to exercise any right hereunder in any manner impair the exercise of any such right.
Any proposed amendment or waiver that disproportionately, materially and adversely affects the rights and obligations of any Purchaser
relative to the comparable rights and obligations of the other Purchasers shall require the prior written consent of such adversely affected
Purchaser. Any amendment effected in accordance with this Section&nbsp;5.5 shall be binding upon each Purchaser and holder of Securities
and the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.6</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Headings</U>.
The headings herein are for convenience only, do not constitute a part of this Agreement and shall not be deemed to limit or affect any
of the provisions hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.7</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Successors
and Assigns</U>. This Agreement shall be binding upon and inure to the benefit of the parties and their successors and permitted assigns.
The Company may not assign this Agreement or any rights or obligations hereunder without the prior written consent of each Purchaser (other
than by merger). Any Purchaser may assign any or all of its rights under this Agreement to any Person to whom such Purchaser assigns or
transfers any Securities, provided that such transferee agrees in writing to be bound, with respect to the transferred Securities, by
the provisions of the Transaction Documents that apply to the &ldquo;Purchasers.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.8</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>No
Third-Party Beneficiaries</U>. The Placement Agent shall be the third party beneficiary of the representations and warranties of the Company
in Section&nbsp;3.1 and the representations and warranties of the Purchasers in Section&nbsp;3.2. This Agreement is intended for the benefit
of the parties hereto and their respective successors and permitted assigns and is not for the benefit of, nor may any provision hereof
be enforced by, any other Person, except as otherwise set forth in Section&nbsp;4.8 and this Section&nbsp;5.8.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 37 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.9</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Governing
Law</U>. All questions concerning the construction, validity, enforcement and interpretation of the Transaction Documents shall be governed
by and construed and enforced in accordance with the internal laws of the State of New York, without regard to the principles of conflicts
of law thereof. Each party agrees that all legal Proceedings concerning the interpretations, enforcement and defense of the transactions
contemplated by this Agreement and any other Transaction Documents (whether brought against a party hereto or its respective affiliates,
directors, officers, shareholders, partners, members, employees or agents) shall be commenced exclusively in the state and federal courts
sitting in the City of New York. Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting
in the City of New York, Borough of Manhattan for the adjudication of any dispute hereunder or in connection herewith or with any transaction
contemplated hereby or discussed herein (including with respect to the enforcement of any of the Transaction Documents), and hereby irrevocably
waives, and agrees not to assert in any Action or Proceeding, any claim that it is not personally subject to the jurisdiction of any such
court, that such Action or Proceeding is improper or is an inconvenient venue for such Proceeding. Each party hereby irrevocably waives
personal service of process and consents to process being served in any such Action or Proceeding by mailing a copy thereof via registered
or certified mail or overnight delivery (with evidence of delivery) to such party at the address in effect for notices to it under this
Agreement and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein
shall be deemed to limit in any way any right to serve process in any other manner permitted by law. If any party shall commence an Action
or Proceeding to enforce any provisions of the Transaction Documents, then, in addition to the obligations of the Company under Section&nbsp;4.8,
the prevailing party in such Action or Proceeding shall be reimbursed by the non-prevailing party for its reasonable attorneys&rsquo;
fees and other costs and expenses incurred with the investigation, preparation and prosecution of such Action or Proceeding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.10</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Survival</U>.
The representations and warranties contained herein shall survive the Closing and the delivery of the Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.11</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Execution</U>.
This Agreement may be executed in two or more counterparts, all of which when taken together shall be considered one and the same agreement
and shall become effective when counterparts have been signed by each party and delivered to each other party, it being understood that
the parties need not sign the same counterpart. In the event that any signature is delivered by e-mail delivery of a &ldquo;.pdf&rdquo;
format data file, such signature shall create a valid and binding obligation of the party executing (or on whose behalf such signature
is executed) with the same force and effect as if such &ldquo;.pdf&rdquo; signature page&nbsp;were an original thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.12</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Severability</U>.
If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction to be invalid, illegal,
void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein shall remain in full force
and effect and shall in no way be affected, impaired or invalidated, and the parties hereto shall use their commercially reasonable efforts
to find and employ an alternative means to achieve the same or substantially the same result as that contemplated by such term, provision,
covenant or restriction. It is hereby stipulated and declared to be the intention of the parties that they would have executed the remaining
terms, provisions, covenants and restrictions without including any of such that may be hereafter declared invalid, illegal, void or unenforceable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.13</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Rescission
and Withdrawal Right</U>. Notwithstanding anything to the contrary contained in (and without limiting any similar provisions of) any of
the other Transaction Documents, whenever any Purchaser exercises a right, election, demand or option under a Transaction Document and
the Company does not timely perform its related obligations within the periods therein provided, then such Purchaser may rescind or withdraw,
in its sole discretion from time to time upon written notice to the Company, any relevant notice, demand or election in whole or in part
without prejudice to its future actions and rights; <U>provided</U>, <U>however</U>, that in the case of a rescission of an exercise of
a Warrant, the applicable Purchaser shall be required to return any shares of Common Stock subject to any such rescinded exercise notice
concurrently with the return to such Purchaser of the aggregate exercise price paid to the Company for such shares and the restoration
of such Purchaser&rsquo;s right to acquire such shares pursuant to such Purchaser&rsquo;s Warrant (including, issuance of a replacement
warrant certificate evidencing such restored right).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 38 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.14</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Replacement
of Securities</U>. If any certificate or instrument evidencing any Securities is mutilated, lost, stolen or destroyed, the Company shall
issue or cause to be issued in exchange and substitution for and upon cancellation thereof (in the case of mutilation), or in lieu of
and substitution therefor, a new certificate or instrument, but only upon receipt of evidence reasonably satisfactory to the Company of
such loss, theft or destruction. The applicant for a new certificate or instrument under such circumstances shall also pay any reasonable
third-party costs (including customary indemnity) associated with the issuance of such replacement Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.15</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Remedies</U>.
In addition to being entitled to exercise all rights provided herein or granted by law, including recovery of damages, each of the Purchasers
and the Company will be entitled to specific performance under the Transaction Documents. The parties agree that monetary damages may
not be adequate compensation for any loss incurred by reason of any breach of obligations contained in the Transaction Documents and hereby
agree to waive and not to assert in any Action for specific performance of any such obligation the defense that a remedy at law would
be adequate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.16</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Payment
Set Aside</U>. To the extent that the Company makes a payment or payments to any Purchaser pursuant to any Transaction Document or a Purchaser
enforces or exercises its rights thereunder, and such payment or payments or the proceeds of such enforcement or exercise or any part
thereof are subsequently invalidated, declared to be fraudulent or preferential, set aside, recovered from, disgorged by or are required
to be refunded, repaid or otherwise restored to the Company, a trustee, receiver or any other Person under any law (including, without
limitation, any bankruptcy law, state or federal law, common law or equitable cause of action), then to the extent of any such restoration
the obligation or part thereof originally intended to be satisfied shall be revived and continued in full force and effect as if such
payment had not been made or such enforcement or setoff had not occurred.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.17</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Independent
Nature of Purchasers&rsquo; Obligations and Rights</U>. The obligations of each Purchaser under any Transaction Document are several and
not joint with the obligations of any other Purchaser, and no Purchaser shall be responsible in any way for the performance or non-performance
of the obligations of any other Purchaser under any Transaction Document. Nothing contained herein or in any other Transaction Document,
and no action taken by any Purchaser pursuant hereto or thereto, shall be deemed to constitute the Purchasers as a partnership, an association,
a joint venture or any other kind of entity, or create a presumption that the Purchasers are in any way acting in concert or as a group
with respect to such obligations or the transactions contemplated by the Transaction Documents. Each Purchaser shall be entitled to independently
protect and enforce its rights including, without limitation, the rights arising out of this Agreement or out of the other Transaction
Documents, and it shall not be necessary for any other Purchaser to be joined as an additional party in any Proceeding for such purpose.
Each Purchaser has been represented by its own separate legal counsel in its review and negotiation of the Transaction Documents. For
reasons of administrative convenience only, each Purchaser and its respective counsel have chosen to communicate with the Company through
EGS. EGS does not represent any of the Purchasers and only represents the Placement Agent. The Company has elected to provide all Purchasers
with the same terms and Transaction Documents for the convenience of the Company and not because it was required or requested to do so
by any of the Purchasers. It is expressly understood and agreed that each provision contained in this Agreement and in each other Transaction
Document is between the Company and a Purchaser, solely, and not between the Company and the Purchasers collectively and not between and
among the Purchasers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 39 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.18</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Liquidated
Damages</U>. The Company&rsquo;s obligations to pay any partial liquidated damages or other amounts owing under the Transaction Documents
is a continuing obligation of the Company and shall not terminate until all unpaid partial liquidated damages and other amounts have been
paid notwithstanding the fact that the instrument or security pursuant to which such partial liquidated damages or other amounts are due
and payable shall have been canceled.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.19</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Saturdays,
Sundays, Holidays,&nbsp;etc.</U></FONT> <FONT STYLE="font-size: 10pt">If the last or appointed day for the
taking of any action or the expiration of any right required or granted herein shall not be a Business Day, then such action may be taken
or such right may be exercised on the next succeeding Business Day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.20</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Construction</U>.
The parties agree that each of them and/or their respective counsel have reviewed and had an opportunity to revise the Transaction Documents
and, therefore, the normal rule&nbsp;of construction to the effect that any ambiguities are to be resolved against the drafting party
shall not be employed in the interpretation of the Transaction Documents or any amendments thereto. In addition, each and every reference
to share prices and shares of Common Stock in any Transaction Document shall be subject to adjustment for reverse and forward stock splits,
stock dividends, stock combinations and other similar transactions of the Common Stock that occur after the date of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.21</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><B><U>WAIVER
OF JURY TRIAL</U>. <U>IN ANY ACTION, SUIT, OR PROCEEDING IN ANY JURISDICTION BROUGHT BY ANY PARTY AGAINST ANY OTHER PARTY, THE PARTIES
EACH KNOWINGLY AND INTENTIONALLY, TO THE GREATEST EXTENT PERMITTED BY APPLICABLE LAW, HEREBY ABSOLUTELY, UNCONDITIONALLY,&nbsp;IRREVOCABLY
AND EXPRESSLY WAIVES FOREVER TRIAL BY JURY.</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>(Signature Pages&nbsp;Follow)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 40 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">IN WITNESS WHEREOF, the parties
hereto have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as of the date first
indicated above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>T STAMP INC.</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Address for Notice:</U></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 46%"></TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 49%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">E-Mail:</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">With a copy to (which shall not constitute notice):</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">SIGNATURE PAGE FOR PURCHASER FOLLOWS]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 41 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[PURCHASER SIGNATURE PAGES TO IDAI SECURITIES PURCHASE
AGREEMENT]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF, the undersigned
have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as of the date first indicated
above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify; width: 13%">Name of Purchaser:</TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 77%">&nbsp;</TD>
  <TD STYLE="text-align: justify; width: 10%"></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify; width: 32%"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Signature of Authorized Signatory of Purchaser</I></FONT>:</TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 58%">&nbsp;</TD>
  <TD STYLE="text-align: justify; width: 10%">&nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify; width: 21%">Name of Authorized Signatory:</TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 69%">&nbsp;</TD>
  <TD STYLE="text-align: justify; width: 10%">&nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify; width: 20%">Title of Authorized Signatory:</TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 70%">&nbsp;</TD>
  <TD STYLE="text-align: justify; width: 10%">&nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify; width: 27%">Email Address of Authorized Signatory:</TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 63%">&nbsp;</TD>
  <TD STYLE="text-align: justify; width: 10%">&nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Address for Notice to Purchaser:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Address for Delivery of Warrants to Purchaser (if not same as address
for notice):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Subscription Amount: $_________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Shares: _________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Prefunded
Warrant Shares: __________________ Beneficial Ownership Blocker </FONT><FONT STYLE="font-family: Wingdings">&#168;</FONT> 4.99% or <FONT STYLE="font-family: Wingdings">&#168;</FONT> <FONT STYLE="font-family: Wingdings"></FONT>9.99%</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Warrant Shares:
__________________ Beneficial Ownership Blocker <FONT STYLE="font-family: Wingdings">&#168;</FONT></FONT> 4.99% or <FONT STYLE="font-family: Wingdings">&#168;</FONT><FONT STYLE="font-family: Wingdings; color: #0070c0"></FONT> 9.99%</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">EIN Number: _______________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-family: Wingdings">&#168;</FONT>
Notwithstanding anything contained in this Agreement to the contrary, by checking this box (i)&nbsp;the obligations of the </FONT>above-signed
to purchase the securities set forth in this Agreement to be purchased from the Company by the above-signed, and the obligations of
the Company to sell such securities to the above-signed, shall be unconditional and all conditions to Closing shall be disregarded,
(ii)&nbsp;the Closing shall occur on the second (2<SUP>nd</SUP>) Trading Day following the date of this Agreement and (iii)&nbsp;any
condition to Closing contemplated by this Agreement (but prior to being disregarded by clause (i)&nbsp;above) that required delivery
by the Company or the above-signed of any agreement, instrument, certificate or the like or purchase price (as applicable) shall no
longer be a condition and shall instead be an unconditional obligation of the Company or the above-signed (as applicable) to deliver
such agreement, instrument, certificate or the like or purchase price (as applicable) to such other party on the Closing Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[SIGNATURE PAGES CONTINUE]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 42; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>7
<FILENAME>tm2317786d1_ex10-2.htm
<DESCRIPTION>EXHIBIT 10.2
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; text-align: right">&nbsp;<B>Exhibit 10.2</B></P>

<P STYLE="margin: 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">June&nbsp;1, 2023</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Holder of Warrants to Purchase Common Stock set
forth on <U>Exhibit&nbsp;A</U> attached hereto</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Re:&nbsp;<U>Amendment to Existing Warrants</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dear Holder:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Reference is hereby made
to the registered offering on or about the date hereof (the &ldquo;<U>Offering</U>&rdquo;) by T Stamp,&nbsp;Inc. (the &ldquo;<U>Company</U>&rdquo;)
of its common stock, par value $0.01 per share (&ldquo;<U>Common Stock</U>&rdquo;), and/or other securities of the Company (collectively,
the &ldquo;<U>Securities</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This letter confirms that,
in consideration for the Holder&rsquo;s participation in the Offering and purchase of Securities in the Offering (the &ldquo;<U>Purchase
Commitment</U>&rdquo;), the Company hereby amends, effective as of the closing of the Offering, the Common Stock purchase warrants set
forth on <U>Exhibit&nbsp;A</U> hereto (the &ldquo;<U>Existing Warrants</U>&rdquo;) by (i)&nbsp;reducing the Exercise Price (as defined
therein) of the Existing Warrants to $2.30 per share and (ii)&nbsp;amending the expiration date of the Existing Warrants to five (5)&nbsp;years
following the date of closing of the Offering (the &ldquo;<U>Warrant Amendment</U>&rdquo;). The Warrant Amendment shall be effective
upon the closing the Offering and the satisfaction of the other terms and conditions referenced below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Warrant Amendment is
subject to the consummation of the Offering and the Holder&rsquo;s satisfaction of the Purchase Commitment. In the event that either
(i)&nbsp;the Offering is not consummated, or (ii)&nbsp;the Holder does not satisfy the Purchase Commitment, the Warrant Amendment shall
be null and void and the provisions of the Existing Warrants in effect prior to the date hereof shall remain in effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Except as expressly set forth
herein, the terms and provisions of the Existing Warrants shall remain in full force and effect after the execution of this letter and
shall not be in any way changed, modified or superseded except by the terms set forth herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">From and after the effectiveness
of the Warrant Amendment, the Company agrees to promptly deliver to the Holder, upon request, amended Existing Warrants that reflect
the Warrant Amendments in exchange for the surrender for cancellation of the Holder&rsquo;s Existing Warrants to be amended as provided
herein. For any registered Existing Warrants or if the shares of Common Stock underlying the Existing Warrants are registered for resale
on a registration statement, the Company shall file a prospectus supplement to the applicable registration statement in connection with
the amendments hereunder by the closing of the Offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>[Signature Page&nbsp;Follows]</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">IN WITNESS WHEREOF, the parties hereto have caused
this agreement to be duly executed by their respective authorized signatories as of the date first indicated above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD COLSPAN="2"><FONT STYLE="text-transform: uppercase">T STAMP,&nbsp;Inc.</FONT></TD>
  <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD COLSPAN="2">&nbsp;</TD>
  <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 5%">By:</TD>
  <TD STYLE="border-bottom: Black 1pt solid; width: 45%"><I>/s/ Gareth Genner</I></TD>
  <TD STYLE="width: 50%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>Name:</TD>
  <TD>Gareth Genner</TD>
  <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>Title:</TD>
  <TD>Chief Executive Officer</TD>
  <TD>&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Name of Holder: Armistice Capital Master Fund Ltd</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Signature of Authorized Signatory of Holder: <I><U>/s/ Steven Boyd&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Name of Authorized Signatory: Steven Boyd</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-variant: small-caps"><I>[Signature
Page&nbsp;to IDAI Warrant Amendment Agreement]</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">EXHIBIT&nbsp;A</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">EXISTING WARRANTS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">Transaction/Warrant Date</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">Shares</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">Strike Price</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 38%; text-align: center; padding-left: 5.4pt">September&nbsp;14, 2022</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 25%; text-align: right">390,000</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 25%; text-align: right">8.85</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>tm2317786d1_ex5-1img001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2317786d1_ex5-1img001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  H'!PD'!@H)" D+"PH,#QD0#PX.
M#QX6%Q(9)" F)2,@(R(H+3DP*"HV*R(C,D0R-CL]0$! )C!&2T4^2CD_0#W_
MVP!# 0L+"P\-#QT0$!T]*2,I/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]
M/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3W_P  1" "= 5H# 2(  A$! Q$!_\0
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M',A'-;@[=Z4"C&*R;N:+0<**04'(-(8N:,TW<<TW<V>V*5P),TM,!)'-+G%
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7>I49J8  <"E*HVK!&-@ Q2TE+4%G_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>9
<FILENAME>idai-20230601.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.18b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: +aA5w7xRiXgen8uLa3ZcWaCD+bOdzZR+6YkxtmB6bamKnyUrtVXckCnUunk28UYL -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:srt-types="http://fasb.org/srt-types/2021-01-31" xmlns:IDAI="http://truststamp.ai/20230601" elementFormDefault="qualified" targetNamespace="http://truststamp.ai/20230601">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://truststamp.ai/role/Cover" id="Cover">
	  <link:definition>00000001 - Document - Cover</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="idai-20230601_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="idai-20230601_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2021q4" schemaLocation="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd" />
    <import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd" />
    <import namespace="http://fasb.org/us-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2021" schemaLocation="https://xbrl.sec.gov/country/2021/country-2021.xsd" />
    <import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd" />
    <import namespace="http://fasb.org/srt-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>10
<FILENAME>idai-20230601_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.18b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>11
<FILENAME>idai-20230601_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.18b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://truststamp.ai/role/Cover" xlink:href="idai-20230601.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://truststamp.ai/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140653504898320">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Jun. 01, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun.  01,  2023<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-41252<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">T STAMP INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001718939<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">81-3777260<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">3017 Bolling Way NE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Floors 1 and 2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Atlanta<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">GA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">30305<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">404<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">806-9906<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Class&#160;A Common Stock, par value $0.01 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">IDAI<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Elected Not To Use the Extended Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>tm2317786d1_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2021q4"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="idai-20230601.xsd" xlink:type="simple"/>
    <context id="From2023-06-01to2023-06-01">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001718939</identifier>
        </entity>
        <period>
            <startDate>2023-06-01</startDate>
            <endDate>2023-06-01</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2023-06-01to2023-06-01">0001718939</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2023-06-01to2023-06-01">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="From2023-06-01to2023-06-01">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="From2023-06-01to2023-06-01">2023-06-01</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="From2023-06-01to2023-06-01">T STAMP INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2023-06-01to2023-06-01">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="From2023-06-01to2023-06-01">001-41252</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="From2023-06-01to2023-06-01">81-3777260</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2023-06-01to2023-06-01">3017 Bolling Way NE</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="From2023-06-01to2023-06-01">Floors 1 and 2</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="From2023-06-01to2023-06-01">Atlanta</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2023-06-01to2023-06-01">GA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2023-06-01to2023-06-01">30305</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2023-06-01to2023-06-01">404</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2023-06-01to2023-06-01">806-9906</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="From2023-06-01to2023-06-01">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="From2023-06-01to2023-06-01">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="From2023-06-01to2023-06-01">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="From2023-06-01to2023-06-01">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="From2023-06-01to2023-06-01">Class&#160;A Common Stock, par value $0.01 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2023-06-01to2023-06-01">IDAI</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2023-06-01to2023-06-01">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="From2023-06-01to2023-06-01">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="From2023-06-01to2023-06-01">false</dei:EntityExTransitionPeriod>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>14
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M;%!+ 0(4 Q0    ( &5BQ59EK"DE[@   "L"   1              "  :\
M  !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    ( &5BQ5:97)PC$ 8  )PG
M   3              "  <P!  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#
M%     @ 96+%5H+6EZ^0!   TQ$  !@              ("!#0@  'AL+W=O
M<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0    ( &5BQ5:?H!OPL0(  .(,
M   -              "  =,,  !X;"]S='EL97,N>&UL4$L! A0#%     @
M96+%5I>*NQS     $P(   L              ( !KP\  %]R96QS+RYR96QS
M4$L! A0#%     @ 96+%5JK$(A8S 0  (@(   \              ( !F!
M 'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    ( &5BQ58D'INBK0   /@!   :
M              "  ?@1  !X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+
M 0(4 Q0    ( &5BQ59ED'F2&0$  ,\#   3              "  =T2  !;
H0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@     )  D /@(  "<4      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>24</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="tm2317786d1_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://truststamp.ai/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="tm2317786d1_8k.htm">tm2317786d1_8k.htm</File>
    <File>idai-20230601.xsd</File>
    <File>idai-20230601_lab.xml</File>
    <File>idai-20230601_pre.xml</File>
    <File>tm2317786d1_ex1-1.htm</File>
    <File>tm2317786d1_ex10-1.htm</File>
    <File>tm2317786d1_ex10-2.htm</File>
    <File>tm2317786d1_ex4-1.htm</File>
    <File>tm2317786d1_ex4-2.htm</File>
    <File>tm2317786d1_ex5-1.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="24">http://xbrl.sec.gov/dei/2021q4</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>19
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "tm2317786d1_8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2021q4": 24
   },
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "tm2317786d1_8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "idai-20230601_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "idai-20230601_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "idai-20230601.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"
     ]
    }
   },
   "elementCount": 59,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2021q4": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 24,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "IDAI",
   "nsuri": "http://truststamp.ai/20230601",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "baseRef": "tm2317786d1_8k.htm",
      "contextRef": "From2023-06-01to2023-06-01",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00000001 - Document - Cover",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://truststamp.ai/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "baseRef": "tm2317786d1_8k.htm",
      "contextRef": "From2023-06-01to2023-06-01",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://truststamp.ai/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://truststamp.ai/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AnnualInformationForm": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.",
        "label": "Annual Information Form"
       }
      }
     },
     "localname": "AnnualInformationForm",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://truststamp.ai/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditedAnnualFinancialStatements": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.",
        "label": "Audited Annual Financial Statements"
       }
      }
     },
     "localname": "AuditedAnnualFinancialStatements",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://truststamp.ai/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://truststamp.ai/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://truststamp.ai/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://truststamp.ai/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAccountingStandard": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
        "label": "Document Accounting Standard"
       }
      }
     },
     "localname": "DocumentAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://truststamp.ai/role/Cover"
     ],
     "xbrltype": "accountingStandardItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://truststamp.ai/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://truststamp.ai/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://truststamp.ai/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://truststamp.ai/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentPeriodStartDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.",
        "label": "Document Period Start Date"
       }
      }
     },
     "localname": "DocumentPeriodStartDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://truststamp.ai/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://truststamp.ai/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://truststamp.ai/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentShellCompanyEventDate": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of event requiring a shell company report.",
        "label": "Document Shell Company Event Date"
       }
      }
     },
     "localname": "DocumentShellCompanyEventDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://truststamp.ai/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentShellCompanyReport": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
        "label": "Document Shell Company Report"
       }
      }
     },
     "localname": "DocumentShellCompanyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://truststamp.ai/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://truststamp.ai/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://truststamp.ai/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://truststamp.ai/role/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://truststamp.ai/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://truststamp.ai/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://truststamp.ai/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://truststamp.ai/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://truststamp.ai/role/Cover"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://truststamp.ai/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://truststamp.ai/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.",
        "label": "Entity Bankruptcy Proceedings, Reporting Current"
       }
      }
     },
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://truststamp.ai/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://truststamp.ai/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://truststamp.ai/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://truststamp.ai/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://truststamp.ai/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Elected Not To Use the Extended Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://truststamp.ai/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://truststamp.ai/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://truststamp.ai/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://truststamp.ai/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://truststamp.ai/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPrimarySicNumber": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.",
        "label": "Entity Primary SIC Number"
       }
      }
     },
     "localname": "EntityPrimarySicNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://truststamp.ai/role/Cover"
     ],
     "xbrltype": "sicNumberItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://truststamp.ai/role/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://truststamp.ai/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://truststamp.ai/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://truststamp.ai/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://truststamp.ai/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://truststamp.ai/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://truststamp.ai/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_Extension": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extension number for local phone number.",
        "label": "Extension"
       }
      }
     },
     "localname": "Extension",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://truststamp.ai/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://truststamp.ai/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://truststamp.ai/role/Cover"
     ],
     "xbrltype": "trueItemType"
    },
    "dei_OtherReportingStandardItemNumber": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.",
        "label": "Other Reporting Standard Item Number"
       }
      }
     },
     "localname": "OtherReportingStandardItemNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://truststamp.ai/role/Cover"
     ],
     "xbrltype": "otherReportingStandardItemNumberItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://truststamp.ai/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://truststamp.ai/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://truststamp.ai/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_Security12gTitle": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(g) registered security.",
        "label": "Title of 12(g) Security"
       }
      }
     },
     "localname": "Security12gTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://truststamp.ai/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://truststamp.ai/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SecurityReportingObligation": {
     "auth_ref": [
      "r9"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.",
        "label": "Security Reporting Obligation"
       }
      }
     },
     "localname": "SecurityReportingObligation",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://truststamp.ai/role/Cover"
     ],
     "xbrltype": "securityReportingObligationItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://truststamp.ai/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://truststamp.ai/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://truststamp.ai/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 3
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r10": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r11": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r12": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r13": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r14": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r15": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r16": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r17": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r18": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r19": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "g",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r6": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12, 13, 15d",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r7": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r8": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r9": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>20
<FILENAME>0001104659-23-067945-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001104659-23-067945-xbrl.zip
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MT?\ ;RB.\E^(?0-97QH-+]=4R[]02P,$%     @ 96+%5CT7:RG_"@  ;(<
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MS0,PM?0A(@69[ 6K"/3-UX)$&]E?[J9'R_LDH[83S[;$6?\$F*MZ)R,]"#X
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MW?)(FP( C%3DUICDJ6EPLZ+9I7KO&25UVP<)\5O),R=32TBIH(9*=BZ'\YS
MU:-!,UK[+35E9AISIZREEWY,$+;#J^%UT\ [0U.XC*8B<E55]^A#<F72#T?#
MK>:.IT:; GX=(PL%2"C7W^.^V(FFH'N*[F4>@Z4L>$C?28.5 $!?5"A-XCFP
M38ED8+L,-B>">X$K=A1_;D$;W9F^E1P">ROH7S)[X1 *"=3HF\>(A$IF'!
ML(Q9W.*SQ!#<=]S8[<?C( UC7J^Q0?>$[4Q,^Z%A'\9+>MR\CO7]!!8R"%4<
M&N-'*1ZT;'R["L_#)_[[=IJ2PYL/R>%M-N'NR+0KOC/=8B"VPPM]Q_>=B;J&
M)%KAECFRM]@ V$NX)3!*IC1L7+E<!):HG/,1Z<"X?,]VD!RYWL@9NHG7[DS#
M'Z-*J?U22G39=US @'Q\U^*#&P9],,^Q3&.;J9NZ)WF_'MW/@P=Q5O',KZ 9
MH65IY]__6U^O;4O\JK^QJ:XFYOKRV._O7)T>7>[OL=YEYW*_]W:U'ZW("P/2
MV^]>71Q='NWW6.=TC^W_WGW7.3W<9]VSDY.C7N_H['0N= \:"]\'W6?NC<&K
M]1WH=:_:K;)&;:W5_EZ('B+H B@CJOHQ2W5P=G&B(/"FW"8!C=9?&TQL-&HK
ME3UG$*"-@O[$]2"TOR-+_&M],G$N/__^QU]_@JK_;J,H/EYI9[/R(6T1O5U%
M2'=>ZX(],_4"9UWLGUZRB_WSLXO+'\E'YU<7O:L.@')YQH#C+X&M)6KJ379V
MP>IK*\:;'PG?V0&[?+?/8L(H%$2=[B6#V_5VL_4C(=24](,@0*.4.4/FBJGC
M^FQ%_Q8<# [A^4S<0DMU6QAOM@!DEA83S928.">C=E^:O/GR8J^[=KAV?UL;
M[UG?+"]D? J<FWM_RX"1)O#<V."S&0 O[#QYD@"LM/,^L 6KEQEV^G-)F$;K
M>:DRO<(;:H6ECWPA1J:'(4(?8P;Y"[QO33JMULSL>HTG4 AYXY9V+M'..3EG
M1Z?=ZC.MWS<C<67_G@]\FH+D+PWZ\A+WF#<5 _13#68"FGV/#<!O@.?>O 9:
M\WG?$M"#90$*!Q3\KY7H]Y0;AO[]:/!B1GMHBP\<R^)3#ZQK_4WZ@V]][1*]
M]0T]U*UP?7/ +3U'F%320"]8C'#H9@/=!2+M&/25(9^8UFSK(?A3(^7R22W!
M)T?VP'%!<%(0O>>#S.G*<''7,0K8YO"O3U_?O^M_=3N;3R$7,=:/ 0M?3%WG
M%HDQ*1@7@!-TA+#X'8C4N2RFOOI&=MWR5B2]EI(><Y93+1VNG";3O#%^ MHX
M2-#&@6D)0&1?N/F$<+<Q[AW.FKN-_E,8U.DQ,7A6K[3JC;7&/ZOZ7:O:3JSJ
M);\_4C'( 7'3O"4V)YWQQ_/FY.RX]61+7   .%'U2G-C8Z.Q7EMPP>&/6RR+
M%UE]6"W0@R1/F.,RQQ\+EWT)7-,SS '"]K;OJI S0QUIQL70FR>GNHRY_:W]
MRWEUG<G$]+S4-)#%F,3YJY_!4?6BVJNR_<G4<F;"C4\C24.)"45TL4J&PLX+
M&U8_UO5.L_]Z@OT[AN$*SU,?QZ8MZOFL/VI\_IVO-?TOQOJ3L7[.X*6=9JV^
MP7;!M@*SC7WF,W:Z7\#_Y8Q;M_' W!KY<Q.U#\[IX.+3I26><6[@51Q8CN-Z
MK,ZX;; B/9:=5BMO6EWX>N9>.G=V@;_Z1W=O<KS9=MKCIYY4-'1II^-;X"+P
MA>>RFS<7DKAG[CE8?"!2"PS-\3O_PVWO^'BP^>W^V:,-S7P 2SN'P@$.+)IV
M9M9K>;,^=V!XZT]S6FQ<0_/>\6;G>//]DU-F8G1DNV9M[=6YI I6U+53%S!O
M3KFUO"3NQ2#PS5OT4T'BXTAPSPK0TV-?S2F@QA#?Y9C^C+(^BC7\^W\W&_6-
M;0^:66(Z=FS!;-*'<3R!>\0)45L,M,1*FF+W%<4BKW>@:3&-OCOM&9_;?UI6
M_2D$37R\TDZKUBJ@R3>%PO_8 ;OA'&<]SY05C=O#D\-U8](=/0'4Z3'!>H4V
M;="VKXVE?GP %R X=7S6F4XML-; 'OMQXN4 U %8^#+DY9)V$.[R$I=2![AE
MB&$N>R3 5D6YSRSNZ=#RJPA\?3.VJ#M62T+R)?# A)Z5=KIC,;AAX/TP/@7M
M"*(7/:*^<\_ZPG+N$"]X$]$G =JL?)!?AB;9;::WO&1B#9\!J/,=P-XDL'QN
M"R?PK!GSP$CWAC/J1#WA] $&:;L[LO<H ,D"Z,<%HVFF[PW!/G3N\#E4WB;Z
M--[6DV'EE<87Y\082EFO2L<3FM/[/+?LZ2(,A3U]!L0@<KQ28=3QLVOZ0"7H
MF0:V\MV\?(%]N??E2_W]L/UN:#Q)_J7O.);@-I6OQ45Y+DB2(C:W"Z5Y\B//
MRWW&)5 @ QKB,+-IX'H!L@\P()9YL%9C3;$2\E /C"AXT(2A.@.?K8#;U3VX
M8(#O*C1\DQ]9>0(/^A\F>R$FVU-,UG- T<)"VZ,3$.,@RZU\#KM]UWKW:?VH
M.>YO/"N'9>%YW>P5P0L4+ '.\):J(6CQ2KTAOT>,MG\OC8@XF\DVC5:M*I_Y
MA]U^>G;K*'8[=P4J#ZQ$IHH@-(+<L^&PR!/9<_C[9MT\J(DG2: 5LETQ7*^;
M_0#NRB &N*3C!W2=YD>CTECIOWDL1\JG_N')GYXG6_D\>>1Y@7 ?Y,Q@T+H=
MU=R/)Q^?5R$^!-W?ES^;HM):&3R6/]53+\^?W]]AS.B6_JUPP4..8P=:(,H4
M@E .::<7D/%?Z^/*($B.^$F5R/?3)?)W8],7%9R2P&U9=RZ?;C,UH_"I.H9;
M'I6EWWSJ+/TE;HV4=8R#,1M8W/.^J:#A6PL7'L+C'&0T:$\#3,'EB%6=E>W-
M)GW'6O'>/"[S^P,F(%>SOW.J2M]H"82207HZCKV\!,0T&$L@(NX-IS>__N!;
M*T.>N1I$%\PKP32K-_I$BOD:<=;X^/OY'_=WW8_M)XB:I\<L[721[B6".PQU
MHF.SGN\,;LK LRZ[Y58@V+]JU5J=37&_W?C'%'D]3PW0,Z^TSD$J-I7LF;_,
MYY<-^^NH-FZO?WF"94X,6-K!7=7_K-EB:]9-<:<VC(JKF.]N-Z\.VA?W-YO?
M7J>1SI*C*,PFR/-@*NU<@J%RRCV#_R49EYUP]T;XCR[A>L567$'2Y,@VT-P5
MK#]C TJ@P%,W8( (*B-+I31,C\%*@\&,'8_8R'7N_/'R$IC-4\QS<(\98FC:
MLMY:1F]K:]H23(5NX6J]W6RR%9SHQC9%<'5CDRJUIUBIC2FNF.W=Z%=4J"K3
MZ_)2P@*7_;=D8ST(&N*I+F)C59_/4/W^#O>36&<*Z?$=98_T,YN)^@[=_R%U
MWY6]Y[/KVN?SDS_?FWMCPWQ*%]-W Y&M_,B%B_#;J#WH7+[6Y2SBQF$.?^F5
MQCJ(7&8UTZG'Y:4QL**PP"D#5K0=<M$"3U S&%=E./'P&9.2EW)[/*X)#6;-
M</0[$\9&MK9A2G#'%;>F!\\!@W-[@/%D/J!S6; QGOQC<-?P9&[3B/F'RTL9
M![&YPD,',<ZTU>^@YD:2FN\OP^G)[4CYI-RLK>WNG0X^V1??7AR\2+2D"*I%
MHR3/1<B+;""/Y_B;.3E^N8'\$9O%8PY.[F;QV&;R)]\8_GB,/2'R\]".T&Y#
M^[\"C$5!MQ)T,O6R6"S<5?_@COYULM:FR47-%&CH(PTRP[N"WU3Z F@=8)P2
MS/$AUPOHXK%#QA?SB=<Q2?DO%#[ZOOATK;JQ9MID9!_Y8L+J53SJ9)' 1*A2
MX-%]W&,$R@/$,&<Z>\GVT%(SJ2"Q,W(%14&K.6&!I[-IY5^:4J[^4Q=!RPGL
MOZ*;]H'4014&MH%!.,?=DO&QEU'*<X9_:^[$K<_SP 5-YL70"4+]9[-!YDSW
MS&:XDU>I<+F=M[R\= DN$Y],V9$]J):!P/0V-A;;9<)64--CA2?:;'W$G#+D
M)(JPO _NU;??E!EYJ.1!$+UZD=<PU0CF&L$Y_?;..^D^EY>D*0.,[?H<=X+:
M,%<_0,B $4S[5GB^XY83$6V*FI&!TM7>#8Y*A6$FYCJH'-X#48%7L)WNAZV8
M*C< 0_%8Q'QYR3!=0:[)$-;#'I791G.]W*K5F#K4*V<ZZJ";Y(S0=OJ6J).R
MN9:7])QRUJ6HVPP,W(?93<%8H6[_U:@V:]%(94+/U!6584#6)I $FJ9Y<\1<
MS &U6E[ZK)IE1@,DA^L?3/'G6JM9;D:XFX<2A!4 ;+3;"0A]LK;OA3L PU9.
M97D)YP)82Z-M#KIQIBMF8M'!= 2R=9%$H=M;M-FGH+&):,M4\N2@@8N@A;-*
M8 A$;PI'LI=SW0LKPE19SXAT&YKT,$D^ N(=J4,')/KJY<9&N[SQ$ *7E_0L
M<["5L_!S<?6*'>S'2D,,&<5D$R"T#XM&DH&B'Y%'1M(LQ?GL3A"JAIE,6DSB
MA!7QWEA8T=YV$JBT!X3H 'Y$):V]2I.MX.:XY:5FLUEI;-1K[?J;7+F"75[$
MN^SI+K,4188"MZP9%KX"P/U90C*2>$V%>) IM&M'\D;MXLN#9;^;8??"BC\5
M-BICL(E/I">;TV7BH<R$,#'".D#"ED1;4VHS MH0 XOCJ@A8G8'<L)%H7&_(
MUE6&-! )KY C<9="@@F#*?2 I(&GX](@=R;H#5=,0!O1SI"H*?B)X%C#7>4>
M/]"_)+9A8%E_,][*"+Q(-[ 51"$B9Q'13W@/5T%&0)0,"U%<)%O?2#[%"$I<
MC1<1IU0%A:PMQ>=D2MPV=)U)(FQ#5UT\6=8E(+R"N*F.KP 8B3A)(38)V$3\
MI;7"WZPTWA3$46D4F,AJ(O*Z5EM'@$!B!):$=0]!F006JI4Y2%$A#,TM1:@F
MHC8G$V%@V3Y(FD(&*DON$?=3P!0()&!0/(K&(Y0N+R$$AM)TT2.X,, HV@(<
MF.X@F,CCJCT@UAE([QA+.:3#N3>V<!]7GWNF5V5'BZ%[" 3 AMRTEI>D\IW!
MJG(/:<\!X6(!O.Y"A!O2*YARII%#M5G! ./-X9LR\X+^%U1# (D38$1O(,PI
MR52>'@5HWE3"BK94A 9$T@(H:UW@ _OK.*(G?#0\0"DH19AGX>4"RR)8 8M(
M$HHCR.Z>\IG>WZ%VX;"Q8QERBQBM%ZD%RX1'D 1 F/,)'Z$V\C) @<.6)UIA
MOL50S1'Y<Y\#@>XY:AL;.$8@ $%F@D_>#V85U "N.1I#*X4M>1:4HJ)\JDE8
MD$0HX;)@WD9 $U3*JL/8VF3QD+\X#^#AYPRPS_/E%^+M*Y1Q4L2 *IAX<Y7T
M7 RBIRQI5THS5#$H@FPZ;9RH/5Q1%"&X>4MM,\*?7C 8@ULK.\,M7V5)!2/S
M%JU+:;K0'J: JD)D3^44*\O]E=AG 67UA2V&YD":?LZ='9E^"O85WQE1IE#Y
MV'C&$A_B[BCH'R>)NY\HDPCDYV%-'1]0O@"M-\QOD"\BNXC,2-6YD]@])2^&
M-G%R%",::7E)#W4W=@![T1QH!JXW-J>9B=XY@64P2G_@EWX,2T8:KA $%.^@
MWZ<P"J$NG>,PM(8%F)+WUG-T>U[R,F[EOE% BON!$$:91B^@O3)K5]OM7[81
M,?&&1(P@]W*HL84/:*@>I LG\"GA0[OF8CJ;#X$MLD08-[IH2I)\89VP'@&C
MO-'*F)A#1N;2:61,,KD&6<[A0H3,1^0=LH&,V<2Z58H=!"^J8.@/G-CL0H(%
M;LGED4RT7@>],?/4;:T)D[Y97)460@1X#;-A_AC&IILI^&"*MB-E/KH"N+AR
M^?Y^0C8105P+(XAQM XLQQ/&0]ZSMDHRL96HR0I6:4K_S9I)P9?P$,]40^43
M:A<1[KS![P"6RTU/96$]2FOBTG@RY%%NMQKEC?7UZD:-R:0(4*T12-D600-K
M#'^'0OG#4A*&(((%*VR4'6#7D#&3=*O!XE2&BC0(B(+0,WS B([,6,KGDE64
M]-;)]P33#RQG3'.H.&AVGK2/]MZ<$',O+R6F+4TAW2<2LDXPV\*/>@G='(UO
M NK.<6_P^X!/39];9?U%H@0@"EPMUR7. (_"A?LZI@Q(T9+W;^3WGJ?B0"14
M*"))NN*\DUQ(TXNL8V7MM=9(=.'B96+UV"N&;\*8]$.AI'ITG%1L1S6Y-1-=
M=!"#A>H,Q@+<%W@2+-:1B32MN1B76W*UQZW0B5G4@4?1C1Y<W)>7@F-Q9SY)
ML7'DJ>H(V@_@*FM'^FPT&"@RL+XHQC?@V)#$>!R'5.+0%]"!B(6-U)K4-^OA
MHB"$*.(0&]I)C7.'I'GH[$:(:38\$"U5-(H2"FCC>^B%8_S(=J)L!*A6CZRC
M.6+#"7V+9+0D[53\#7F-EBYCT!.OD>S**"P5HMM0G$:8(;LGX5[K0 ,J= KX
M2(\6Y23R"=&TRG51IFMY*4PQT=*$628R@FV8P$!*US",B,8G\"2IR^BB<@\*
MS#8W^9M>8P3<2)8*'B5!@6,9L<@7$-(BY_IE*D0X 7CC"FC$A>^4E=  A653
MBLC!<UC]P(NWU5;IO$!T=7D)5*!6466%^3U076B?)LT('2^ T<9FWT2[G=9/
M,0H>UN!*?)/1:LMX7 +ARF"5TB%"Z$#E01[$(?*<8Y'MB^$4D)8D )'GJ-:*
M2QMS)5DFJ<CM=1<?+E*XTOBG<.4E"E>>2U(F:B]J\\L>8L'%#IAF@]G/4O,@
M_Q;4GY1V.C),A^E;6WF$H<\9J6@G60BQO"0%4-P<2A4Q)#V"P6QN!4.DG_-Q
M&\N2$7 G'$QT=HBQE.6EX^/N@UUF^JFR7,LS-*D* 2KGW/=5H00I5K26,"84
MLZ;Z=-Q]9%*1#3(2H4*(FX>R^J&<'^-8)%2KU@.C4V CZ?AQ!F#RDM!/0W'.
M*>:Z4:V%\9"49R2=D5##D#6(4'OQU)XYZ0-.17(\R2Y2^6D+ =,4@(G0&<20
M1SQASR=88ZN2]O]:JY5KM=HKUA7?E.M+$1BB2?,'%N$"FKQ8U-P54Z *#*%H
MPTJNN4X[A\SEI3SJ<JP3Z%>:%=*NES8YE5B+B1T>R0K.5WC$4\@/84&0BD*D
MR"E^7ATNM 5V@&G)(%]QYE#%!K*C3;F+K<IHF!E,1L:DG12=(O4WHH>$P9<H
M(=<,HR2;!=97)9@J&19?]!7<"HD!]H0,/,;V5],YTI0"+)2]C7N&,BH?2G-Z
MKP"/R$=+3.W5Q1T(S+')PQY=29DRCH6GJ8[YK:IC4Q%:KI-GT,%Z3?H6*0=$
MU]RA!T$8$?8(+0V2&-E3QLKA+AXY+(;P7=I#('^527TX@0R)PH0\&4"35*>J
MDMPXR9YWMF3TBC(+PK* *.F#N-3E*N6 -7%@YALC\'!&,C(+]K%1#L,)=^12
MTKMO99@?7T'I2!\><99V6LBEB?@%!J,J6M0FI& QP!Y/%Z.EKZ+I81%4<7PA
MJRXUJ40\FJ:5[9CK)L&[XU."0\5+I%*;A'$[/5NI\FQJ15G+N[$C(8;OR.KE
M^%H*F*HSD5L1/&5HDV!(9#*P91;D[>6E";^1V2.0:4A^B ?"32RQ1*E'\FHH
MM"$)7E;Y%,6)$@=RQMU!+_( R3(!*8V.7^AB)[I3KFH.X&G<QIRG,B&ZS,:2
MNJ+X5 S?KL "!0PW.04C -7&//50)42^^C9YUP$(XP%P#5 GA:55E2>^Y%<Q
MON$D.0\FZ,#(?R-Q?!F?%\Q7>%+Z4/35]16]<+EM2/@8!O<&KCG52TR[TA>U
M(_.LO/DQ/:44I7!2(4*&)ESBK2^X8$"6,S0'PA>N:L&-M5.$E#BX9-,9ZG5&
M.K'$W9 S,%U'80:/U:OH K3@+VM5&_A'UI'5:WA)L8#.0CAZ/EA;(]\%)2M3
MPL"VP9"% / XK'\C@NJZSITAC^H\YG=E=GQ\3EHD)MT#D'56*M]6UD40% EF
MSM2TD<*XI]M1^8KISQ9P'63E=F[D658J%M2.+5"!4R96F!(4DFB 'M,THP)7
MU7HQ/=!)I/\U- $J5R&0A>]I?MUQA,+=U ^$#A+N@^6!-9F*%"A7)A9BS0\5
M9/ 5"=-D=$"ZU)-H>T*578467::7F.>5 C;<_$"0*9<5M#D5,VO&RA;IIVO/
MFVUR8&/L%QOE_[QYS%B<T=W7@&@VS#'II[A]51[DJQ)*Z6T;P%\]T/^QV#)8
MVXVR*E; GLJQM$M8G9<R_)-KK2N4,Q#*,('T A:IJB>_-N[]+2_I_%$Z0['Y
MBB5#VJ#P@@F97@IY6:I6>45M7E#4!\OL8TH^K=0C"9S?9;XX!G7=D"0!G7?5
MW@TEDA-YT<W*AV=$\,^V([%9K36JC]^2>&7'JCMZ*N*W#TXW*/#(3G^1[8B+
M[T9\U9L1+Y-UL:8M=Z63I$B4?(8;2<.C-AZ@=M0[T"KA(2<:Y(>EE>4;BEF5
M4:-RACFI:-/[;[*&<<,=EQL100J&B<_EI0O0F"YYV(!JT*]&Y=AQJ&8F;.3]
MA";27 *&I4\2GH[]4LD)(<%22 AC$5Z\SGDBN!U3Q1X?"E"Q;E^FRE6L5-^]
MPI=R:4*,16./X4.=Z7\AJ-0E+,ALKU67EPZ*05$%WF76#WSR%E%U6>:$LM$8
M%8FU)<M$W$_I33$Q&RBL+@T##8#?/O@^8NB5*4LPT'%O3$DCDXPP/(P&CGK?
MFQ=6SE)L)#8HA48BTR<]Y## PBLJT;TE9,BJ 'F5BM \F?_6H7/E&2\O#<"(
MP4)+]3XS52=,U@HL\D@6+*/.55)DPF=E';E5E] @2E^3T_72ES'6CV_5P>+?
M]"US$EZ+]E!.'<(ESPP@YY:^*E\"D>E[:G$[<Y&6YC8+"-B45#B7 PV2M6D'
MF6$M\P:+:'TGC&F']6\>$)'%74TPM,CQ5U4HQ,]8,:. Z61AN'<$RX5TB45#
M<]A*\1[2B1<NK#P7QG$-F5[#4JCH"4WPP,=@3J-%P89 2BHG S?[7.VM45MC
M,6@;(V<6HDSM'7:^"$7/O*_#U&F2[0=@?*M-.AA*#Z.H%!P \U(&]$ T&51?
MB7X+2"X^2D<RR[*"'<<ACN4RW!B&_!#1@?3]PT0@^0 8FD4K-OX6$.T$S,'2
M*."H\(1T@A2/@;U/:IOTI P,846)8*[IW7A8 *.2(%&N*S9'62"*I:@F)AT"
MBY2OD@MEG'8L+D$+(F:."I^E\4H!?0<#_!&&,!6)TE45]^ Q/.7<AV6^"RF9
MX0Y'N>?>QXTYT@F:6^ZGW"IU'%M7%H8N+\D3V51]'!7V$T[DI*,Z;Y2_85F-
MS*B8 _7RFW@1KGR!BWH\[NBB=Z#+5G';#(I*_-3.]/)2;[^K(X(XKHJ;YZ%A
MX&,R&1@6E@(E=+2Z<NT&8Q0=2A\XM&P FCZN'W?;RNI9AXH3"8^J)AY3VH7,
M6V4=>YXDP-=B<T2T14>V*9J5[J0='7PP(QI!QM%8C[!$22&?WV LW7;B[\'!
MI/^4^N+S@,!V8-"A/Q_7+(EM>7(W002;,E<3-D)91>TI+1>F[8#18[:PQ>]>
ML<FX6'%5\Y_BJA<IKGJ1 Z6+3."G=,S;X.%]@V-^$![NUHOI+-K++_,=__CD
MB[LTX0XPC;R?.6Y4.,\?<T*Z!$R=@9V(Y)TZ<^@^/)<[]SSU[SNL6_7=5B>+
M[T69T-S3MA_'YOD,R]G8Q>,)_4FC6=_8V%PWZM?BOEZI5\?^).^8W_C1O?5J
M/=QBQE/XFHN(9X"E.#=,RMS&/9G^G1#V(A58R?)+,$K4-&.E-/.AD84V^N2"
M$#LOLWJMQ3#6>HG56Q"6R"2CX%XZ+?K#$-E8#)&-ET#D0K"D$%D0)?U!^%Q;
MC!C67H(P%X3E3-4)H,>9*#S NH,?A,9Z;4'Q7*O6?WT! ;T@. G2C,5+L\<>
M/B2Q'SJ(C\FS.WXJH0U85 R.B<3G72XU4#:S^31XSQ2<OE(Y X#])((&2Q=B
MT9M,&1#O.[?BS7-3;AU?2_Y]..HZ> P->N#RT2.TL[@LB-CC/F=X]!Q;P1(*
MPXAV)2,A'MD6S)_]OGMQ'!;6X9ZW9W(D'^NJ_61I^!8\_^O""Q>Y)NN_)'>9
M4ZA@O5;' \'6H@/!8J=\]3#&Y@W&P@@P,$H5*WV4+LX$W]]K1'M>L&XX<&W3
M&^L3M*+MGB!EZ!0MG7DJ."B0Q<X)I. Z1O1 -CT?G3QSC"#V^OC>T>%IY_+J
M8O]IWAS_?.'(]%ZP!\ZDRSVW1N[-C[TY!%]( !2DPN6&C.3*L+RJ(?8 89)P
M,%70%V-N#?7^'0HWJP98$!"@7T?=\< ?.RX(8N.G+LIYNC=<*MC_V_ZF9"$@
M#Y7I;Z6&?,D;ZUUV3L[9T6DW+W[Y2-S.&2O6X-NUMZ*+M=H#+X_3[7ZA.I+=
MV98L"/F.T%5+];7JK;)#[@I_S Z%;0LW[/F)D$9OK=MBJ8NI(9]P.'I36V:\
M[M@40Q!@(,S(A#F3>[6>-[K=K%*<_LG%]AX:[UO9\RI>LZI9)/.UMLW.9()[
M"^QISW\]B;"7RTJM]AUCAA2X"JZ(M9-$6$_ ;"0_W1OWV^QHC[Y<US9WK^EE
M/[)<A("CY\3[^X,O5[4/=U\Z'\=7JQ_/[N[_/*@U]OKN7S6^>^CVNK9YZIO3
MW5/_9#+H#=]Y5O_0NMW_XW/GC^;MK=B?'7T^^UP_,>^^VI\^69WQI^:0.^V/
M?SAG)VWG>/?F<[WYX8^+?LN_:GUMN^N;P\;NX<>KP\[&V>"]<'KCTW?K)YT-
M]^#LPK3_,M>NS-U/'\RK07MVO+X^MO^\]R^<6V/?YP>W>S?<LD?UC:\GW4]7
MO]Y\_AQ,#KTS<W_CXU=^\&?W#_O7C_4/[T?.6?MT][PU#?8<;[Q_<+1Y:?[Y
M==JTV^Z&MW:Y^ZOW.6CO6>]O>ZNUCX,+<77SJT3'_P-02P,$%     @ 96+%
M5A/DM_:+-P  K4 ! !4   !T;3(S,3<W.#9D,5]E>#$M,2YH=&WM?5ESVU:V
M[CNK^!]P?;O35!4D:[ SV&Y7T9+LL(\MJR0E7:E;YP$D-T7$(, &0,GL7W_7
MM"<,%.50B2PK#[%( GM<>^TU?NO5SQ<?WK_N=E[]?-P_@G\#_._5Q>#B_?'K
M5T_Y7_CUJ?S\ZLW'H]^"\XO?WA__\\DD2\L7P=[NO PNXIDJ@A-U'9QELR@-
M^8LP.%=Y/'D"+\*KI_J]4GTNMZ,DODQ?!'E\.2U?!K,HOXSAX^Z3UZ_>O#[^
M/(V'<1GL[>R]>OH&QG%::6'=GIV&X='=EX';]4BEI<JIP]/W_</C#\<G%T'_
MW?')X6_PS]DQ?;'1_I^\_BX=%O.7=S0A64OZ*D['"IO<W7D>IT]>_VN1*NY[
M+PSV=_</[N^<GKS^D.]PF^^B7)73X)U*4Y5OL(/#::PFP?%G-5J4\94*/DXF
M\6BC/5P$YV4TFP>#=+2SP69?O?T(-"JM#*/1I\L\6Z3C[5&69/F+X'H:E^K)
MZX/=O1^"-UF2Q.EE\.]H&9P<A\';),ORHMO9"Z)T'.R_>HI-;9*TUQM;OTRB
MM(Q"V> ^_WNP>[#[?/-#NIO35CE:1RK* TNR1*LO[OTDA&7\OBC*>+)LGMG%
M-"Z"Z#)7:@9?![URJH+ODO%_%MG+5[^\[NL?7CW]Y?5W.7V]U>V,LA2:+!<E
MC A?L.\/57FM5!I\B#['L^ =4,<\>/_^,.C9-NDGI[T@RP._U],D&G%S_<M*
MWT38<O"Z'3QY81 %1RJ)KH&/!*,LGV=Y5,996IW*83:;1^G2;2R$?J-2QEI,
MHR0)"I4#KXAX6NKS*%D4R#SF9D01CBB8R)BET;#;@0XCW=LHF\U4/HJAP660
MJZC(TFB80'L3>*\L]+R'41'#!L8I#!L(:D2COHZ!&6+3\SR;9X4:.WWW6I;)
MWYQL$O3B+::H7%W&!5R T S,+X?MJK1Q3M]Z*PSO.U/[+B_PZR+ 2<'XBC(;
M?0J#.9R'JRA9J.!ONSN[>PV+#0]W.^?XM+_DO;AA</-<;4^ D<"?L(\Y< _8
M@2R8+_+1-"J4'CP,C5L.J.':@D K;[F5?TLK_M(@\4#_>@"KNEK9CWZVH9<0
M%BI)<#.O%.R^V4X[MFY'OQ96Z-YM+M14@F/&QV1<<5$LB)@6<QB>^HQT!B.1
M3;NAY:"VW;PF^##_%)HFJ&/_/7]NU3[.X:;-XS+VR6DGN("G8)=GA1ZD/=Y\
MYH8JF"W*!9X6& ZRDC'/;KCT#ID<5#U@O6.Y:=B.(.BI:#0-[9%T=BUW>0\V
MMFI2YJ4&2DJS<HJW[Q1(F ^QPQ0-7[G.%LDXF$; 16C4V;7*D>5%BW*:P6B7
M2'W#6"8E<Z4'X!_3/7\19$-@Z<S>@)5T.^XKT P2AZ(7G:6 -^'LSA-5*G_Y
M<6N ^1L>;U9VG(T6^$6!] 7B$^P'_C16":P1'E=_8RP-V=5JXVJF<^1[P%W'
MN(#NJPW#,139 [[,BQU-@*)@0),X5>,MIJ-N9ZC\PY>KB<IQO+ TLDG"V>T&
M7T#31<2C/-+SQKW>T22"]#N.2G/&1DE6X*A;J;G;:>[8)<9#:>0(&J[UIG=4
M?0:^6!0P$Y"TTNPZ4>-+Q0>3CHE+9X9/6Q(!01 [1Z8#Q .W(]U1-UQ.?"O!
MH]@K;0#TP)<A2=+0!DW<(YQQ!F.!X^"< >@I49=1$B"9(GGC;+'ON&1!82GG
MP^6]E4,,E!NG99Z-%R,55$D]O5)P%^6\'&8 *BT6.3]<+$8C6+W)(K%7*-V.
M]5ZP39 ;:'8EKAD\)3>\M(*3EO.,I S;,@<RPX$4U!),CHXMOAT 54;IB&@$
MF)@"LIA4;M6=;N?"HQT2=$"(PRTI(Z 7;FF89Y^(P2&Q1PG^"5T"N2(]%8OA
M-HDC]'NAD/#5>%L_"'W'N)_<?_-Y['8\;@#3A7<;V"EVZK&CZY@9M[J*09P<
M,4^(9#'H%;.IK<)E_<C[/%;+DN[.XV;#EDR=H>#A0FXXL]2,!V:DYB41-HR]
MV@+MY$YP&,WC$H3D_^))I1N*J!V/"M(2;<$UW*[=CG :?9@--Y^I*(5]+H)+
MX#@ID0,.CAN+TQ;.M@/20(STQ2,K0$IW&4KM^1!^(N6U,/2K9Z/W(;J*XD1/
M%SC:-2W,?Q9QCGLQR;,9"I1$M"C/6D:]2<WUK]-B/+T4N]N>1+,X6;ZXJ4-Z
MM@ *X/%!2R#('!]>##Z>B"EE!XE2U-;O_N^/^P<_O?S2?Z#ML^/3L^/SXY.+
M/G9QWNWT3XZ"?_?/SOHG%X/C\^#CV^#BY^/@\..'T_[);R_ACU^/3^"WZB]T
M9WS=6[>WV8WK[_S!W=&;)!8*V"N%UR^,5=^F_MFC+0B.0<[4)S?W7R!6(SH&
MR:1E=JF(K1/[Q>.;@^**XM4X+E"LP*NK&$W5>)&P9@V70;8E0BHP&)2"NIU9
M-%85$4RS$E\ :Y&K;A+-0(PD1@==@(PF&K5E?D,1K)#M=SMP06=5<:!'4E:V
MN)P&</N2F%&43A,\(]1](R.[6PFK)I+:AURI*=1CQ.4 23@+N560C*,K8*[9
M)*Q,B^[8G6  ]\5X'/-ES\L&MX>ZS*#ET%M4LY_>5O(M<8^M/T^L>>W_;&\'
M;V.5C%\$IR JO(3G_[/ C8-F7P:_H@+_(M@/MK?%*_#J:/"K[IW;W"ZS.3R\
M/S<&_.UA5I;9[$7P/7XWS'(0+\UW;V"U/P5[,(PB2^(Q#,6;C7-BF^STI@OJ
M=+>A3^;1SK3TA$!R7LZAZ7X>#>/1R^ DFBF>]$F&\]MS7WJJW\)?<+%>/86)
M-ZS!$$2*3]M#A03R(IC3$KI#_)Z&<T<NB^JXW G@Q'C;[B,%_@7L?V]#[-__
MYP)%9,T.@(VBH6H>Y:(03^($#5::@?ZR<[[C"LWXR/%GX+[I)?&4&:CG-</D
MF]?V%_1#64-GP/8QL682 Q45)@W>@KC+>W:^?1#TSMPG3S(Q4Q\<'&S+;1;L
M_["W^]/>%O-(.!KIF!5\N6/X>WT;P223> 9*3+XT4N.BP-77=D]W:-T.:Y@5
ME:$/2@JP[;V?#@Z(SU.GT'AE]OX;[@J$368=5HN  5=N-VTCZ':NIS'<R,:R
M1"81NA9 )0!>%>&IE_L7==K9G*TI*"%79P8?4()6O%3UT<" 893<8?-FA=T.
M*FJ9G;VU>LRSHMP&K5M$<KLI81!/4#K8@O&/X.O /@1M]^=YG(ALNL]^OIV@
MSSIZ"6<$QTE*"%!G]48#V4&5,DU_9CY!M6THD/>B=:Z@#"FF*+_U0I&]'%8<
M-N$,)!ONY]G>\UZTU=O;ZGT6<RSURC:M"AVQ #2;)_@%;5X1Q6-J;,>SF) Z
MA,?2GDKGX(%*6BS0G G7OC.0_6>]H3L$5HS](83&&I6C;,9/\YFY7"0B[U5(
M^\Q_\LP^Z1UT*U6:<0(Q+I)+/(NT'&+#07-FL9C/$UYN*[O,L U[4,6RQE1?
MK-@P.N]D@..FK*>A1NO6Q@</D0EHC"W&PX5G-,&'D$U&XZL8?1<- AB^BV=S
MLLCI+,<ISD!<-F(YB1)JB0[[EF=Q04&O(J,1J9&I#8Z[);:29<V5)%LU0BJ.
M27#9HF5<8@<3014WQI540RTU:^/D""8I*^"0A#N,<ST,AQQ>\H9YFVFW&?YF
M;A/#F9C/5806 7F@N>FU1O4&.>BIZ=(;CG$_&,*#U^LT%YIQU :J3125V_)6
MY[+G[U-EP 'S6'>(6S">-6;NM'%NWL;Y&WML/W74'=X,3T$1<FQ>_9!9276X
M<HDV=FYOKC'V0'1-_;-A9ZP/=\50[REJKH:FSP$Q)Q D[=P'[BN.Z=MA3>[&
M#&!*H ?4+PO>Z&OH1;:X\?8P@A#+!=T." ;/5@D&[@L5L2#%%62A?(7N&.IU
M9J^(:\*O; B(5"MV)-1.@Q&^A2;:H>)S$:U'&VP-E)G1;(USS_T27S%>.1B0
M_&:I6K]4M4#?0'^UTW(;\B-^VTI_+&(01X>ET-3H$("WZWP.OWC#NITUY]"T
M8:%SG% J=&F_;#!L@$@%RV ^%O7=I96Q]Y6Y4UCNMU8<<Y%Y-YUPQ\*&#*1H
M]E<UTM!W>?7[L2I&</W:'^S9-J.NO61N1R?T0O]$!AK]_<H[94VJ A'*DE6/
MS@LL*2^%L["PPTG\";9DAAZ8K2;^AU9VC_8H4H-EW'76'XY3^P:@DZE801W#
MVAG?X+HTD>H.:' 89C$/R+0"$X474RNC:&4@%;?4BLM?^EX47\;Y2)0;H@N&
MM2@6@M,,[_V14C2DB;C/6&Q9Y!BS@@NJAPP_VU92N MH43,09GU![A\P%N/C
M)&&JG.8*'DX]?[.(##MX!^GNBB968B^2"7P77.,UA$I7DY1#(W3<.=U.F\ZR
M^[Q5-S*2DNWY0M2Q<W2J-<I7U"/WW:QTHUQ%W!77R[4>$_MMGIDR&F2(6S^^
ME2_>9>2^6-'M-,D5#\$)L7]WMJ.6@]G3XH/6@NR2,PMJ%9:W KDJ"N*"1F.I
M,+W"*D;#99-.[7LN6H:I1]EFJG#T),< $9<UPT6HU?<QZ0DX<N##L&=1HB69
MPLZVY6#YPH1\"6I0$H_(\]FN;W.,0$PA._@WLEW0:$7P1.>YHSKPX3'-AJS
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MW;F$_\R5\/^XPV)P<G3\X63P=G!H!7T./3=7FV!A9A):.5:SE%T N/GV5C)
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MB.S&F%0[W85!#&B?/(I"(&;&J!E5CK-]41(!0<3452R2&*[!1*+5M>F,!.F
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M2.'2<.:Q,>.(I5#@*LA;5N?5MW5"W+2Z%G^&2<-H0RPR5!TJ)#IX^"5\@TO
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M.)8*$JQW6!U%9#&,8I5X?Q33K1.C248O%BA8@<A9D,6&U0;'^5)KL@B#:@*
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M6K7<*C;.S*W-UQ%]0I3T25'1YPQ%=I1WL8IJ.36G-E7D2"NI&SML9RQ^,:+
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M'MGRM$-FPL)G"CF F([,.V1+ 4+CU%7>D71;@#?<R.V>3JL3>@Q1LN% /Y4
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ME,YBV#A2G<>O^6T3[K=&#==S,* -=AJUTH3>1 PTKL_I,75T)G6;U00/ZTJ
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M!A?EKXI>.' "V-Y'1?FUA3#\A:[]IV\^'OU&#N2?+SZ\?_W_ 5!+ P04
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MS;DI1%<I+KZ^Z3R<@_.0)Q/$)MA?6910 >6G8_^#!\EHL_D8R5 VQL'3I[@
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MW]N8!)VZO>1-U>**:@-LW5[A@WR/J:L.6JS7#!M0M7+$,':17_YP+AO2S4"
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MJY!DH;F5DZV%XFN=.CJ&N8_6I2K3@8/.UW!S6=XEN>I0'FT10U)Y#9:5R26
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M02-O-+%K;$6R"?I^MEB(H=T_'DV0URWAJQ#SF=V0]?QW)D*S+7:^LB03'FZ
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M;+GNT!7/3U(6_3!PAVS8OC6,#%\W("MW/62F6WP1)E?"!Y:,0VA]9UV!Z@P
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M@I^2;L\RF#(C,09>YU@7OJ5K1R6U"(NETQIU0B4>!0\H24F9W73J>LVJW*X
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MJXG6!S<]R2<1&XXZ<^Y:E^O1JPNLNKD>J?/DD-/NN[!?]]],OFN["N3MG99
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M-4@"/*2M[.G=%$D5T\E3+'KJ3$ ^S-,RY^XH?Y&\-#U=G@0[,1S8AM_:2(C
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MW.$4M;D_@0>FV/<:46>+UU9S.FP %*V\MK2[66;&WC=6F8]WS'"F8."Q \C
MF@=C[#OQZ<R05G)0D-2A\(*&R1U/P!_=:R5#GP=4M5\^6U>U5[6JO0J1[*MO
M&LGZC,7FQ@DD5BOP&EF6X[" O9U?JZ(Y:MN "S=!;R[&Q:!VA5J\#N^@(:#5
M\PZ[J:<$]&:HM0M6$.P$?<LV%XLR%A9$Z[(84R:&9",KCC94M=J=D!?@I.)O
MIT4.]<(I/*"5U)W@V5>7^<7,)L52RCY7/D#8MM$$=$D]J9T;A8!LY[K1J>:I
MT6R?<9EXG&PZ+*9U8SY[FD.+)F<@*356W,7Z5GYYZ;N#;ECCRA9"6\:#-=.;
MO*QG>&;[SBZ3^?/IP-8C#@'D_@UP!5A9\UJB)"UP^^-G)8W]*EB'G[ZE=3@L
M)D]:RG=D'/KD3;6%,6%N2@*Z2*_Y82D$""ZHMBA%2Y^EL077J-;Z8Q>^,$X;
M2&R5LX!B0^U/%12=B:HKD5%$ RF>5>CY@GN,!B/C-+GP"[5J >,@O,9(U1-^
M$1EZ$*F,\^P& O+@"SK[[7FJGF2K.<E-B;HY-3>VXU2UT/X 02DZ@S%5;QO*
MFD8<VV/IS3>M1RP@(X2>-U2-;=KFOND"0R%M612_6+K >O%)W&O9H]#\4=)\
MDO[1!!%<P62(. M)8LUM.<OP'46]X1)7=11X>2F$FXE%'[OW5.O2<D'&Y@:)
M.Z.N)S50Q)FZF"W^RV9+\2C[K/P:> CX+$L.?,ZX(?[ZO#3O\N-&$#)B9,"_
MH]UQD590NAKU."A=E/_N&0%M6?_Q2R^S:U*85ZBS@62[V+9U(S$-$(:D>HNX
MH:Q5I"JVH\Q :&QD9S(_U(4+\_6;&^'::\;8SA^<C9UYRHI9)=*>F *2!F$)
MK3FA@V48^XNVM$%(5,PE&^>UM]=L'B&_>D][R12_2QG,573W'A+;/U_']NO8
MOMM[__E;>N_GG (_+HN!\\&JP&T'IC^%#+O]#;F P54VG#E#A.,^?YND=9W"
M[Q*IY38-W4Q2P^Y:4[Z/0;Y[3 =2!8HQ\-QH@.ZX+<I/A%F?YLSO06@/A(+Y
M)'V520F#[O/&9W)]!VA$S-+@/U':3_5IAMD%] 777DN(B1O@"W@@NE_  :6B
M>@4<# #==YY\Z0DGXPMKPH&H'W,4!(2Q#;(*%"1\$;X0MLRA.]WMV$.&C#+\
M=_^_9_D-H"_AU%>\NDZ%9U?CBSE/0 41G7/%94_T>;:&0K,S26[R8IS*(-[O
M'N_ C8_>[^S:-/-*&O!5V/&OORW2S2V@"=$WY2P;[G,L(K4;M)F%J:(VF/+K
M%MKXG&]$J1S('\8^!/P>G%WON5I_U@"EP!G+@+,FD/'VT0T%$Q@[;VFUV@3D
ME7#LC1"+Z4+CL?.X,MT;25D(?1)]P44=[L:&][0>D\!4H!B:)G@:BY^&GPI%
M3_%7VSU^<$H.W%X5DH*LXK!GRZ!>@ U1(&7!=#]_U4&(#(\>(@:?Q;V B!?T
MW2,F9NB:> X9-C<:;P"3O/H.'F?BDR7F'7H=EIMX_03/-Q;CICRR+7@I@.3E
M_+%_"\=04M76%C<;UY@+(4HR#QG9W!@7%7(TN0 +6T0HRO1HD1ZEQN&_!3*D
M0=L7?(;1SO#[BH-AP_CD,\QN&_UK-KRDK!;WEU0*P?;F&]X/'#2UN: 19W"'
M=%%.LKN*SYUD)+N&/@Y!)RJ"\,!]3!6M3YP9[!*K9@+*1$B^5=O&%8M]-' 0
M4![(UU/=1<'U!!C$R,)*(N'AGA$=[IF\06'RQA75&J+Z0D/:F-A++!REO0P+
M9]R%&29_0$15 .(%S!)5'+8>D\2(E*^=BY("M"_*-USC,!J)!Q^?8YH=YQQ.
M;D:(1GP18#NX']C*#C8+V?2F6@$02\  YR57DRT!LJ*@"L\1D/V-H4V!6"01
MJI7Z+*-_XS%M&.^U=OUJNP@H-I=EL*#>(%-OEHH4(,2*Q+:7AX*+&U-.FGHE
MZ*U]*71Q=8*J%BZQ8U$Z(;X-:#1I5[B4JT'R>P;",UW7HI0V\"/F9$:%1AP@
M&!FAJJC,8^2G1V4Z&_:2R])9*D"@.].4,=$&'-*CV3BYSBN^-]'GZ,HW_4H7
M93&#A@K9 &'VFL87HMIYM.0#\+1B9RE>I]'VM..Q=&T/+T.)26*B?<_I8SS?
MVB*19GL(-L-FG'<9@0&F9#<\ ;Q_(^:#D-7B=I(,K@I"Z,R5Q8R>X&FRTS)G
M7<.B8]4M%7?6PO*189")X60;+WKBD2N%>E$L7?0X4-MDIAJQ_7+BF%.2U4#E
MM7.&CC_8N7T%-%,W\W)!6Q@]U34W1N$D0[,L]LE*#PTNYW167Q6E\UL;Q6/[
MDH/V+R_5 )>$7JM,P,"I/0JY!QM,(.M\\1+@-E":-/2/]#7H(@CU-":!":R9
MCZNG:I#FKBV2J\8Z0J)MG!.MM,W(,R[/5D>1H-LP=<;54O-W7B6-(V$1]@=S
M>I4SX%5NB9/,T[2NH$F17%/? A20)YE(IM *1O<$GCM,.6*@P,I;X$31]FFS
M+@9*I+8BV;HS 2WUT6A &Q'R\T+%/"1 N2PXK(4BO D6$V2@3S9<9"$HL 41
M^"NNF?]I@W'AA@28[/BN;>,X%]>9;'8@Q6&DMGAI1P;T0TWH@SDSYU,-RWA=
MW)??!<V&=Y>' >1"4=77?EV)NT:;$!KFI%E1^J&I@YJMP^:&(4\(\RBANXH3
M/B+YLI26)C*&N8D:4]\H@19(4,[VD0:/5 <. Q<"8+$$W8U$=F#[W,GKFS%B
M50D,!/!!5KV!=J05:5U*4T' MU I]-H$& J)5"T$KUJG#8]\M$*U9!63, _)
MHK]89]'76?3NG-HOWS*G=N),:'GC\VDV!4L9M1TU<8;#)2J1(]08+L3M[<VC
MF;((,S3U_%'\)+'R:5<S$< X0T&3)D294S!M4VI%1H :)#\@CG>>(YP["YG#
MQ17@Y#L"[N'HBRN@*HHE[*'=[G[2HO\XEV$UKNEV*3JU7V6=D^[:/\^?/>H&
M6KAE#O*JENQF<[M8'Y&A(P(6*5IY*0$R@(1OL ;&=&TX1YWK(]I W6(6J@[%
M4/E"/.2\9GH'J**/[_#"&7=$N;WH_^!+\=2\T19\ HH!]P9<1<:66:%?V2[W
MW1,%1R(1XI_5Q"A@)@76<'I&S9O;_:@28@^X>?@*I;V+WF&#M GQ'?1N-12V
M[PE! T,2)_$IWKC= [JV<V+GF6BSB09I!"&A@'G>0\^=<,OV,^2[03^4Z?B6
MH!R)0289B!5 %1"R,N@A/OSF7NP869!I+>HZ&NJ+:)L=9$J2I0 _N]@"HKN6
M: RG#Y\*%^V ?7R-<NPS(:B03R2SL/#PXOLSGJE!X]^V6/'^R"*&@3ZK?T!&
MJ6H@ FW*D#@0>\C^*/=G486X<Y-02W>2>#,D ?Q2YBUC;X("<T/JF9;?%Y,1
MX;F9C=UCE,7$!3V&90C3:GB13NTMC&SI:9S-@].V@G+[8)RE)<%LW&%<,KJJ
MB>O:W+# KHL[H9,Q!>P1/]2B89C5M6@D+?U0G(YHF8?UF=QU)C__NF<RD*!,
MI$KG3F;JXEI9&MZ5>$6/RYV\N!='&4 V-_K$5'2:.ANVLB]II3A!OR%7,A!4
M<(NO(?$D2JV?7R&%GN&N8#<2Y7-Z7;W<Z LIRE290S0_3<3R@,I'!K BK(@A
MR1F%:7@I$IVEY)JA8W=>PQ0;)RSI CNU;3'B' !2I(>-K"+$O=%*)B\E//>/
MH?RBFCD_+O,5! "<&506UEW* EV&&8"H]=,%5JB#(N><3I#GKS7G!X4[]BJZ
M6.\#5.WID]=MS< 8JC)6P@4ODVSDW%7HM5K]3;MD?N[E.C^WJOFYE;+!WY"7
M>9X-_HEY#CN-<&NAS%E')#-".9KBVO0%80,L*\.P\34-CQ Z<8LG5C7%MBY-
M_7,ONXN"-K:E-<''AFMRI64;BI8WQ?B&#-T_W3TPDW@"\V1J04]-LVWGAYJ2
MOFE A*8%2/NHX;%%739 MD<]2HB_A2DEE\= **A85F('V@WH4L*(8,*1R@$Q
M;U2!+255*'(P#5(*K;YSL4AK/" _V"6F2">SZNMAY8Z&0OT8P.;;\UE*UK8K
M=7#,Q5DJ_TL^8%[;O K -$@GN;EQ0Z_?DBQAO(I?Q/'9K)?GT^P8OQ5+,M19
M;FU(_3D@6N+WX!9O_")P-E7:CU%_?B+,%-B'#Q_75+%(<P=RW$C/61770GU-
M>Y=YAI<9;+1H<%<IE50QH"0>?XU ")164<@>R3(H3G5\1PM'_X4X-R@3<@RM
MF.ZH1L]O@N5%#8UZL(N]AX3VH^+%K)Q(\6["M$8O].T0@Z"9  !^J!P1(H20
MK9JGQ?DV^.RD($XF1W9Y6C]Q0WS"(T8:1G=%WMO(>H6IV;@@25YE90CP<%O(
M^_-8)7K]U$8UYAD3*JVJF>^G3)X:46H,1/I8;'3-)B(-QH2/S:L*<D:O0:N.
M0RK@(8$5-(:Z< C7:3(WN_&PQDB#XK6UJ NE6;=@T-IX#(\L6D$7($?MW=Q*
MLYJI03&&9(J 25??D_S6KL?@V[D>BRF66J0_7QBP"54/8N98H(V_=I.ZK\M(
MH%C8IUYTG^1&3Z]YF95<2BN1[GE<DN*%Z9X^:1^?N2BFEG1MW*QQ2(#/'-"E
M^&8CBI+K8NC!.I[ZM@'OV?96!RT]G8*(-1?@,&/TX9\0E2>&? W[36]35 <N
MRM:;:AM)XG/M+=!=AA>CTP(T8>'# :M_.JX*':,(6=,EIXS%MMKS31C3>QCX
MV&T-':+TD_%.]$,U[<%0+1= )AKAS8U+*,S0(*+>ENA8)$H^)H >ZG7&*$,<
ML]9A7PP>_!D6@%H45VI8$2'.%"8&QN@>K(K[XAB:?DMH(7RF$@_**KJ&4%=0
M"@.$WCEUD@*&>#9MI?(0O6OH0:\$@8@>_$TAE<90[$OY!->6ILO2/"YY\4)+
ML^M>M7-:P-:8K@!81;LAW0)WB$9+M@)I$<+NLNK*O]S!%I3&N2](EYKMZHAH
M53Q3I6]Q4$Z5Q%"J%&4#$!* _.GN4AEV(<A@5A.9A*S92GC%@\:;TRMHE\?,
M.B(4#&(RKC^:6'2NU)/. XU"S6 ##=,EZD0^PX*FC?!J); &N,GP7(V2YXV5
M1WP8%5)P(AV]T2V**7.>_D:+E)5$>,U^B=5!:1H_)6RZ.N>#>90;$]+"W!S9
MZL>9F;B1 2#'R!!M*L<-SN$1KQ"H[;.(!/,CR5JQH9^ Q +5&TIH#*4-P!"'
M2^^V6]*VE1D>1*<"!3$JT%,FO5A^+Q8F?)-5VR)V<DBO/^J+#'Q;@K,T6B<G
M=R0<HBC;9M^6<NM#\UY:WH4YN.PO?!_C!13/1G_2TOT C2VEED($M'8<W=E^
MHT0#758'$-AZ-KF$9.]<1B#"I1N2BQ#!Z[,N7M+HZVUTI$=><CW[S$2@Y6F[
M!E"_C1W'SM0HNC#A))&Q[Z0"P6D<#(IRV*IO''=4C9ID\$O.;9?1^,)6-&$U
MH_:U:IJ$YM$@ 0@>_A3P]+ 5Z)[99<F3B/;HL]F3E(3H81Q$-NUGTGV?<7ZQ
M(>.#ZW">)>O);&+CC&BNJ5XW)S'3!&A]\B?.S7,/.N1.!7R(F^S*+9],\V8:
M30"":52,<P 6P;?*BG\(/R(=^.W$6^#^5QDC7]$':5X5%Y';O?2:$K6;85L%
M#G:8#;CGWS;9=HT473/*8/- /35PDR*,!MICZ\XVUE.-I!?N=[SLL3^&DA^M
MH8<G[N"GEWF/![RYP2.F-X4/U?'(W$:!@R:DGM\^,-RRS0BO9"3SD$+NC^M"
M[JH6<E<B,'U<+N+%@2DQ_FQN[&+)B)->YRHP":V&=QGRZC;T<A=5<(G7?PBA
M+^!=G7&!"U"W=E$Z3W!(?=])Y7R-FC@-,+T2TJ<TRCA+,<]'B1<AOH"^T'\5
M)6G0>>6^$#-LW7<9]>:&':L<1]*=IX?79>'BTE$*ME0J,0% _ET!C^W^L>>/
M\DZ ?2NFGL[G"$B[BM9Q);;3XY+W+LXH<QG6.9A D35T@6'E>RX@CH2W>J@:
M$JI+&P>6"QIMS'&.'C>*Q_H0=ZHWAPB$&TB;FP(!6 C;+GP!>8F[8U;<E^\Y
MGN4N[)X*L/BP&?)-.69%.2HP44WGZ*)!Y>7B87VTGJXFBP!P0*PW4/-UQS#X
MV\Y-RR>?GCA3<(G:$2WOI#%(XB/F?A/(_6=#]R,\X.4LQ5QUAF@0MA]W4[R>
M_QL).SB/_W]P6K;)RW47:KDYKA4[00]_66<-RWQ53#QBPT3-BU:=3WLSC>:]
M6BM:PDQ<O)"!Z1EZ:LII8$PIZLB!MG9WZ6%M!CO,X..R("XT@QZPN??KYL:[
M,30K?KISGA] /:MF$YIO_>#^"1;%,]=IC4]D@;4U^1C5%E85.U'RO&1/."B4
M,-RMO^F= +9ZOIT'L2QP)783@B[SMKWE6Y9\LY+QC81KQ?3\*&0C;&JR&YZQ
M$( K^4L("@5DY?X,=4PA;)DS)_@-9(0$A%Q<FJH#IX[E!%K30.ZF#&&15RN
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M&G G,U9;T&/7WKL,7M4"<6]*PC9XL8(W5C90PRWBI)U><2@,[.?1^MNYWTZ
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M)74-\ZYI8#@X._0O90XT[8V<U1&L)FMR'&*Y*(L(9PNOG<-[X+WU<ORKFC1
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M'FXTOU]F%XP TTX*5("!8'Q#T+F5O7,V!,4&J9RS)A=]EK2*X0 D3D%J?:7
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MZAPL3?R?+?12;]AMM%*^,QO3Z;Y(*PVO2JB39F(Y=J8.BV%[!<UTS7 [-GO
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MX"[#UU-$\_"\ $Z9*F>#<W*87UO.CA<1F-R)D#JA&EF+'GML!>MULEU3F<E
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MZTQD[)#)9R237^^%_DN-2E*CKY^@;85"7,L>K57D/;2KY"N('1^P2;&OY8B
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MVISB5SD]WWO^W<';HW]2E.N7L]>OGO]_4$L#!!0    ( &5BQ5;26K#Y T$
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MA]/5>\XS<(=43)<D*!GE>!YHES??9*$QM*?7MAHH#!\F5]*LHMV@&63TGHT
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M->.!M4\Q/'0IA_5(Y<8#DF1?Y"K:]X\)E,^"3X=-!-K0AIUA'S_Z&E#K;P]
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M+;RTEARR7Q)#\^Q"1BVLVY$7DE@4A$'?"NPR(@P&OA(1-D.Q7ND-)%=V9K1
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MV(YJVL]PL!H""GZPDX?4HR'8(Y&1%U@1S;FZ>48NK$9DA#XG*V>ID>;UM:_
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MFR;2G*SO^VA^VCG:^YV"(N_.WA^\^?]02P,$%     @ 96+%5G8NMX/Q#
M.3<  !4   !T;3(S,3<W.#9D,5]E>#4M,2YH=&WM6VMOVS@6_6[ _X$;[!89
M0$[L.&EVDDR O-K)(M,&M7>+^;2@)=IF*XL:4HKC^?5[+DG)LBPGZ3:=%#M;
MH$DL\7%Y7^<^Z).?A[_<G+9;)S]?G5WB-Z-_)\/KX<W5Z<FN^XVWN_[UR?G[
MRU_98/CKS=5/6V.59$>LUTTS-I0S8=@[,6<?U(PG@7L0L('0<KR%B9AZ6\S+
MQ'W6X;&<)$=,R\DT.V8SKB<2'[M;IR?GIU?W4SF2&3O8Z9WLGH..V]H*3]VY
MLC"&TN+7O[QE@P\7(&*VU^\='O[]==3[M[@_Z/3D;-+M]G8^I9,M=G8S_&GK
MK>;I5(9;Q:930;1BVX/#]/Z8S66438]8?_]U>K_UG#2^2D8F/7[&!?^1)X(=
M!&RON]?_GND\5UQ'3(W9I=0BS)0VS[AXO]L[9.<JCF4R81_Y@KV["MB;6&$7
MUF,\B=A>\(S;G64Q3S(>L+="X07^Z'?[70CAGX.S[UD&0\6RJ6#KHCCZ?JD^
M9E6/\BDWF1PO_$.91((6[>X<R&3K]*-@7.-_F)$:<,-"E2=&Q.U6IMB0#3(^
M2]EU$NX$C+-+$?,Y#0^53I7FF50)VR;VO(JCWW)U#%=U<GUZH68I3Q8GN]>G
MY*U>:?ONAX#)!#.3!/RCB7.932UOI3$Y3T)AE<[P6!"?M^4/[+#_.MCO=MLM
M,\6NIF&K@7U1WXGFTU!/R"MMZ+%A%S$WAIW1\QD(&&0J_!RPE&MVQ^-<L+]V
M=[H]E@K-[(9-1Z,5VJW5)=8/NBU!?:I%9YR#W1$#TS2TO^D$MQCUQHWZZ$>M
M'0>B2',=3KD1+$_IX\%^/^@_R)GU==EF9C4QAK8DN62T'RW_04RDR;S4H1B9
MF$&3F$K:K3=*S]B@TV?;;R3$]T[ML'Z_W]D[['5_[($?8SR-E@(?B##7,I,@
MG$1^=8^C)1,KKQF4H5FK!E<7:Z33^71M24@GS.A0O1_[_8!4FH-.XL/ZFABY
M+CSL?I9J&;.^0XB&><VLJ"_5;M'IYH#,*1N)$&0P,1Z3]M^)Y2Z]/;=-8,^A
M86(9:!V1K%.M3(KQ.>P\LH\?(^R<IMV6T]8.YTBB:<NUF<G3-+8G*+:Q -G;
MN,MR S8HY];VLI+-U$1@MEZ*OD8@"'I@]779U!7IZF)%33_DT+[]O?WM454W
M(.4=]K/00L)MSHG'8WKCM-H9!>AH,,3 'F*C)9%NK:MIJ8@%]3N>_)=P[R\'
M+-=-OEX:IE*92/(9L<@RH:U IAP&(>[Y3"8B>L#7.!.I:$_=F]P67O)LHH5S
M3T]3:#\/OJ.8N.9K1@NK#2.1S85(JOC"2IORRVC"E&Q!S[2 GFW>4*^K.,:V
M6V-RJ/!AC4I)JQ4^C;:&*F;VE*'0$(@,\8$FRZ2*TZN86'6,;L71 N!NZL.<
MPS Y7)BREARI,"?^8*3&SM@A,@QB%L9PO2"(5[EFH$C.W+XXOQ;6%GE22'\'
M(84;9X5N!RXU 5B$+1Q+8S'A,0MYRD.9+=HMD,?CF&%*KO$"6&U4XGDR$4D.
M#4I "O/C#!25AHJ";3E^)IFDQ8HQRQ.9?#23&7$21.?6OA7R,1 8^_E0:1*-
M)05CBK=5KCQA42\G/ (/TZG*% E0AE@^+4"QB5IZ5A)$#T@N[9:;M?-'V/H+
MAZI6/<:YMIJX5!.>.1BI>(*YA!!&+K;T9F)4')%^TDB0E5"8Y^S&/]P0X!32
MJ/H=>F:CV5D:2QN[DH=S5' @(FQP%%N0O9,4SY1V1;%)L: &6AEOP9,\MON6
M PG:K/_(O>VX.69Y1.C.B*)6\WG!"M.]XUJJ'#&0/=E2D^!I9^X3-#B2*SNM
M.\V=/Q=444P244#F7-WH$X3LPP/KB<5$V>3(\]+YP5C"JIW( O9;CGVLX[6,
MI9%6.U/WV8B,81U X'09A5""4=BT\XI6DY\OK?SO>3\\.[^Y8A=7-S>#V[.+
MZW=O?]KJ;MG/MV>7E\7G+Z;.%XAZW>[?MFQE[63XH5CECEQBR.."W$RE6[[Z
M=C*\+$;Y%?;VJ<)4$#V\?&3@R9OW[X95<CMCH$Z\.'J,8#O6R-^%.]_6:0^6
M08N=-N_:Z#"?;_?AJHNSSG"$6,31$>7QPB(&$.)WZ#,4;IE9CQ955%\Y!7Y\
M^#)I-'+^07$\B"3/2,/S\7KOY27M$A/DCX@VK7"UQ2=XD,C1HQQLC93Z7#IS
MP%=B*+WADP*[M(<U7>!<0IDHO<$"(S'E\;@.!0YO[,YU %W5)$<(O8Q$C+16
MT] )EXG)$ ,O+'Y:%+/:" \;4L!8 F8%FS:"45!B^1T8'H$/CB0D@WF,3RF7
MT9*,1"4=N%Z*1@' 38J.7^3>:CZV4F_?!$35DGSQ\B^=#GLC11P=L5MP_!@2
M_2T7.!XDR3J=0G$NK_^UNDH'VHPA>VE9ZN^,5):IV1%[3<]&X)+0Y;/SF(>?
M60\N%C*0$0AH[!V$8)?0:_I4;F$W[3;L:95N>>Z371#<0/M("_ZY,R)A8NG4
M'KBZ].N&I>F,57HK$+5QRPI7=XFMCI-/$]?_L6N#3^F_N$=K2F8='4_P--_8
MR3@Z;)[;0.:J"W)U (10%!6J$7BV&KJ7*;:@9#$4-A4H"*X>:9U61P;&2.U(
M_C]4/ZI:^]^A8CLJ'H+P;X#>4UB-T*:.W4T87;.M/,5BXE[H4!JW>&%7?NE*
M3EL.2[4,RQ2FL5!5 VY'R#IZ/Q&X(=42NK\Z.7(_*?MY2IK4Z>[LO7"2^G&M
M.,81&A65CPQ[%*(H@O[ ]=(J@E]LEI;7U2/;=RMJ3Y1)^"(>N5=,KNF-%7"B
M,DM:NT7)")NIJ*QM8<50NA*CSYZU6)W$5(B$QGITK.?[0-#TF,\9=\T2.%G:
MTRJ1+*JJ"JRT7;9-Q=!VZZ%JZ&KY<]5OEXE^<T64"0Z0H"H>T9UDL?7CKK$3
MU [GLK,J1ZJDEC6JQ!H#LV!AW[C57 \%IW3'+%B'&1Q(-<;1))EHDL]&<!E4
M#G1MB0T-O7:KDAWZ,P* [KB,K6&O)(S+[LD7%)5]0R19,N1/5DEZG^NBF&-L
M@<=7DVRQ>,23SSI/LW!!G7"$.'=(%/"WI@L1//&F%L" P%R(*9_!26J> SA(
MS*%*[L3"&7;E\1(R"!)L:<I(0!D PVJO;2A:&U+M%BE@:50AK$[230;?'W=7
MCPR5T87FY)Q="Z]XP)#:R,S7-:$&,J7RY38 BNLH]D5WX(ZE =0:&5FLH2B'
M*J&A$!0QM5ND';34PAI$1G3:RP%AG-N0"G-#D;I:>@@%)KS!]D@^C$IH?ZKP
M!VRB5,3&G"(\(A1_:3@Z'E=K=:DR1A+%>>(57<:NF-YN43&7%)N:"%34MWIO
M(\A/>>*:M&">%.-OK,0OBBK$/?B,U)<\K6^C.%7;[H73F+*79ANGVG4RJ-&C
MG<+-*1H J\1=Y;9 :0;UXB?;IDT($%9;8M?EK@U=ZUIK*"AVP9$<84_</+"X
M:4'.'M7WZ92+_)<D8,38NG%>:S7] %K@Y6PPY\W6.7;2((MSKB<<4GHQXPMX
M:X=]V)7Z0DM*K4"Q%C3?K,!!4>80]PC\"F4&WZR^ ]P29T5+#UV@E(3)?,JU
M-)$,"^]<=2T%F4L$_ )*IQR'F_(*J0[S+7)9SQ' VN;>$7FD<;Q%Q!CF&5;W
M88@+,)W16:*K.90[5DT<'NOK0B)R',36BI]!L6>T'O=6Y>[ZLU6<K6_Q=+'Q
M=LM*+BA30XOD*RE@84AD.>69FR6AQD$CJ;:EY)NV(&Y.,SXC*U"5C@.Y6*/&
MG'ID[D3+=_Z&B2E,I1KTX$3B/H4[,.!FJ$J6J2JLU4WJ3P;Q_L*<90=D['T:
M-Q;BK4NR %ND=V4[B6":A[Y.D,1E*%X-,6W/T5XR]!?MG$'.12$6$G/1+)K7
M7'<U3;,@9S,#4IJ ]*U"F@N@DZ!. JF!BR"J7J2*S&,1V4@ ,_Z0=O/W)OQW
M2_9+<CW$$W>Y@1(.8NMHT2@8N!,?IG#*=SC%?4J[_K'(RBL+#UU]J;:?"94A
M+(3AU>SLN[+$Q@6^CIQU2RRN E"T*9;PGQN?#%?O&UGH@B&YF_0/WVGT@:^[
MD(>8ARKZ]( <X5@"M2KI$7=NU<<R-_:^RB^<[C:9XBJ<K]PL);C3;ET#T.4=
M*9!UT/X$MC,<*9=!.G7BT8SH]<Z>:U<H]$M25C91+K'W=V$0@BLC2I9(2@$0
M;9,K=U0/_)VL0QL%U^Y-V+N3NG(]P6;Q:[<3*C<UEY<4=O[ (GS9(@E5'//4
MB"-6_/5H?=ZU)C:7Z ^HQO_,M[KM3E^_Y*_00$/>)%X$S[IPM1/S0%/"LN8+
MJ\$;V?WT)M=7?+WE=-?LL@NMYM'%5&#]&SX/&/30)1GUXW[UV1XMN'\5Q]:J
MS\]7QSX;[+X]:RRD-U/_?*78;_"EC:?T9_>.V7MW/^<(2F&R_Y%V[>.]T^<2
MTRY]]<U]%XZ^,O<?4$L! A0#%     @ 96+%5E!](JL\ P  ^ L  !$
M         ( !     &ED86DM,C R,S V,#$N>'-D4$L! A0#%     @ 96+%
M5CT7:RG_"@  ;(<  !4              ( !:P,  &ED86DM,C R,S V,#%?
M;&%B+GAM;%!+ 0(4 Q0    ( &5BQ5;$B7C^5@<  ,-8   5
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8=&U02P4&      H "@"9 @  OK4!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
